"Molecule ChEMBL ID"	"Molecule Name"	"Molecule Max Phase"	"Molecular Weight"	"#RO5 Violations"	"AlogP"	"Compound Key"	"Smiles"	"Standard Type"	"Standard Relation"	"Standard Value"	"Standard Units"	"pChEMBL Value"	"Data Validity Comment"	"Comment"	"Uo Units"	"Ligand Efficiency BEI"	"Ligand Efficiency LE"	"Ligand Efficiency LLE"	"Ligand Efficiency SEI"	"Potential Duplicate"	"Assay ChEMBL ID"	"Assay Description"	"Assay Type"	"BAO Format ID"	"BAO Label"	"Assay Organism"	"Assay Tissue ChEMBL ID"	"Assay Tissue Name"	"Assay Cell Type"	"Assay Subcellular Fraction"	"Assay Parameters"	"Assay Variant Accession"	"Assay Variant Mutation"	"Target ChEMBL ID"	"Target Name"	"Target Organism"	"Target Type"	"Document ChEMBL ID"	"Source ID"	"Source Description"	"Document Journal"	"Document Year"	"Cell ChEMBL ID"	"Properties"	"Action Type"	"Standard Text Value"
"CHEMBL3668385"	""	"None"	"402.47"	"0"	"4.76"	"BDBM167626"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(Cc4cccnc4)C3)cc12"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311408"	"UO_0000065"	"19.51"	"0.36"	"3.09"	"14.53"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4649135"	""	"None"	"456.50"	"0"	"3.35"	"58"	"CCn1cnc2c(NCc3nc4ccc(F)c(F)c4[nH]3)nc(N3CCCC[C@H]3CCO)nc21"	"IC50"	"'='"	"1090.0"	"nM"	"5.96"	""	""	"UO_0000065"	"13.06"	"0.25"	"2.61"	"5.53"	"0"	"CHEMBL4613415"	"Inhibition of CDK9 (unknown origin) in presence of high ATP"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4613207"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4455718"	""	"None"	"394.48"	"0"	"2.61"	"4"	"COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1"	"IC50"	"'='"	"370.0"	"nM"	"6.43"	""	""	"UO_0000065"	"16.30"	"0.30"	"3.82"	"6.81"	"0"	"CHEMBL4323546"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4321825"	"1"	"Scientific Literature"	"J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4062803"	""	"None"	"320.36"	"0"	"3.73"	"19"	"Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4007695"	"Inhibition of CDK9 (unknown origin) after 60 mins by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4007384"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2016"	"None"	""	""	""
"CHEMBL189963"	"PALBOCICLIB"	"4.0"	"447.54"	"0"	"2.97"	"SGCV1170, PD0332991"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'='"	"794.33"	"nM"	"6.10"	""	""	"UO_0000065"	"13.63"	"0.25"	"3.13"	"5.81"	"0"	"CHEMBL2422672"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2417410"	"1"	"Scientific Literature"	"J Med Chem"	"2013"	"None"	""	""	""
"CHEMBL3673434"	""	"None"	"385.44"	"0"	"3.53"	"BDBM164883"	"COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"308356"	"UO_0000065"	"22.11"	"0.42"	"4.99"	"10.61"	"0"	"CHEMBL3707939"	"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638701"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327496"	"UO_0000065"	"19.62"	"0.39"	"4.16"	"8.77"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3589663"	""	"None"	"292.29"	"0"	"3.58"	"5k"	"COc1cccc2c1[nH]c1c3ccccc3nc(C(=O)O)c21"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	""	"UO_0000065"	"23.68"	"0.43"	"3.34"	"9.20"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589667"	""	"None"	"418.19"	"0"	"4.18"	"5o"	"COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(I)c3[nH]c21"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL451570"	""	"None"	"275.29"	"0"	"1.24"	"R-89"	"Nc1nccc(-c2cc3c([nH]2)[C@H](CCF)CNC3=O)n1"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	""	"UO_0000065"	"25.49"	"0.48"	"5.78"	"7.26"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL4439395"	""	"None"	"331.42"	"0"	"4.53"	"24"	"O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CCC2)[nH]n1"	"IC50"	"'='"	"911.0"	"nM"	"6.04"	""	""	"UO_0000065"	"18.23"	"0.33"	"1.51"	"10.45"	"0"	"CHEMBL4326799"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4325851"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2018"	"None"	""	""	""
"CHEMBL4741061"	""	"None"	"401.51"	"0"	"4.78"	"18"	"Cc1cccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)c1"	"IC50"	"'='"	"195.8"	"nM"	"6.71"	""	""	"UO_0000065"	"16.71"	"0.31"	"1.93"	"10.93"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4755696"	""	"None"	"402.50"	"0"	"4.05"	"21"	"CC(C)N1c2cc(Nc3nccc(-c4cccc(N)c4)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"5.9"	"nM"	"8.23"	""	""	"UO_0000065"	"20.45"	"0.37"	"4.18"	"9.42"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4798690"	""	"None"	"470.62"	"1"	"5.82"	"28"	"CC(C)N1c2cc(Nc3nccc(-c4cccc(NC5CCCC5)c4)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"121.9"	"nM"	"6.91"	""	""	"UO_0000065"	"14.69"	"0.27"	"1.09"	"9.42"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4742169"	""	"None"	"438.54"	"1"	"5.02"	"40"	"CC(C)N1c2cc(Nc3nccc(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"22.4"	"nM"	"7.65"	""	""	"UO_0000065"	"17.44"	"0.32"	"2.63"	"10.30"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4763994"	""	"None"	"457.56"	"0"	"3.58"	"THZ-CE-B-20"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(C(=O)OC(C)(C)C)CC3)s2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL3902691"	""	"None"	"462.53"	"0"	"3.20"	"BDBM60462"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CCC(C3)N4C(=O)CN3CC(O)C3)cc12"	"IC50"	"'='"	"131.0"	"nM"	"6.88"	""	"218819"	"UO_0000065"	"14.88"	"0.28"	"3.68"	"8.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL454646"	""	"None"	"394.57"	"0"	"3.91"	"9"	"CC1CNCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	""	"UO_0000065"	"16.65"	"0.35"	"2.66"	"8.21"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL4462530"	"AZD-4573"	"2.0"	"429.95"	"0"	"3.81"	"24"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678812"	"Reversible inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues preincubated for 6 hrs followed by compound washout and measured after 2 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL3655770"	""	"None"	"369.47"	"0"	"2.99"	"BDBM106958"	"CC[C@H](Nc1nc(NCc2ccncc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"610.0"	"nM"	"6.21"	""	"226146"	"UO_0000065"	"16.82"	"0.31"	"3.22"	"6.17"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3663763"	""	"None"	"323.40"	"0"	"2.68"	"BDBM167537"	"COc1ccc(N)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"6600.0"	"nM"	"5.18"	""	"311319"	"UO_0000065"	"16.02"	"0.29"	"2.50"	"5.83"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663792"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167567"	"Clc1cnc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311349"	"UO_0000065"	"18.79"	"0.36"	"2.49"	"11.97"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4870276"	""	"None"	"464.54"	"0"	"4.02"	"23"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"14.98"	"0.28"	"2.94"	"8.52"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668374"	""	"None"	"381.41"	"0"	"2.99"	"3"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)CO)CC3)cc12"	"IC50"	"'='"	"72.0"	"nM"	"7.14"	""	""	"UO_0000065"	"18.73"	"0.35"	"4.15"	"9.10"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3668485"	""	"None"	"380.42"	"0"	"3.81"	"4"	"CNC(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"18.29"	"0.34"	"3.15"	"9.91"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL296468"	"BMS-387032"	"1.0"	"380.54"	"0"	"3.66"	"SNS-032"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"22.07"	"0.46"	"4.74"	"10.49"	"0"	"CHEMBL4271327"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4270504"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL4286578"	""	"None"	"387.44"	"0"	"3.61"	"Atuvecicilib"	"COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1"	"IC50"	"'='"	"385.0"	"nM"	"6.42"	""	""	"UO_0000065"	"16.56"	"0.32"	"2.80"	"6.36"	"0"	"CHEMBL4271327"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4270504"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL526092"	""	"None"	"257.30"	"0"	"1.29"	"86-1"	"CCC1CNC(=O)c2cc(-c3ccnc(N)n3)[nH]c21"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	""	"UO_0000065"	"30.20"	"0.56"	"6.48"	"8.04"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"1"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL4348721"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346699"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL3933205"	""	"None"	"401.51"	"0"	"3.36"	"BDBM223940"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccccc2-4)CC1"	"IC50"	"'='"	"115.0"	"nM"	"6.94"	""	"391042"	"UO_0000065"	"17.28"	"0.32"	"3.58"	"12.51"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3982885"	""	"None"	"460.55"	"1"	"5.05"	"BDBM223959"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"391061"	"UO_0000065"	"15.63"	"0.29"	"2.15"	"9.94"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327473"	"UO_0000065"	"19.65"	"0.39"	"3.81"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327497"	"UO_0000065"	"19.33"	"0.38"	"4.04"	"8.64"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327498"	"UO_0000065"	"19.33"	"0.38"	"4.04"	"8.64"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327516"	"UO_0000065"	"18.18"	"0.36"	"3.13"	"9.27"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3972796"	""	"None"	"470.53"	"0"	"4.72"	"BDBM180849"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCC4)n2)c1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327517"	"UO_0000065"	"17.10"	"0.33"	"3.33"	"7.83"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3967588"	""	"None"	"463.90"	"0"	"4.91"	"BDBM180851"	"COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327519"	"UO_0000065"	"18.10"	"0.37"	"3.49"	"8.38"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"248.0"	"nM"	"6.61"	""	"327591"	"UO_0000065"	"16.33"	"0.32"	"2.26"	"7.51"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	"327611"	"UO_0000065"	"16.77"	"0.33"	"2.28"	"7.98"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3973367"	""	"None"	"465.43"	"0"	"4.53"	"BDBM180819"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327613"	"UO_0000065"	"18.31"	"0.36"	"3.99"	"8.50"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327622"	"UO_0000065"	"19.11"	"0.38"	"3.94"	"8.54"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4790868"	""	"None"	"371.47"	"0"	"2.27"	"THZ-CE-B-18"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(C)CC3)s2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4752238"	""	"None"	"580.70"	"2"	"7.67"	"MFH-3-192-1"	"C=CC(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c(C(F)(F)F)c1"	"IC50"	"'='"	"298.0"	"nM"	"6.53"	""	""	"UO_0000065"	"11.24"	"0.23"	"-1.14"	"7.31"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"27"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"0"	"CHEMBL3856518"	"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated Histone H1 as substrate after 1 hr in presence of 33P-ATP by liquid scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3856187"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"CHEMBL3308860"	""	""	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"Alvocidib"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL4271327"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4270504"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL4754081"	""	"None"	"413.50"	"0"	"3.30"	"23"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678812"	"Reversible inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues preincubated for 6 hrs followed by compound washout and measured after 2 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL4872494"	""	"None"	"395.43"	"0"	"3.99"	"9"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(NCC(=O)O)CC3)cc12"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	""	"UO_0000065"	"18.21"	"0.34"	"3.21"	"8.25"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668508"	""	"None"	"437.52"	"1"	"5.01"	"10"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N[C@@H](C(=O)O)C(C)C)CC3)cc12"	"IC50"	"'='"	"91.0"	"nM"	"7.04"	""	""	"UO_0000065"	"16.09"	"0.30"	"2.03"	"8.07"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668553"	""	"None"	"463.55"	"1"	"5.50"	"13"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	""	"UO_0000065"	"15.31"	"0.29"	"1.60"	"9.05"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4851229"	""	"None"	"467.52"	"1"	"5.25"	"15"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"81.0"	"nM"	"7.09"	""	""	"UO_0000065"	"15.17"	"0.28"	"1.84"	"9.04"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL393525"	""	"None"	"452.29"	"0"	"2.97"	"53"	"Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)/N=C/c1cnc2ccc(Br)cn12"	"IC50"	"'='"	"1.4"	"nM"	"8.85"	""	""	"UO_0000065"	"19.58"	"0.45"	"5.88"	"8.04"	"0"	"CHEMBL3856509"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3856187"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3949057"	""	"None"	"484.55"	"1"	"5.11"	"BDBM180800"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"327468"	"UO_0000065"	"16.21"	"0.32"	"2.74"	"7.64"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327484"	"UO_0000065"	"19.84"	"0.39"	"3.56"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668386"	""	"None"	"402.47"	"0"	"4.76"	"BDBM167627"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(Cc4ccncc4)C3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311409"	"UO_0000065"	"18.98"	"0.35"	"2.88"	"14.13"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673546"	""	"None"	"425.49"	"0"	"4.90"	"BDBM167864"	"O=C(O)C1CC=C(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311645"	"UO_0000065"	"18.04"	"0.33"	"2.78"	"7.40"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3974193"	""	"None"	"425.58"	"1"	"5.48"	"BDBM60454"	"CN1CCC(c2cc3c(-c4cccc(NCCCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"217631"	"UO_0000065"	"17.52"	"0.32"	"1.98"	"13.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3694404"	""	"None"	"412.47"	"0"	"3.08"	"BDBM120939"	"COc1ccccc1-c1cc(NC(=O)c2ccc(C)c(NS(C)(=O)=O)c2)ncn1"	"IC50"	"'='"	"0.116"	"nM"	"9.94"	""	"249038"	"UO_0000065"	"24.09"	"0.47"	"6.86"	"9.01"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3655777"	""	"None"	"423.44"	"0"	"3.53"	"BDBM106965"	"CCC(Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)C(O)C(F)(F)F"	"IC50"	"'='"	"2140.0"	"nM"	"5.67"	""	"226153"	"UO_0000065"	"13.39"	"0.26"	"2.14"	"5.63"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL4115908"	""	"None"	"None"	"None"	"None"	"BDBM180855"	""	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327522"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4453878"	""	"None"	"435.44"	"0"	"4.14"	"3"	"COC(=O)Nc1nc2cc(Sc3nnc4ccc(-c5ccc(F)cc5)nn34)ccc2[nH]1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4426791"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4425133"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL210540"	""	"None"	"480.64"	"0"	"3.90"	"4"	"Cc1cc(-c2cnc(Nc3cnc(CN4CCN(C)CC4)cn3)s2)nc(OC2CCCCC2)n1"	"IC50"	"'='"	"2500.0"	"nM"	"5.60"	""	""	"UO_0000065"	"11.66"	"0.23"	"1.70"	"6.08"	"0"	"CHEMBL870945"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1137419"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2006"	"None"	""	""	""
"CHEMBL427045"	""	"None"	"367.48"	"0"	"4.76"	"3"	"Cc1cc(-c2cnc(Nc3ccccn3)s2)nc(OC2CCCCC2)n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL870945"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1137419"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2006"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"Dinaciclib"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4348725"	"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated peptide as substrate after 1 hr in presence of [33P]ATP by TopCount scintillation counting method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346699"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"CHEMBL3308860"	""	""	""
"CHEMBL4066664"	""	"None"	"348.29"	"0"	"3.82"	"8"	"FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4007695"	"Inhibition of CDK9 (unknown origin) after 60 mins by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4007384"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2016"	"None"	""	""	""
"CHEMBL3343039"	""	"None"	"443.46"	"0"	"3.50"	"7c"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(N)=O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327515"	"UO_0000065"	"17.94"	"0.35"	"3.03"	"9.15"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327607"	"UO_0000065"	"18.99"	"0.37"	"3.90"	"8.13"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3953160"	""	"None"	"443.48"	"0"	"4.56"	"BDBM180853"	"COc1cc(F)ccc1-c1nc(Nc2cc(C)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327647"	"UO_0000065"	"19.62"	"0.38"	"4.14"	"8.68"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663771"	""	"None"	"335.45"	"0"	"4.36"	"BDBM167546"	"COc1ccc(C)cc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"311328"	"UO_0000065"	"20.63"	"0.38"	"2.56"	"16.82"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663744"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167518"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"311300"	"UO_0000065"	"23.53"	"0.44"	"3.82"	"15.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663803"	""	"None"	"325.39"	"0"	"3.80"	"BDBM167578"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C)C3)cc12"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"311360"	"UO_0000065"	"23.53"	"0.44"	"3.86"	"18.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663804"	""	"None"	"403.92"	"0"	"4.97"	"BDBM167579"	"Clc1ccc(NCc2ccccc2)nc1-c1ccnc2[nH]c(C3CCNC3)cc12"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311361"	"UO_0000065"	"18.82"	"0.36"	"2.63"	"11.58"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663805"	""	"None"	"411.94"	"0"	"4.19"	"BDBM167580"	"Clc1ccc(NCC2CCOCC2)nc1-c1ccnc2[nH]c(C3CCNC3)cc12"	"IC50"	"'='"	"200.0"	"nM"	"6.70"	""	"311362"	"UO_0000065"	"16.26"	"0.32"	"2.51"	"8.95"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668355"	""	"None"	"425.96"	"0"	"4.58"	"BDBM167596"	"Clc1cnc2[nH]c(C3CCCNC3)cc2c1-c1cccc(NCC2CCOCC2)n1"	"IC50"	"'='"	"640.0"	"nM"	"6.19"	""	"311378"	"UO_0000065"	"14.54"	"0.28"	"1.61"	"8.27"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668361"	""	"None"	"323.37"	"0"	"3.75"	"BDBM167602"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCNCC3)cc12"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"311384"	"UO_0000065"	"24.74"	"0.46"	"4.25"	"16.02"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668384"	""	"None"	"402.47"	"0"	"4.76"	"BDBM167625"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(Cc4ccccn4)C3)cc12"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"311407"	"UO_0000065"	"18.44"	"0.34"	"2.66"	"13.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663772"	""	"None"	"322.41"	"0"	"3.44"	"BDBM167547"	"COc1ccncc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"2600.0"	"nM"	"5.58"	""	"311329"	"UO_0000065"	"17.32"	"0.32"	"2.15"	"10.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663781"	""	"None"	"418.93"	"0"	"4.75"	"BDBM167556"	"Clc1ccc(NCc2ccncc2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311338"	"UO_0000065"	"18.15"	"0.35"	"2.85"	"9.68"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668481"	""	"None"	"401.49"	"0"	"4.84"	"BDBM167724"	"Fc1cnc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"18.0"	"nM"	"7.75"	""	"311505"	"UO_0000065"	"19.29"	"0.35"	"2.90"	"11.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327606"	"UO_0000065"	"18.85"	"0.37"	"3.85"	"8.08"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL508506"	""	"None"	"394.57"	"0"	"4.05"	"7"	"CC1NCCCC1C(=O)Nc1ncc(SCc2ncc(C(C)(C)C)o2)s1"	"IC50"	"'='"	"1600.0"	"nM"	"5.80"	""	""	"UO_0000065"	"14.69"	"0.30"	"1.75"	"7.24"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL4206957"	""	"None"	"539.63"	"2"	"5.02"	"20b"	"CN1CCN(CCCCOc2c(OCc3ccc(C#N)cc3)cc(O)c3c(=O)cc(-c4ccccc4)oc23)CC1"	"IC50"	"'='"	"870.0"	"nM"	"6.06"	""	""	"UO_0000065"	"11.23"	"0.21"	"1.04"	"6.11"	"0"	"CHEMBL4194446"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4190366"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL3668375"	""	"None"	"433.51"	"1"	"5.32"	"BDBM167616"	"CN1CCC(c2cc3c(-c4cccc(NCc5c(F)cccc5F)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"311398"	"UO_0000065"	"18.27"	"0.34"	"2.60"	"13.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668391"	""	"None"	"424.52"	"0"	"3.50"	"BDBM167632"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CCN4CCOCC4)C3)cc12"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	"311414"	"UO_0000065"	"17.35"	"0.32"	"3.87"	"13.74"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668396"	""	"None"	"354.43"	"0"	"3.13"	"BDBM167637"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CCN)C3)cc12"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	"311419"	"UO_0000065"	"20.90"	"0.39"	"4.28"	"11.03"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668407"	""	"None"	"367.42"	"0"	"4.10"	"BDBM167648"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311430"	"UO_0000065"	"20.02"	"0.37"	"3.26"	"12.64"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668412"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167653"	"Clc1ccccc1CNc1cccc(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	"311435"	"UO_0000065"	"18.42"	"0.35"	"2.34"	"11.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668420"	""	"None"	"399.47"	"0"	"2.91"	"BDBM167662"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(O)CO)CC3)cc12"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311444"	"UO_0000065"	"19.22"	"0.36"	"4.77"	"9.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668442"	""	"None"	"410.49"	"0"	"3.11"	"BDBM167684"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(CCN4CCOCC4)C3)cc12"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"311466"	"UO_0000065"	"17.16"	"0.32"	"3.94"	"13.14"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668540"	""	"None"	"435.50"	"0"	"3.52"	"BDBM167784"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"311565"	"UO_0000065"	"16.18"	"0.30"	"3.53"	"8.26"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668543"	""	"None"	"459.53"	"0"	"3.67"	"BDBM167787"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CC4CN(CC(=O)N(C)C)CC4C3)cc12"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	"311568"	"UO_0000065"	"15.38"	"0.28"	"3.40"	"8.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663756"	""	"None"	"413.53"	"0"	"4.71"	"BDBM167530"	"COc1ccc(NCc2ccccc2)nc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"490.0"	"nM"	"6.31"	""	"311312"	"UO_0000065"	"15.26"	"0.28"	"1.60"	"8.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668528"	""	"None"	"427.50"	"0"	"3.67"	"BDBM167772"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=C[C@H]4CN(S(C)(=O)=O)C[C@H]4C3)cc12"	"IC50"	"'='"	"91.0"	"nM"	"7.04"	""	"311553"	"UO_0000065"	"16.47"	"0.32"	"3.37"	"9.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327493"	"UO_0000065"	"17.63"	"0.40"	"3.41"	"9.69"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"95.0"	"nM"	"7.02"	""	"327600"	"UO_0000065"	"17.36"	"0.34"	"2.67"	"7.98"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327593"	"UO_0000065"	"16.97"	"0.33"	"2.23"	"9.27"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663790"	""	"None"	"466.99"	"1"	"5.15"	"BDBM167565"	"O=S(=O)(Nc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)c1)c1ccccc1"	"IC50"	"'='"	"570.0"	"nM"	"6.24"	""	"311347"	"UO_0000065"	"13.37"	"0.27"	"1.09"	"7.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668409"	""	"None"	"332.41"	"0"	"3.58"	"BDBM167650"	"COc1cc(C#N)ccc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	"311432"	"UO_0000065"	"22.29"	"0.40"	"3.83"	"10.05"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3961156"	""	"None"	"460.55"	"1"	"5.05"	"BDBM223961"	"CN1Cc2c(C3=CCN([C@H]4CC[C@@H](C(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	"391063"	"UO_0000065"	"15.41"	"0.29"	"2.05"	"9.79"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3668469"	""	"None"	"416.96"	"1"	"5.96"	"BDBM167712"	"Clc1ccc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"311493"	"UO_0000065"	"18.08"	"0.34"	"1.58"	"14.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668472"	""	"None"	"453.92"	"1"	"5.64"	"BDBM167715"	"Fc1ccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCCNC5)cc34)n2)cc1F"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	"311496"	"UO_0000065"	"16.96"	"0.33"	"2.06"	"11.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668476"	""	"None"	"400.50"	"1"	"5.45"	"BDBM167719"	"Fc1ccc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"311500"	"UO_0000065"	"19.87"	"0.36"	"2.51"	"15.09"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673504"	""	"None"	"402.48"	"0"	"4.24"	"BDBM167822"	"Fc1cccc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"311603"	"UO_0000065"	"19.88"	"0.36"	"3.76"	"10.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673505"	""	"None"	"385.48"	"0"	"3.49"	"BDBM167823"	"c1cncc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"311604"	"UO_0000065"	"19.55"	"0.35"	"4.05"	"8.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673524"	""	"None"	"553.62"	"1"	"3.94"	"BDBM167842"	"CCOC(=O)NS(=O)(=O)N1CCC(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311623"	"UO_0000065"	"14.19"	"0.28"	"3.91"	"5.52"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673532"	""	"None"	"401.45"	"0"	"4.11"	"BDBM167850"	"Fc1cccc(COc2cncc(-c3ccnc4[nH]c(C5=CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"311631"	"UO_0000065"	"20.31"	"0.37"	"4.04"	"10.77"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673554"	""	"None"	"437.52"	"0"	"4.81"	"BDBM167872"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)OC(C)(C)C)CC3)cc12"	"IC50"	"'='"	"570.0"	"nM"	"6.24"	""	"311653"	"UO_0000065"	"14.27"	"0.27"	"1.43"	"9.26"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668490"	""	"None"	"389.43"	"0"	"3.56"	"BDBM167733"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(F)c4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"53.0"	"nM"	"7.28"	""	"311514"	"UO_0000065"	"18.68"	"0.37"	"3.72"	"11.01"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668503"	""	"None"	"433.49"	"0"	"3.43"	"BDBM167746"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"126.0"	"nM"	"6.90"	""	"311527"	"UO_0000065"	"15.92"	"0.29"	"3.47"	"8.09"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3900378"	""	"None"	"440.54"	"0"	"4.15"	"BDBM223784"	"CCCN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"340.0"	"nM"	"6.47"	""	"390886"	"UO_0000065"	"14.68"	"0.28"	"2.32"	"9.33"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3924254"	""	"None"	"475.57"	"0"	"3.39"	"BDBM223795"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"70.0"	"nM"	"7.16"	""	"390897"	"UO_0000065"	"15.04"	"0.28"	"3.76"	"9.45"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3969672"	""	"None"	"512.59"	"2"	"5.25"	"BDBM223818"	"CN1Cc2c(C3=CCC(N[C@@H](Cc4ccc(O)cc4)C(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"81.0"	"nM"	"7.09"	""	"390920"	"UO_0000065"	"13.83"	"0.25"	"1.84"	"6.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3914697"	""	"None"	"438.53"	"0"	"3.61"	"BDBM223856"	"CN1Cc2c(C3=CC4CN(S(C)(=O)=O)CC4C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"62.0"	"nM"	"7.21"	""	"390958"	"UO_0000065"	"16.44"	"0.32"	"3.60"	"10.40"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3977523"	""	"None"	"387.41"	"0"	"4.61"	"BDBM223859"	"CN1Cc2c(-c3ccc(CC(=O)O)cc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"68.0"	"nM"	"7.17"	""	"390961"	"UO_0000065"	"18.50"	"0.34"	"2.56"	"10.35"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3919423"	""	"None"	"505.59"	"1"	"2.75"	"BDBM223861"	"CN(CC(O)CO)C(=O)CN1[C@H]2CC[C@@H]1C=C(c1[nH]c3nccc4c3c1CN(C)c1ccc(F)cc1-4)C2"	"IC50"	"'='"	"140.0"	"nM"	"6.85"	""	"390963"	"UO_0000065"	"13.56"	"0.25"	"4.10"	"7.14"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3951345"	""	"None"	"426.52"	"0"	"3.76"	"BDBM223867"	"CN1Cc2c(C3=CCCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"390969"	"UO_0000065"	"16.23"	"0.32"	"3.16"	"9.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3899896"	""	"None"	"446.53"	"0"	"4.31"	"BDBM223968"	"CN1CCc2c(C3=CCN([C@H]4C[C@H](C(=O)O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"391070"	"UO_0000065"	"15.22"	"0.28"	"2.49"	"9.38"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3663768"	""	"None"	"307.40"	"0"	"3.71"	"BDBM167543"	"COc1ccccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"311325"	"UO_0000065"	"24.62"	"0.45"	"3.86"	"15.16"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663799"	""	"None"	"311.36"	"0"	"3.45"	"BDBM167574"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCNC3)cc12"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311356"	"UO_0000065"	"24.95"	"0.46"	"4.32"	"15.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663800"	""	"None"	"311.36"	"0"	"3.45"	"BDBM167575"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNC3)cc12"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311357"	"UO_0000065"	"24.42"	"0.45"	"4.15"	"15.22"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663807"	""	"None"	"327.36"	"0"	"3.04"	"BDBM167582"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CNCCO3)cc12"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	"311364"	"UO_0000065"	"22.70"	"0.42"	"4.39"	"12.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668348"	""	"None"	"339.41"	"0"	"4.36"	"BDBM167589"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCC(N)CC3)cc12"	"IC50"	"'='"	"24.0"	"nM"	"7.62"	""	"311371"	"UO_0000065"	"22.45"	"0.42"	"3.26"	"11.92"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668354"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167595"	"Clc1cnc2[nH]c(C3CCCNC3)cc2c1-c1cccc(NCc2ccccc2)n1"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	"311377"	"UO_0000065"	"17.73"	"0.34"	"2.05"	"11.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668437"	""	"None"	"342.37"	"0"	"3.38"	"BDBM167679"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3(O)CCOCC3)cc12"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	"311461"	"UO_0000065"	"19.19"	"0.36"	"3.19"	"9.75"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668438"	""	"None"	"388.45"	"0"	"4.37"	"BDBM167680"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(Cc4ccncc4)C3)cc12"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	"311462"	"UO_0000065"	"18.37"	"0.34"	"2.77"	"13.21"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668360"	""	"None"	"431.97"	"1"	"5.88"	"BDBM167601"	"NC1CCCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)c(Cl)cnc3[nH]2)C1"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"311383"	"UO_0000065"	"16.02"	"0.30"	"1.04"	"8.69"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4442620"	"RONICICLIB"	"2.0"	"430.45"	"0"	"3.96"	"6; BAY-1000394"	"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"19.28"	"0.39"	"4.34"	"7.67"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4764173"	""	"None"	"368.49"	"0"	"3.59"	"11"	"CC[C@H](Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	""	"UO_0000065"	"20.58"	"0.38"	"4.00"	"8.63"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL445813"	"AT-7519"	"2.0"	"382.25"	"0"	"2.45"	"14; AT7519"	"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl"	"IC50"	"'<'"	"10.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4759074"	""	"None"	"429.95"	"0"	"3.81"	"32"	"CC(=O)NC1CCCC(C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	""	"UO_0000065"	"17.00"	"0.33"	"3.50"	"8.22"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4784363"	""	"None"	"420.52"	"0"	"3.03"	"25"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(C#N)cn2)C1"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	""	"UO_0000065"	"16.23"	"0.30"	"3.79"	"6.05"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4752748"	""	"None"	"427.52"	"0"	"3.69"	"21"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)CC4)c(F)cn2)C1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"18.71"	"0.35"	"4.31"	"9.00"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4786995"	""	"None"	"429.95"	"0"	"3.96"	"15"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"92.0"	"nM"	"7.04"	""	""	"UO_0000065"	"16.37"	"0.32"	"3.08"	"7.91"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4789009"	""	"None"	"415.93"	"0"	"3.57"	"9"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc4n3CCCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"14.24"	"0.28"	"2.35"	"6.66"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3973367"	""	"None"	"465.43"	"0"	"4.53"	"BDBM180819"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327487"	"UO_0000065"	"18.69"	"0.37"	"4.17"	"8.68"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668399"	""	"None"	"516.62"	"2"	"5.87"	"BDBM167640"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN(CCCNC(=O)OCc4ccccc4)C3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311422"	"UO_0000065"	"14.79"	"0.27"	"1.77"	"9.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668433"	""	"None"	"475.00"	"0"	"4.80"	"BDBM167675"	"CN1CCC(c2cc3c(-c4nc(NCc5ccc(C(N)=O)cc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"311457"	"UO_0000065"	"15.90"	"0.30"	"2.75"	"7.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668435"	""	"None"	"351.45"	"0"	"2.84"	"BDBM167677"	"CN1CCC(c2cc3c(-c4cccc(NCCO)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"311459"	"UO_0000065"	"21.41"	"0.40"	"4.68"	"9.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668448"	""	"None"	"481.04"	"0"	"4.76"	"BDBM167690"	"CC(=O)N1CCC(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCN(C)CC5)cc34)n2)CC1"	"IC50"	"'='"	"55.0"	"nM"	"7.26"	""	"311472"	"UO_0000065"	"15.09"	"0.29"	"2.50"	"9.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668459"	""	"None"	"510.06"	"2"	"5.10"	"BDBM167701"	"CN1CCC(c2cc3c(-c4nc(NCc5cccc(S(C)(=O)=O)c5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"311483"	"UO_0000065"	"14.39"	"0.29"	"2.24"	"8.06"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663801"	""	"None"	"311.36"	"0"	"3.45"	"BDBM167576"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@H]3CCNC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311358"	"UO_0000065"	"24.53"	"0.45"	"4.19"	"15.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668366"	""	"None"	"361.49"	"0"	"4.26"	"BDBM167607"	"CN1CCC(c2cc3c(-c4cccc(NCC5CC5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"311389"	"UO_0000065"	"20.66"	"0.38"	"3.21"	"13.14"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668378"	""	"None"	"441.54"	"0"	"4.77"	"BDBM167619"	"CN1CCC(c2cc3c(-c4cccc(NCc5ccc6c(c5)OCO6)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"13.0"	"nM"	"7.89"	""	"311401"	"UO_0000065"	"17.86"	"0.33"	"3.12"	"10.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668467"	""	"None"	"450.97"	"0"	"4.48"	"BDBM167710"	"N#CC1(CNc2cc(-c3ccnc4[nH]c(C5CCNCC5)cc34)c(Cl)cn2)CCOCC1"	"IC50"	"'='"	"730.0"	"nM"	"6.14"	""	"311491"	"UO_0000065"	"13.61"	"0.26"	"1.66"	"6.22"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668509"	""	"None"	"435.50"	"0"	"4.86"	"BDBM167752"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCC[C@H]4C(=O)O)CC3)cc12"	"IC50"	"'='"	"70.0"	"nM"	"7.16"	""	"311533"	"UO_0000065"	"16.43"	"0.31"	"2.29"	"9.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3639673"	""	"None"	"452.53"	"0"	"3.20"	"BDBM167762"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)NC4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311543"	"UO_0000065"	"16.23"	"0.30"	"4.15"	"8.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668525"	""	"None"	"456.49"	"0"	"2.90"	"BDBM167769"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3CCN(CC(=O)N4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"102.0"	"nM"	"6.99"	""	"311550"	"UO_0000065"	"15.32"	"0.29"	"4.09"	"8.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668537"	""	"None"	"429.52"	"0"	"4.20"	"BDBM167781"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(C)(=O)=O)C(C)(C)C3)cc12"	"IC50"	"'='"	"122.0"	"nM"	"6.91"	""	"311562"	"UO_0000065"	"16.10"	"0.31"	"2.71"	"9.18"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673490"	""	"None"	"464.54"	"0"	"3.45"	"BDBM167808"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N4CC(O)C4)C(C)(C)C3)cc12"	"IC50"	"'='"	"83.0"	"nM"	"7.08"	""	"311589"	"UO_0000065"	"15.24"	"0.28"	"3.63"	"8.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673499"	""	"None"	"423.54"	"0"	"3.50"	"BDBM167817"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(NCC5CC5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"260.0"	"nM"	"6.58"	""	"311598"	"UO_0000065"	"15.55"	"0.30"	"3.09"	"7.24"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673513"	""	"None"	"426.52"	"0"	"4.36"	"BDBM167831"	"CC(=O)N1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"311612"	"UO_0000065"	"17.64"	"0.32"	"3.16"	"8.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673516"	""	"None"	"330.79"	"0"	"3.88"	"BDBM167834"	"Fc1ccc(Cl)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"2600.0"	"nM"	"5.58"	""	"311615"	"UO_0000065"	"16.88"	"0.33"	"1.71"	"10.42"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673517"	""	"None"	"403.46"	"0"	"4.21"	"BDBM167835"	"Fc1cccc(COc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"311616"	"UO_0000065"	"19.63"	"0.36"	"3.71"	"10.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673550"	""	"None"	"457.51"	"0"	"4.67"	"BDBM167868"	"CNC(=O)C1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	"311649"	"UO_0000065"	"15.47"	"0.28"	"2.41"	"7.63"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4781334"	""	"None"	"522.68"	"1"	"4.56"	"MFH-3-137-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CNCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"7140.0"	"nM"	"5.15"	""	""	"UO_0000065"	"9.85"	"0.19"	"0.59"	"4.58"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4789890"	""	"None"	"479.63"	"0"	"4.67"	"MFH-3-203-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ccccn4)s3)C2)cc1"	"IC50"	"'='"	"1000.0"	"nM"	"6.00"	""	""	"UO_0000065"	"12.51"	"0.25"	"1.33"	"6.88"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4641226"	""	"None"	"434.59"	"0"	"4.08"	"B2"	"C=CC(=O)N1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CC1"	"IC50"	"'='"	"3.16"	"nM"	"8.50"	""	""	"UO_0000065"	"19.56"	"0.40"	"4.42"	"9.62"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3343040"	""	"None"	"401.43"	"0"	"3.92"	"10"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(N)nc2cc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL4740156"	""	"None"	"401.51"	"0"	"4.78"	"19"	"Cc1ccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)cc1"	"IC50"	"'='"	"488.5"	"nM"	"6.31"	""	""	"UO_0000065"	"15.72"	"0.29"	"1.53"	"10.29"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4761833"	""	"None"	"484.65"	"1"	"6.21"	"29"	"CC(C)N1c2cc(Nc3nccc(-c4cccc(NC5CCCCC5)c4)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"168.8"	"nM"	"6.77"	""	""	"UO_0000065"	"13.97"	"0.26"	"0.56"	"9.23"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4749819"	""	"None"	"416.53"	"0"	"4.36"	"32"	"Cc1ccc(N)cc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1"	"IC50"	"'='"	"151.2"	"nM"	"6.82"	""	""	"UO_0000065"	"16.37"	"0.30"	"2.46"	"7.81"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4783301"	""	"None"	"472.98"	"1"	"5.67"	"42"	"CC(C)N1c2cc(Nc3ncc(Cl)c(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	""	"UO_0000065"	"16.15"	"0.31"	"1.97"	"10.29"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4756353"	""	"None"	"499.66"	"1"	"5.03"	"B8"	"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)cc1"	"IC50"	"'='"	"8.9"	"nM"	"8.05"	""	""	"UO_0000065"	"16.11"	"0.32"	"3.02"	"8.02"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4761001"	""	"None"	"582.80"	"2"	"5.49"	"MFH-4-13-1"	"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"65.0"	"nM"	"7.19"	""	""	"UO_0000065"	"12.33"	"0.25"	"1.70"	"6.94"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3986015"	""	"None"	"440.51"	"0"	"3.24"	"BDBM60466"	"O=C(CO)N1CC=C(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"218942"	"UO_0000065"	"17.34"	"0.32"	"4.40"	"7.14"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL526092"	""	"None"	"257.30"	"0"	"1.29"	"86-1"	"CCC1CNC(=O)c2cc(-c3ccnc(N)n3)[nH]c21"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	""	"UO_0000065"	"27.74"	"0.51"	"5.85"	"7.38"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL3655765"	""	"None"	"386.48"	"0"	"3.73"	"BDBM106953"	"CC[C@H](Nc1nc(NCc2cccc(F)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	"226141"	"UO_0000065"	"18.36"	"0.35"	"3.37"	"8.07"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3655762"	""	"None"	"397.53"	"0"	"3.60"	"BDBM106950"	"CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"226138"	"UO_0000065"	"17.61"	"0.33"	"3.40"	"6.95"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3953160"	""	"None"	"443.48"	"0"	"4.56"	"BDBM180853"	"COc1cc(F)ccc1-c1nc(Nc2cc(C)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327521"	"UO_0000065"	"19.22"	"0.38"	"3.96"	"8.50"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663761"	""	"None"	"341.84"	"0"	"4.36"	"BDBM167535"	"COc1cc(Cl)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311317"	"UO_0000065"	"22.59"	"0.44"	"3.36"	"15.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663769"	""	"None"	"339.41"	"0"	"4.19"	"BDBM167544"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311326"	"UO_0000065"	"22.89"	"0.42"	"3.58"	"18.88"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663776"	""	"None"	"452.39"	"1"	"6.01"	"BDBM167551"	"Clc1ccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311333"	"UO_0000065"	"16.97"	"0.34"	"1.67"	"11.70"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668466"	""	"None"	"428.94"	"0"	"3.86"	"BDBM167709"	"F[C@@H]1CN[C@H](CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)C1"	"IC50"	"'='"	"910.0"	"nM"	"6.04"	""	"311490"	"UO_0000065"	"14.08"	"0.28"	"2.18"	"7.78"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3978185"	""	"None"	"412.49"	"0"	"4.53"	"BDBM180801"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1"	"IC50"	"'='"	"67.0"	"nM"	"7.17"	""	"327595"	"UO_0000065"	"17.39"	"0.34"	"2.64"	"8.16"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3906489"	""	"None"	"476.51"	"0"	"4.93"	"BDBM180796"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327464"	"UO_0000065"	"16.99"	"0.34"	"3.17"	"7.88"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3978185"	""	"None"	"412.49"	"0"	"4.53"	"BDBM180801"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327469"	"UO_0000065"	"19.63"	"0.38"	"3.57"	"9.21"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668454"	""	"None"	"426.49"	"0"	"2.67"	"BDBM167696"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CNCCO)CC3)cc12"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"311478"	"UO_0000065"	"17.95"	"0.34"	"4.99"	"8.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668457"	""	"None"	"397.45"	"0"	"2.82"	"BDBM167699"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"311481"	"UO_0000065"	"21.13"	"0.40"	"5.58"	"10.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3774632"	""	"None"	"417.52"	"0"	"3.94"	"5b"	"CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1"	"IC50"	"'='"	"240.0"	"nM"	"6.62"	""	""	"UO_0000065"	"15.86"	"0.29"	"2.68"	"5.93"	"0"	"CHEMBL3777660"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3774312"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3668486"	""	"None"	"402.45"	"0"	"2.67"	"BDBM167729"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(N)(=O)=O)CC3)cc12"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"311510"	"UO_0000065"	"18.69"	"0.37"	"4.85"	"7.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668493"	""	"None"	"408.48"	"0"	"3.55"	"BDBM167736"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	"311517"	"UO_0000065"	"18.14"	"0.34"	"3.86"	"12.05"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668508"	""	"None"	"437.52"	"1"	"5.01"	"BDBM167751"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N[C@@H](C(=O)O)C(C)C)CC3)cc12"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	"311532"	"UO_0000065"	"16.22"	"0.30"	"2.09"	"8.13"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668526"	""	"None"	"438.50"	"0"	"2.92"	"BDBM167770"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N(C)C)[C@H](CO)C3)cc12"	"IC50"	"'='"	"111.0"	"nM"	"6.96"	""	"311551"	"UO_0000065"	"15.86"	"0.30"	"4.03"	"8.51"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673502"	""	"None"	"392.51"	"0"	"3.33"	"BDBM167820"	"c1cc(-c2cncc(NCC3CCOCC3)n2)c2cc(C3CCNCC3)[nH]c2n1"	"IC50"	"'='"	"31.0"	"nM"	"7.51"	""	"311601"	"UO_0000065"	"19.13"	"0.35"	"4.18"	"8.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673506"	""	"None"	"385.48"	"0"	"3.49"	"BDBM167824"	"c1cc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)ccn1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"311605"	"UO_0000065"	"19.31"	"0.35"	"3.95"	"8.14"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673511"	""	"None"	"412.54"	"0"	"4.47"	"BDBM167829"	"CN1CCC(c2cc3c(-c4cncc(N(C)Cc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"620.0"	"nM"	"6.21"	""	"311610"	"UO_0000065"	"15.05"	"0.27"	"1.74"	"10.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668398"	""	"None"	"341.39"	"0"	"2.95"	"BDBM167639"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3(O)CCNCC3)cc12"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	"311421"	"UO_0000065"	"20.87"	"0.39"	"4.17"	"10.15"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668401"	""	"None"	"382.48"	"0"	"3.91"	"BDBM167642"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN(CCCN)C3)cc12"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311424"	"UO_0000065"	"20.53"	"0.38"	"3.94"	"11.69"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673523"	""	"None"	"477.54"	"0"	"3.27"	"BDBM167841"	"OCC(O)CN1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"311622"	"UO_0000065"	"16.67"	"0.31"	"4.69"	"7.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4297488"	"CT-7001"	"2.0"	"394.52"	"0"	"2.85"	"CT7001"	"CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"15.01"	"0.28"	"3.07"	"6.84"	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL3823030"	""	"None"	"494.99"	"0"	"3.55"	"28; AZD9362"	"Cc1nn(C2CCN(C(=O)[C@@H](C)O)CC2)c(C)c1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1"	"IC50"	"'='"	"450.0"	"nM"	"6.35"	""	""	"UO_0000065"	"12.82"	"0.25"	"2.80"	"5.59"	"0"	"CHEMBL3825313"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3822394"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3334979"	""	"None"	"396.51"	"1"	"5.50"	"1"	"COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC"	"IC50"	""	""	""	""	""	"Not Determined"	""	""	""	""	""	"0"	"CHEMBL4014537"	"Inhibition of human CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4014275"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL490355"	"SULFURETIN"	"None"	"270.24"	"0"	"2.42"	"67"	"O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21"	"IC50"	"'='"	"2160.0"	"nM"	"5.67"	""	""	"UO_0000065"	"20.96"	"0.39"	"3.25"	"6.51"	"0"	"CHEMBL4014537"	"Inhibition of human CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4014275"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL3589660"	""	"None"	"296.71"	"0"	"4.22"	"5h"	"O=C(O)c1nc2ccccc2c2[nH]c3c(Cl)cccc3c12"	"IC50"	"'='"	"15000.0"	"nM"	"4.82"	""	""	"UO_0000065"	"16.26"	"0.31"	"0.60"	"7.31"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589661"	""	"None"	"341.16"	"0"	"4.33"	"5i"	"O=C(O)c1nc2ccccc2c2[nH]c3c(Br)cccc3c12"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	""	"UO_0000065"	"19.92"	"0.44"	"2.47"	"10.30"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3655766"	""	"None"	"381.48"	"0"	"2.81"	"BDBM106954"	"CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(CC3CC3)c2n1)[C@@H](C)O"	"IC50"	"'='"	"7890.0"	"nM"	"5.10"	""	"226142"	"UO_0000065"	"13.38"	"0.25"	"2.29"	"5.06"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3343045"	""	"None"	"378.34"	"0"	"3.20"	"14b"	"O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1ccc(O)c([N+](=O)[O-])c1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL505474"	""	"None"	"366.56"	"0"	"4.40"	"7"	"CC(C)(C)c1cnc(CSc2cnc(NC3CCCC(N)C3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL4462530"	"AZD-4573"	"2.0"	"429.95"	"0"	"3.81"	"AZD4573"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'<'"	"4.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4408761"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4406837"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2019"	"None"	""	""	""
"CHEMBL4788401"	""	"None"	"512.70"	"2"	"6.65"	"MFH-3-103-1"	"C=CC(=O)Nc1ccc(O[C@@H]2CCC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"66.5"	"nM"	"7.18"	""	""	"UO_0000065"	"14.00"	"0.28"	"0.53"	"8.04"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4786429"	""	"None"	"499.66"	"1"	"5.03"	"B7"	"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)c1"	"IC50"	"'='"	"10.7"	"nM"	"7.97"	""	""	"UO_0000065"	"15.95"	"0.32"	"2.94"	"7.94"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4788136"	""	"None"	"511.67"	"2"	"5.17"	"MFH-4-70-1"	"C=CC(=O)Nc1ccc(C(=O)N2CC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	""	"UO_0000065"	"14.62"	"0.29"	"2.31"	"7.45"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3655775"	""	"None"	"341.42"	"0"	"2.21"	"BDBM106963"	"CC(C)n1cnc2c(NCc3cccnc3)nc(NC[C@@H](C)O)nc21"	"IC50"	"'='"	"6530.0"	"nM"	"5.18"	""	"226151"	"UO_0000065"	"15.19"	"0.28"	"2.98"	"5.14"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3668388"	""	"None"	"454.55"	"0"	"4.69"	"BDBM167629"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CCNC(=O)OC(C)(C)C)C3)cc12"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"311411"	"UO_0000065"	"16.58"	"0.31"	"2.85"	"9.48"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668499"	""	"None"	"426.47"	"0"	"3.69"	"BDBM167742"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311523"	"UO_0000065"	"17.23"	"0.32"	"3.66"	"11.95"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668501"	""	"None"	"396.44"	"0"	"3.69"	"BDBM167744"	"CN(C)C(=O)CN1CC=C(c2cc3c(-c4cccc(F)c4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	"311525"	"UO_0000065"	"18.48"	"0.35"	"3.64"	"14.03"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668506"	""	"None"	"464.54"	"0"	"3.45"	"BDBM167749"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3)cc12"	"IC50"	"'='"	"53.0"	"nM"	"7.28"	""	"311530"	"UO_0000065"	"15.66"	"0.29"	"3.83"	"8.91"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668519"	""	"None"	"438.50"	"0"	"2.76"	"BDBM167763"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"77.0"	"nM"	"7.11"	""	"311544"	"UO_0000065"	"16.22"	"0.30"	"4.35"	"8.71"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3959283"	""	"None"	"443.48"	"0"	"4.64"	"BDBM180815"	"CCS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1)=NC#N"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327483"	"UO_0000065"	"19.62"	"0.38"	"4.06"	"8.68"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327485"	"UO_0000065"	"19.49"	"0.38"	"3.41"	"9.27"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4754399"	""	"None"	"415.93"	"0"	"3.57"	"6"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678817"	"Reversible inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues preincubated for 6 hrs followed by compound washout and measured after 0.5 to 2 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL4066819"	""	"None"	"430.51"	"0"	"2.63"	"52h"	"COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	""	"UO_0000065"	"15.26"	"0.31"	"3.94"	"5.64"	"0"	"CHEMBL4029555"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4028808"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2017"	"None"	""	""	""
"CHEMBL4635959"	""	"None"	"497.64"	"0"	"2.89"	"Fig 7, Cpd II"	"Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1"	"IC50"	"'>'"	"20000000.0"	"nM"	""	"Outside typical range"	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4611867"	"Inhibition of CDK9 in human HCT116 cells assessed as inhibition of Ser2 phosphorylation"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"CHEMBL3308372"	""	""	""
"CHEMBL3343033"	""	"None"	"386.41"	"0"	"4.34"	"1"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3694407"	""	"None"	"338.34"	"0"	"2.87"	"BDBM120942"	"COc1ccc(F)cc1-c1cc(NC(=O)Cc2ccncc2)ncn1"	"IC50"	"'='"	"0.029"	"nM"	"10.54"	""	"249041"	"UO_0000065"	"31.15"	"0.58"	"7.67"	"13.69"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3694401"	""	"None"	"330.36"	"0"	"2.23"	"BDBM120935"	"COc1cccc(F)c1-c1cc(NC(=O)C2CCCNC2)ncn1"	"IC50"	"'='"	"0.039"	"nM"	"10.41"	""	"249034"	"UO_0000065"	"31.51"	"0.59"	"8.18"	"13.67"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3694403"	""	"None"	"398.44"	"0"	"2.78"	"BDBM120938"	"COc1ccccc1-c1cc(NC(=O)c2ccc(NS(C)(=O)=O)cc2)ncn1"	"IC50"	"'='"	"1.25"	"nM"	"8.90"	""	"249037"	"UO_0000065"	"22.34"	"0.43"	"6.12"	"8.07"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3972845"	""	"None"	"414.49"	"0"	"4.02"	"BDBM223788"	"CN1c2ccc(F)cc2-c2ccnc3[nH]c(C4=CCNCC4)c(c23)C1c1cnn(C)c1"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	"390890"	"UO_0000065"	"16.02"	"0.29"	"2.62"	"10.75"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3891725"	""	"None"	"420.49"	"0"	"4.13"	"BDBM223889"	"CN1Cc2c(C3=CCN(CC(=O)O)CC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"1600.0"	"nM"	"5.80"	""	"390991"	"UO_0000065"	"13.78"	"0.26"	"1.67"	"8.00"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3944945"	""	"None"	"433.53"	"0"	"3.54"	"BDBM223907"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CCN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"67.0"	"nM"	"7.17"	""	"391009"	"UO_0000065"	"16.55"	"0.31"	"3.63"	"12.93"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3937985"	""	"None"	"447.56"	"0"	"4.45"	"BDBM223946"	"CC[C@H]1c2c(C3=CCN(CC(=O)N(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"60.0"	"nM"	"7.22"	""	"391048"	"UO_0000065"	"16.14"	"0.30"	"2.77"	"13.02"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3892177"	""	"None"	"474.58"	"1"	"5.44"	"BDBM223960"	"CN1Cc2c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"71.0"	"nM"	"7.15"	""	"391062"	"UO_0000065"	"15.06"	"0.28"	"1.71"	"9.87"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3891658"	""	"None"	"450.49"	"0"	"4.41"	"BDBM223971"	"CN1Cc2c(C3=CCN(C4CC(C(=O)O)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"76.0"	"nM"	"7.12"	""	"391073"	"UO_0000065"	"15.80"	"0.29"	"2.71"	"9.82"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3343055"	""	"None"	"459.46"	"0"	"3.04"	"33"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(N2CCC(=O)NC2=O)c1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343058"	""	"None"	"423.43"	"0"	"2.13"	"37"	"CCNC(=O)Nc1ccc(NC(=O)c2cc(OC)cc(-c3c[nH]c(=O)[nH]c3=O)c2)cc1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL496785"	""	"None"	"351.54"	"1"	"5.47"	"9"	"CC(C)(C)c1cnc(CSc2cnc(NC3CCCCC3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL507536"	""	"None"	"269.39"	"0"	"3.30"	"11"	"CC(C)(C)c1cnc(CSc2cnc(N)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3668394"	""	"None"	"465.57"	"1"	"5.19"	"BDBM167635"	"CCOC(=O)C1CC1CN[C@H]1CC[C@H](c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"311417"	"UO_0000065"	"16.04"	"0.30"	"2.28"	"9.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3916775"	""	"None"	"461.49"	"0"	"4.11"	"BDBM180803"	"CNC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327471"	"UO_0000065"	"17.67"	"0.35"	"4.04"	"7.72"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"13.0"	"nM"	"7.89"	""	"327599"	"UO_0000065"	"18.67"	"0.37"	"3.40"	"8.97"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668460"	""	"None"	"415.52"	"1"	"5.19"	"BDBM167702"	"CN1CCC(c2cc3c(-c4cc(NCc5ccncc5)ccc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311484"	"UO_0000065"	"18.38"	"0.34"	"2.45"	"13.44"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668347"	""	"None"	"371.87"	"0"	"4.33"	"BDBM167588"	"COc1cc(Cl)ccc1-c1ccnc2[nH]c(C3CNC(C)(C)CO3)cc12"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"311370"	"UO_0000065"	"18.61"	"0.36"	"2.59"	"11.70"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668521"	""	"None"	"428.48"	"0"	"3.78"	"BDBM167765"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"311546"	"UO_0000065"	"16.44"	"0.31"	"3.27"	"11.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668545"	""	"None"	"407.45"	"0"	"3.23"	"BDBM167789"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CN(C(=O)CO)CC4C3)cc12"	"IC50"	"'='"	"71.0"	"nM"	"7.15"	""	"311570"	"UO_0000065"	"17.55"	"0.33"	"3.92"	"9.11"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673531"	""	"None"	"474.54"	"0"	"3.21"	"BDBM167849"	"OCC(O)CN1CC=C(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311630"	"UO_0000065"	"16.55"	"0.31"	"4.64"	"7.13"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL2006765"	""	"None"	"392.39"	"0"	"3.82"	"5"	"CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1"	"IC50"	"'='"	"5330.0"	"nM"	"5.27"	""	""	"UO_0000065"	"13.44"	"0.26"	"1.45"	"5.57"	"0"	"CHEMBL4007695"	"Inhibition of CDK9 (unknown origin) after 60 mins by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4007384"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2016"	"None"	""	""	""
"CHEMBL3343042"	""	"None"	"506.57"	"2"	"5.39"	"12a"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(NCCc3ccccn3)nc2cc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343044"	""	"None"	"363.37"	"0"	"3.30"	"14a"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)ccc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3341771"	""	"None"	"457.45"	"0"	"2.64"	"24a"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL510566"	""	"None"	"394.57"	"0"	"3.91"	"21"	"C[C@@H]1CNC[C@@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1"	"IC50"	"'='"	"4100.0"	"nM"	"5.39"	""	""	"UO_0000065"	"13.65"	"0.28"	"1.48"	"6.73"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327480"	"UO_0000065"	"19.85"	"0.39"	"4.27"	"8.50"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3981911"	""	"None"	"438.89"	"1"	"5.00"	"BDBM180852"	"COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327646"	"UO_0000065"	"18.58"	"0.38"	"3.15"	"9.27"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"327604"	"UO_0000065"	"17.92"	"0.36"	"3.08"	"8.60"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"327642"	"UO_0000065"	"16.26"	"0.32"	"2.27"	"8.29"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668535"	""	"None"	"438.50"	"0"	"2.92"	"BDBM167779"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N(C)C)[C@@H](CO)C3)cc12"	"IC50"	"'='"	"82.0"	"nM"	"7.09"	""	"311560"	"UO_0000065"	"16.16"	"0.30"	"4.17"	"8.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668554"	""	"None"	"463.55"	"1"	"5.50"	"BDBM167798"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"311579"	"UO_0000065"	"15.63"	"0.29"	"1.74"	"9.23"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668556"	""	"None"	"484.55"	"0"	"2.79"	"BDBM167800"	"CNS(=O)(=O)CC(=O)N1CC2C=C(c3cc4c(-c5cc(F)ccc5OC)ccnc4[nH]3)CC2C1"	"IC50"	"'='"	"93.0"	"nM"	"7.03"	""	"311581"	"UO_0000065"	"14.51"	"0.28"	"4.24"	"6.74"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673527"	""	"None"	"481.55"	"0"	"3.88"	"BDBM167845"	"CS(=O)(=O)N1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"60.0"	"nM"	"7.22"	""	"311626"	"UO_0000065"	"15.00"	"0.29"	"3.34"	"7.15"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL1801932"	""	"None"	"380.54"	"0"	"4.40"	"BS-181"	"CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12"	"IC50"	"'='"	"4200.0"	"nM"	"5.38"	""	""	"UO_0000065"	"14.13"	"0.26"	"0.98"	"6.70"	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL319467"	""	"None"	"402.48"	"0"	"2.70"	"6; NU6102"	"NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1"	"IC50"	"'='"	"1100.0"	"nM"	"5.96"	""	""	"UO_0000065"	"14.80"	"0.29"	"3.26"	"4.39"	"0"	"CHEMBL4613379"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4613207"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL445813"	"AT-7519"	"2.0"	"382.25"	"0"	"2.45"	"AT-7519"	"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"20.93"	"0.44"	"5.55"	"8.09"	"0"	"CHEMBL4271327"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4270504"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL495558"	""	"None"	"367.54"	"0"	"4.44"	"8"	"CC(C)(C)c1cnc(CSc2cnc(NC3CCCC(O)C3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3966523"	""	"None"	"464.52"	"0"	"4.80"	"BDBM223970"	"CN1Cc2c(C3=CCN(C4CC(CC(=O)O)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"79.0"	"nM"	"7.10"	""	"391072"	"UO_0000065"	"15.29"	"0.29"	"2.30"	"9.80"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3966259"	""	"None"	"417.49"	"0"	"4.28"	"BDBM223835"	"CNC(=O)N1[C@H]2CC[C@@H]1C=C(c1[nH]c3nccc4c3c1CN(C)c1ccc(F)cc1-4)C2"	"IC50"	"'='"	"200.0"	"nM"	"6.70"	""	"390937"	"UO_0000065"	"16.05"	"0.30"	"2.42"	"10.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3639672"	""	"None"	"403.48"	"0"	"3.52"	"BDBM167661"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311443"	"UO_0000065"	"19.03"	"0.37"	"4.16"	"10.20"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668534"	""	"None"	"438.50"	"0"	"2.92"	"BDBM167778"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=C[C@H](CO)N(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"115.0"	"nM"	"6.94"	""	"311559"	"UO_0000065"	"15.83"	"0.30"	"4.02"	"8.49"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668538"	""	"None"	"436.53"	"0"	"4.33"	"BDBM167782"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N(C)C)C(C)(C)C3)cc12"	"IC50"	"'='"	"81.0"	"nM"	"7.09"	""	"311563"	"UO_0000065"	"16.25"	"0.30"	"2.76"	"11.54"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668549"	""	"None"	"406.46"	"0"	"4.05"	"BDBM167793"	"CNC(=O)N1C[C@@H]2CC(c3cc4c(-c5cc(F)ccc5OC)ccnc4[nH]3)=C[C@@H]2C1"	"IC50"	"'='"	"71.0"	"nM"	"7.15"	""	"311574"	"UO_0000065"	"17.59"	"0.33"	"3.10"	"10.18"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668562"	""	"None"	"482.53"	"0"	"3.59"	"BDBM167806"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N4CCC(O)CC4)CC3)cc12"	"IC50"	"'='"	"83.0"	"nM"	"7.08"	""	"311587"	"UO_0000065"	"14.67"	"0.28"	"3.49"	"8.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673534"	""	"None"	"399.50"	"0"	"3.84"	"BDBM167852"	"CN1CCC(c2cc3c(-c4cncc(NCc5cccnc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	"311633"	"UO_0000065"	"18.49"	"0.34"	"3.55"	"8.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673544"	""	"None"	"494.52"	"1"	"5.17"	"BDBM167862"	"CNC(=O)N1CCC(c2cc3c(-c4nc(NCc5cccc(F)c5)c(F)cc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"311643"	"UO_0000065"	"16.18"	"0.30"	"2.83"	"9.31"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673553"	""	"None"	"424.51"	"0"	"4.30"	"BDBM167871"	"NC(=O)C1CC=C(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"2200.0"	"nM"	"5.66"	""	"311652"	"UO_0000065"	"13.33"	"0.24"	"1.36"	"5.16"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663758"	""	"None"	"475.98"	"1"	"5.84"	"BDBM167532"	"COC(=O)N1CCCC(c2cc3c(-c4nc(NCc5ccccc5)ccc4Cl)ccnc3[nH]2)C1"	"IC50"	"'='"	"770.0"	"nM"	"6.11"	""	"311314"	"UO_0000065"	"12.84"	"0.25"	"0.27"	"7.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL498200"	""	"None"	"325.29"	"0"	"2.22"	"93-2"	"Nc1nccc(-c2cc3c([nH]2)C(CCC(F)(F)F)CNC3=O)n1"	"IC50"	"'='"	"395.0"	"nM"	"6.40"	""	""	"UO_0000065"	"19.69"	"0.38"	"4.18"	"6.62"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL3668516"	""	"None"	"405.43"	"0"	"3.68"	"BDBM167759"	"CNC(=O)N1CC=C(c2[nH]c3nccc(-c4cc(F)ccc4OC)c3c2C#N)CC1"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"311540"	"UO_0000065"	"18.63"	"0.34"	"3.87"	"8.03"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668520"	""	"None"	"451.54"	"1"	"5.40"	"BDBM167764"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N[C@H](C(=O)O)C(C)(C)C)CC3)cc12"	"IC50"	"'='"	"95.0"	"nM"	"7.02"	""	"311545"	"UO_0000065"	"15.55"	"0.29"	"1.62"	"8.05"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668428"	""	"None"	"438.58"	"0"	"4.65"	"BDBM167670"	"CN1CCC(c2cc3c(-c4cccc(NCc5ccc6c(c5)CNC6)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	"311452"	"UO_0000065"	"16.67"	"0.30"	"2.66"	"10.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668431"	""	"None"	"510.06"	"2"	"5.10"	"BDBM167673"	"CN1CCC(c2cc3c(-c4nc(NCc5ccc(S(C)(=O)=O)cc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	"311455"	"UO_0000065"	"14.48"	"0.29"	"2.29"	"8.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668434"	""	"None"	"420.56"	"0"	"3.18"	"BDBM167676"	"CN1CCC(c2cc3c(-c4cccc(NCCN5CCOCC5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"311458"	"UO_0000065"	"16.55"	"0.31"	"3.78"	"10.04"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668392"	""	"None"	"401.46"	"0"	"3.43"	"2"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	""	"UO_0000065"	"18.35"	"0.36"	"3.94"	"9.78"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668489"	""	"None"	"366.39"	"0"	"4.65"	"5"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C(=O)O)CC3)cc12"	"IC50"	"'='"	"2100.0"	"nM"	"5.68"	""	""	"UO_0000065"	"15.50"	"0.29"	"1.03"	"7.55"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3668554"	""	"None"	"463.55"	"1"	"5.50"	"14"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"350.0"	"nM"	"6.46"	""	""	"UO_0000065"	"13.93"	"0.26"	"0.96"	"8.23"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4849746"	""	"None"	"464.54"	"0"	"4.02"	"24"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"640.0"	"nM"	"6.19"	""	""	"UO_0000065"	"13.33"	"0.25"	"2.17"	"7.58"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL445340"	""	"None"	"271.32"	"0"	"1.54"	"87-1"	"CC(C)C1CNC(=O)c2cc(-c3ccnc(N)n3)[nH]c21"	"IC50"	"'='"	"31.0"	"nM"	"7.51"	""	""	"UO_0000065"	"27.67"	"0.51"	"5.97"	"7.77"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL3668346"	""	"None"	"355.41"	"0"	"3.82"	"BDBM167587"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CNC(C)(C)CO3)cc12"	"IC50"	"'='"	"360.0"	"nM"	"6.44"	""	"311369"	"UO_0000065"	"18.13"	"0.34"	"2.62"	"10.89"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668389"	""	"None"	"480.58"	"1"	"5.18"	"BDBM167630"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C4CCN(C(=O)OC(C)(C)C)C4)C3)cc12"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"311412"	"UO_0000065"	"14.57"	"0.27"	"1.82"	"9.90"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668400"	""	"None"	"369.44"	"0"	"3.55"	"BDBM167641"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN(CCO)C3)cc12"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311423"	"UO_0000065"	"20.78"	"0.39"	"4.13"	"12.51"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668421"	""	"None"	"411.55"	"1"	"5.09"	"BDBM167663"	"CN1CCC(c2cc3c(-c4cccc(NCCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311445"	"UO_0000065"	"18.88"	"0.34"	"2.68"	"13.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668455"	""	"None"	"311.36"	"0"	"3.41"	"BDBM167697"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(C)C3)cc12"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"311479"	"UO_0000065"	"24.16"	"0.45"	"4.11"	"18.28"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663743"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167517"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"16.0"	"nM"	"7.80"	""	"311299"	"UO_0000065"	"23.96"	"0.44"	"3.96"	"15.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663745"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167519"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@H]3CCCNC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311301"	"UO_0000065"	"23.47"	"0.43"	"3.80"	"15.29"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668489"	""	"None"	"366.39"	"0"	"4.65"	"5"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C(=O)O)CC3)cc12"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	""	"UO_0000065"	"19.45"	"0.36"	"2.47"	"9.47"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668416"	""	"None"	"432.57"	"0"	"3.49"	"BDBM167657"	"CN1CCC(c2cc3c(-c4cccc(N(C)CCN5CCCC5=O)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"370.0"	"nM"	"6.43"	""	"311439"	"UO_0000065"	"14.87"	"0.27"	"2.94"	"9.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668450"	""	"None"	"422.55"	"1"	"5.02"	"BDBM167692"	"CN1CCC(c2cc3c(-c4cc(NCC5CCOCC5)ccc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"52.0"	"nM"	"7.28"	""	"311474"	"UO_0000065"	"17.24"	"0.32"	"2.26"	"13.70"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668480"	""	"None"	"436.92"	"0"	"4.89"	"BDBM167723"	"Fc1cncc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCCNC5)cc34)n2)c1"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311504"	"UO_0000065"	"17.78"	"0.34"	"2.88"	"9.89"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668561"	""	"None"	"490.58"	"0"	"3.70"	"BDBM167805"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CN(CC(=O)N5CCC[C@H]5CO)CC4C3)cc12"	"IC50"	"'='"	"125.0"	"nM"	"6.90"	""	"311586"	"UO_0000065"	"14.07"	"0.26"	"3.20"	"8.45"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673496"	""	"None"	"372.43"	"0"	"2.81"	"BDBM167814"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(F)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"250.0"	"nM"	"6.60"	""	"311595"	"UO_0000065"	"17.73"	"0.35"	"3.79"	"8.36"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673507"	""	"None"	"420.47"	"0"	"4.38"	"BDBM167825"	"Fc1ccc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1F"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"311606"	"UO_0000065"	"19.14"	"0.35"	"3.67"	"10.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3957008"	""	"None"	"348.43"	"0"	"3.74"	"BDBM223905"	"CN1CCc2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	"391007"	"UO_0000065"	"21.77"	"0.40"	"3.85"	"17.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"125.0"	"nM"	"6.90"	""	"327612"	"UO_0000065"	"16.50"	"0.33"	"2.16"	"7.85"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327620"	"UO_0000065"	"17.63"	"0.40"	"3.41"	"9.69"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3919798"	""	"None"	"452.51"	"1"	"5.48"	"BDBM223827"	"CN1Cc2c(C3=CCN(C(=O)OC(C)(C)C)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"780.0"	"nM"	"6.11"	""	"390929"	"UO_0000065"	"13.50"	"0.25"	"0.63"	"9.94"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3974363"	""	"None"	"426.52"	"0"	"3.41"	"BDBM223906"	"CN1CCc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"78.0"	"nM"	"7.11"	""	"391008"	"UO_0000065"	"16.66"	"0.32"	"3.70"	"10.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3910044"	""	"None"	"456.59"	"1"	"5.30"	"BDBM223947"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"391049"	"UO_0000065"	"15.43"	"0.28"	"1.75"	"9.72"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"327615"	"UO_0000065"	"16.96"	"0.34"	"2.84"	"8.49"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663777"	""	"None"	"453.92"	"1"	"5.64"	"BDBM167552"	"Fc1ccc(F)c(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311334"	"UO_0000065"	"17.12"	"0.33"	"2.13"	"11.84"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL258721"	""	"None"	"473.36"	"0"	"4.50"	"K00600a, RGB-286147"	"CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	""	"UO_0000065"	"17.00"	"0.34"	"3.55"	"8.65"	"0"	"CHEMBL936787"	"Inhibition of Cdk9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1145498"	"1"	"Scientific Literature"	"Proc Natl Acad Sci U S A"	"2007"	"None"	""	""	""
"CHEMBL3668406"	""	"None"	"439.99"	"0"	"4.93"	"BDBM167647"	"CN1CCC(c2cc3c(-c4nc(NCC5CCOCC5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"311429"	"UO_0000065"	"15.73"	"0.30"	"1.99"	"10.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668444"	""	"None"	"525.10"	"2"	"5.76"	"BDBM167686"	"CN1CCC(c2cc3c(-c4nc(NCC5CCN(C(=O)OC(C)(C)C)C5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	"311468"	"UO_0000065"	"13.57"	"0.26"	"1.36"	"8.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668451"	""	"None"	"450.56"	"0"	"4.57"	"BDBM167693"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CN4CCCCC4)CC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311475"	"UO_0000065"	"16.95"	"0.32"	"3.07"	"12.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668464"	""	"None"	"339.41"	"0"	"4.23"	"BDBM167706"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCCNC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311488"	"UO_0000065"	"22.04"	"0.41"	"3.25"	"14.98"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668465"	""	"None"	"434.95"	"1"	"6.10"	"BDBM167708"	"Fc1ccc(NCc2ccccc2)cc1-c1c(Cl)cnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311489"	"UO_0000065"	"17.20"	"0.33"	"1.38"	"14.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668468"	""	"None"	"446.93"	"0"	"4.15"	"BDBM167711"	"FC1(F)CN[C@H](CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)C1"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"311492"	"UO_0000065"	"15.21"	"0.30"	"2.65"	"8.75"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668470"	""	"None"	"431.97"	"1"	"5.38"	"BDBM167713"	"CN(Cc1ccccc1)c1ccc(Cl)c(-c2ccnc3[nH]c(C4CCCNC4)cc23)n1"	"IC50"	"'='"	"55.0"	"nM"	"7.26"	""	"311494"	"UO_0000065"	"16.81"	"0.32"	"1.88"	"12.77"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668357"	""	"None"	"475.98"	"1"	"5.84"	"BDBM167598"	"COC(=O)N1CCCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)c(Cl)cnc3[nH]2)C1"	"IC50"	"'='"	"1300.0"	"nM"	"5.89"	""	"311380"	"UO_0000065"	"12.37"	"0.24"	"0.05"	"7.08"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668363"	""	"None"	"405.55"	"0"	"4.27"	"BDBM167604"	"CN1CCC(c2cc3c(-c4cccc(NCC5CCOCC5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"311386"	"UO_0000065"	"18.42"	"0.34"	"3.20"	"11.30"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668369"	""	"None"	"411.55"	"1"	"5.07"	"BDBM167610"	"CN1CCC(c2cc3c(-c4cccc(N(C)Cc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"50.0"	"nM"	"7.30"	""	"311392"	"UO_0000065"	"17.74"	"0.32"	"2.23"	"15.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668371"	""	"None"	"324.40"	"1"	"5.43"	"BDBM167612"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCCC3)cc12"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	"311394"	"UO_0000065"	"20.25"	"0.37"	"1.14"	"17.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668514"	""	"None"	"466.56"	"0"	"3.54"	"BDBM167757"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N4CCC[C@H]4CO)CC3)cc12"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311538"	"UO_0000065"	"15.75"	"0.30"	"3.81"	"8.99"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668531"	""	"None"	"423.42"	"0"	"3.82"	"BDBM167775"	"CNC(=O)N1CC=C(c2[nH]c3ncc(F)c(-c4cc(F)ccc4OC)c3c2C#N)CC1"	"IC50"	"'='"	"85.0"	"nM"	"7.07"	""	"311556"	"UO_0000065"	"16.70"	"0.31"	"3.25"	"7.52"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668532"	""	"None"	"479.49"	"0"	"2.68"	"BDBM167776"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N4CC(O)C4)CC3)c(C#N)c12"	"IC50"	"'='"	"135.0"	"nM"	"6.87"	""	"311557"	"UO_0000065"	"14.33"	"0.27"	"4.19"	"6.51"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327490"	"UO_0000065"	"19.07"	"0.38"	"3.77"	"9.55"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3919796"	""	"None"	"508.35"	"2"	"5.02"	"BDBM180823"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327491"	"UO_0000065"	"16.52"	"0.37"	"3.38"	"8.38"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3954215"	""	"None"	"474.58"	"1"	"5.44"	"BDBM223958"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	"391060"	"UO_0000065"	"15.04"	"0.28"	"1.70"	"9.85"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"60.0"	"nM"	"7.22"	""	"327626"	"UO_0000065"	"16.55"	"0.33"	"2.34"	"8.21"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3949630"	""	"None"	"473.48"	"0"	"4.92"	"BDBM180845"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=O)(=NC#N)C3CC3)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327639"	"UO_0000065"	"17.74"	"0.35"	"3.48"	"8.38"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3892881"	""	"None"	"498.53"	"1"	"6.06"	"BDBM180850"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccc(F)cc3)n2)c1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327644"	"UO_0000065"	"16.85"	"0.33"	"2.34"	"9.55"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"1"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL3694408"	""	"None"	"388.79"	"0"	"3.36"	"BDBM120943"	"COc1ccc(F)cc1-c1cc(NC(=O)COc2ccc(Cl)cn2)ncn1"	"IC50"	"'='"	"0.005"	"nM"	""	"Outside typical range"	"249042"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3952495"	""	"None"	"447.56"	"0"	"4.13"	"BDBM223892"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C(C)(C)C1"	"IC50"	"'='"	"870.0"	"nM"	"6.06"	""	"390994"	"UO_0000065"	"13.54"	"0.25"	"1.93"	"10.93"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3898302"	""	"None"	"500.62"	"2"	"5.84"	"BDBM223952"	"COC(=O)C(C)=C1CCC(N2CC=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2)CC1"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"391054"	"UO_0000065"	"14.47"	"0.27"	"1.40"	"11.79"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3907184"	""	"None"	"472.56"	"1"	"5.36"	"BDBM223955"	"CN1Cc2c(C3=CCN(C4CCC(=CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"58.0"	"nM"	"7.24"	""	"391057"	"UO_0000065"	"15.31"	"0.28"	"1.88"	"9.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3891660"	""	"None"	"469.59"	"0"	"3.30"	"BDBM223956"	"CN1Cc2c(C3=CCN(CCS(=O)(=O)N(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"391058"	"UO_0000065"	"16.19"	"0.31"	"4.30"	"10.48"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3971069"	""	"None"	"499.59"	"1"	"5.19"	"BDBM223969"	"CN1Cc2c(C3=CCN(C4CCC(C(C#N)C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"88.0"	"nM"	"7.06"	""	"391071"	"UO_0000065"	"14.12"	"0.26"	"1.87"	"7.33"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3668380"	""	"None"	"429.59"	"1"	"5.30"	"BDBM167621"	"c1ccc(SCCNc2cccc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"311403"	"UO_0000065"	"17.33"	"0.33"	"2.14"	"11.34"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668383"	""	"None"	"395.48"	"0"	"4.35"	"BDBM167624"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C4CCOCC4)C3)cc12"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311406"	"UO_0000065"	"18.60"	"0.35"	"3.01"	"14.60"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668415"	""	"None"	"404.52"	"0"	"3.13"	"BDBM167656"	"O=C1CCCN1CCNc1cccc(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"320.0"	"nM"	"6.50"	""	"311438"	"UO_0000065"	"16.06"	"0.30"	"3.36"	"7.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668440"	""	"None"	"340.40"	"0"	"2.74"	"BDBM167682"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(CCN)C3)cc12"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"311464"	"UO_0000065"	"21.94"	"0.41"	"4.73"	"11.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668453"	""	"None"	"480.58"	"0"	"3.98"	"BDBM167695"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CNC4CCC(O)CC4)CC3)cc12"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"311477"	"UO_0000065"	"15.93"	"0.30"	"3.68"	"8.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668461"	""	"None"	"492.62"	"1"	"5.19"	"BDBM167703"	"CN1CCC(c2cc3c(-c4cc(NCc5ccc(S(C)(=O)=O)cc5)ccc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"311485"	"UO_0000065"	"16.44"	"0.32"	"2.91"	"10.37"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668463"	""	"None"	"426.95"	"0"	"2.88"	"BDBM167705"	"O[C@@H]1CN[C@@H](CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)C1"	"IC50"	"'='"	"810.0"	"nM"	"6.09"	""	"311487"	"UO_0000065"	"14.27"	"0.28"	"3.21"	"6.22"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668510"	""	"None"	"391.41"	"0"	"3.66"	"BDBM167753"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)NC#N)CC3)cc12"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"311534"	"UO_0000065"	"19.34"	"0.36"	"3.91"	"8.05"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668523"	""	"None"	"392.50"	"0"	"3.51"	"BDBM167767"	"COc1ccccc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"82.0"	"nM"	"7.09"	""	"311548"	"UO_0000065"	"18.05"	"0.33"	"3.58"	"11.53"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673509"	""	"None"	"460.51"	"0"	"3.47"	"BDBM167827"	"O=C(CO)N1CCC(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"311608"	"UO_0000065"	"17.28"	"0.32"	"4.49"	"7.44"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668489"	""	"None"	"366.39"	"0"	"4.65"	"BDBM167732"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C(=O)O)CC3)cc12"	"IC50"	"'='"	"62.0"	"nM"	"7.21"	""	"311513"	"UO_0000065"	"19.67"	"0.36"	"2.56"	"9.58"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668563"	""	"None"	"481.54"	"1"	"5.64"	"BDBM167807"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(C4CCC(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"99.0"	"nM"	"7.00"	""	"311588"	"UO_0000065"	"14.55"	"0.27"	"1.36"	"8.93"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673497"	""	"None"	"495.56"	"0"	"4.56"	"BDBM167815"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(NCc5c(F)cccc5F)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"170.0"	"nM"	"6.77"	""	"311596"	"UO_0000065"	"13.66"	"0.26"	"2.21"	"7.44"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673503"	""	"None"	"420.47"	"0"	"4.38"	"BDBM167821"	"Fc1cc(F)cc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"311602"	"UO_0000065"	"19.74"	"0.37"	"3.92"	"10.57"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327623"	"UO_0000065"	"18.92"	"0.37"	"3.86"	"8.46"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668552"	""	"None"	"452.51"	"0"	"3.94"	"BDBM167796"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CC4CN(CC(=O)N(C)C)CC4C3)cc12"	"IC50"	"'='"	"104.0"	"nM"	"6.98"	""	"311577"	"UO_0000065"	"15.43"	"0.29"	"3.04"	"11.36"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668362"	""	"None"	"391.52"	"0"	"3.93"	"BDBM167603"	"c1cc(NCC2CCOCC2)nc(-c2ccnc3[nH]c(C4CCNCC4)cc23)c1"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"311385"	"UO_0000065"	"19.21"	"0.35"	"3.59"	"10.05"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL445340"	""	"None"	"271.32"	"0"	"1.54"	"87-2"	"CC(C)C1CNC(=O)c2cc(-c3ccnc(N)n3)[nH]c21"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	""	"UO_0000065"	"26.30"	"0.49"	"5.60"	"7.38"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL3929697"	""	"None"	"412.49"	"0"	"3.37"	"BDBM223939"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	"391041"	"UO_0000065"	"17.93"	"0.35"	"4.03"	"10.68"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3941083"	""	"None"	"419.50"	"0"	"3.50"	"BDBM223875"	"CN(C)C(=O)CN1CCC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C1"	"IC50"	"'='"	"420.0"	"nM"	"6.38"	""	"390977"	"UO_0000065"	"15.20"	"0.28"	"2.88"	"11.50"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3935574"	""	"None"	"452.56"	"0"	"4.29"	"BDBM223877"	"CN1Cc2c(C3=CC4CCCC(C3)N4S(C)(=O)=O)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"400.0"	"nM"	"6.40"	""	"390979"	"UO_0000065"	"14.14"	"0.27"	"2.11"	"9.23"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3926650"	""	"None"	"459.57"	"0"	"4.42"	"BDBM223879"	"CN(C)C(=O)CN1C2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC1CCC2"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390981"	"UO_0000065"	"15.14"	"0.28"	"2.54"	"12.54"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3965251"	""	"None"	"432.50"	"0"	"4.41"	"BDBM223886"	"CN1Cc2c(C3=CC4CCCC(C3)N4CC(=O)O)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390988"	"UO_0000065"	"16.09"	"0.30"	"2.55"	"9.60"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL496568"	""	"None"	"366.56"	"0"	"4.40"	"5"	"CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@@H](N)CC3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL1967252"	""	"None"	"209.25"	"0"	"2.93"	"SGCV153, 49830586"	"Cc1n[nH]c2ccc(-c3cccnc3)cc12"	"IC50"	"'='"	"630.96"	"nM"	"6.20"	""	""	"UO_0000065"	"29.63"	"0.53"	"3.27"	"14.91"	"0"	"CHEMBL2422672"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2417410"	"1"	"Scientific Literature"	"J Med Chem"	"2013"	"None"	""	""	""
"CHEMBL3663795"	""	"None"	"431.97"	"1"	"5.92"	"BDBM167570"	"C[C@H](Nc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1)c1ccccc1"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	"311352"	"UO_0000065"	"16.92"	"0.32"	"1.39"	"11.14"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3914748"	""	"None"	"434.52"	"1"	"5.34"	"BDBM223780"	"CN1Cc2c(C3=CCN(C(=O)OC(C)(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	"390882"	"UO_0000065"	"15.28"	"0.28"	"1.30"	"10.80"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3946855"	""	"None"	"430.48"	"0"	"3.51"	"BDBM223846"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"390948"	"UO_0000065"	"17.24"	"0.34"	"3.91"	"10.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3905946"	""	"None"	"390.42"	"0"	"3.93"	"BDBM223930"	"CN1Cc2c(C3=C[C@H]4COC(=O)N4CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	"391032"	"UO_0000065"	"18.92"	"0.35"	"3.46"	"12.02"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3900262"	""	"None"	"552.60"	"2"	"6.50"	"BDBM180798"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327466"	"UO_0000065"	"14.56"	"0.28"	"1.55"	"7.83"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3892285"	""	"None"	"505.55"	"2"	"5.82"	"BDBM180802"	"CS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1)=NC#N"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"327470"	"UO_0000065"	"14.75"	"0.28"	"1.64"	"7.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663786"	""	"None"	"431.97"	"1"	"5.38"	"BDBM167561"	"CN(Cc1ccccc1)c1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311343"	"UO_0000065"	"17.77"	"0.34"	"2.30"	"13.51"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663796"	""	"None"	"397.53"	"1"	"5.05"	"BDBM167571"	"CN1CCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311353"	"UO_0000065"	"19.68"	"0.36"	"2.77"	"13.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663798"	""	"None"	"418.93"	"1"	"5.32"	"BDBM167573"	"Clc1ccc(OCc2ccccc2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"24.0"	"nM"	"7.62"	""	"311355"	"UO_0000065"	"18.19"	"0.35"	"2.30"	"12.13"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668436"	""	"None"	"439.01"	"0"	"4.50"	"BDBM167678"	"CN1CCC(c2cc3c(-c4nc(NCC5CCNCC5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"450.0"	"nM"	"6.35"	""	"311460"	"UO_0000065"	"14.46"	"0.28"	"1.85"	"9.22"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668544"	""	"None"	"384.38"	"0"	"4.78"	"BDBM167788"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCC(C(=O)O)CC3)cc12"	"IC50"	"'='"	"124.0"	"nM"	"6.91"	""	"311569"	"UO_0000065"	"17.97"	"0.34"	"2.13"	"9.18"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668553"	""	"None"	"463.55"	"1"	"5.50"	"BDBM167797"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"71.0"	"nM"	"7.15"	""	"311578"	"UO_0000065"	"15.42"	"0.29"	"1.65"	"9.11"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3639626"	""	"None"	"341.84"	"0"	"4.36"	"BDBM167541"	"COc1c(Cl)cccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"300.0"	"nM"	"6.52"	""	"311323"	"UO_0000065"	"19.08"	"0.37"	"2.16"	"13.06"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3982110"	""	"None"	"493.56"	"0"	"3.53"	"BDBM223848"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	"390950"	"UO_0000065"	"14.32"	"0.27"	"3.54"	"9.33"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327501"	"UO_0000065"	"19.24"	"0.38"	"3.52"	"9.55"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327506"	"UO_0000065"	"18.84"	"0.37"	"3.34"	"9.35"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3912866"	""	"None"	"522.45"	"2"	"6.00"	"BDBM180842"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327510"	"UO_0000065"	"15.74"	"0.32"	"2.22"	"9.35"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3944304"	""	"None"	"455.49"	"0"	"4.79"	"BDBM180843"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=O)(=NC#N)C3CC3)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327511"	"UO_0000065"	"19.10"	"0.37"	"3.91"	"8.68"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	"327628"	"UO_0000065"	"16.35"	"0.32"	"2.26"	"8.11"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668356"	""	"None"	"431.97"	"1"	"5.70"	"BDBM167597"	"CN1CCCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)c(Cl)cnc3[nH]2)C1"	"IC50"	"'='"	"180.0"	"nM"	"6.75"	""	"311379"	"UO_0000065"	"15.61"	"0.30"	"1.04"	"11.87"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668446"	""	"None"	"506.01"	"2"	"5.16"	"BDBM167688"	"CN1CCC(c2cc3c(-c4nc(NCc5cccc(OCC(=O)O)c5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"311470"	"UO_0000065"	"13.83"	"0.27"	"1.84"	"6.77"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668449"	""	"None"	"422.92"	"0"	"3.82"	"BDBM167691"	"CN1CCC(c2cc3c(-c4nc(NCc5nnc[nH]5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"78.0"	"nM"	"7.11"	""	"311473"	"UO_0000065"	"16.81"	"0.32"	"3.29"	"7.22"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668471"	""	"None"	"343.38"	"0"	"3.98"	"BDBM167714"	"COc1cc(F)c(F)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	"311495"	"UO_0000065"	"22.09"	"0.41"	"3.61"	"15.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668479"	""	"None"	"419.92"	"0"	"4.72"	"BDBM167722"	"Clc1ccc(OCc2cccnc2)nc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	"311503"	"UO_0000065"	"16.90"	"0.32"	"2.38"	"9.37"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668485"	""	"None"	"380.42"	"0"	"3.81"	"BDBM167728"	"CNC(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311509"	"UO_0000065"	"20.30"	"0.38"	"3.91"	"10.99"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668542"	""	"None"	"452.51"	"0"	"3.54"	"BDBM167786"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CC4CN(S(C)(=O)=O)CC4C3)cc12"	"IC50"	"'='"	"87.0"	"nM"	"7.06"	""	"311567"	"UO_0000065"	"15.60"	"0.30"	"3.52"	"7.13"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673520"	""	"None"	"417.49"	"0"	"4.55"	"BDBM167838"	"CN1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"13.0"	"nM"	"7.89"	""	"311619"	"UO_0000065"	"18.89"	"0.35"	"3.34"	"11.78"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673539"	""	"None"	"479.54"	"0"	"3.79"	"BDBM167857"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"311638"	"UO_0000065"	"16.88"	"0.33"	"4.31"	"8.01"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673548"	""	"None"	"443.48"	"1"	"5.04"	"BDBM167866"	"O=C(O)C1CC=C(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311647"	"UO_0000065"	"16.59"	"0.30"	"2.32"	"7.09"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3969365"	""	"None"	"452.51"	"0"	"4.23"	"BDBM60461"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CC4CCC(C3)N4CC(=O)N(C)C)cc12"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"218799"	"UO_0000065"	"15.57"	"0.29"	"2.82"	"11.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3930674"	""	"None"	"537.60"	"2"	"5.58"	"BDBM60463"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CCC(C3)N4C(=O)Cn3c(OC)cc4cccnc43)cc12"	"IC50"	"'='"	"61.0"	"nM"	"7.21"	""	"218850"	"UO_0000065"	"13.42"	"0.25"	"1.63"	"8.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3970239"	""	"None"	"317.40"	"0"	"2.95"	"BDBM223913"	"CN1Cc2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cccnc21"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"391015"	"UO_0000065"	"22.69"	"0.41"	"4.25"	"12.67"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3975804"	""	"None"	"492.57"	"1"	"5.58"	"BDBM223924"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"82.0"	"nM"	"7.09"	""	"391026"	"UO_0000065"	"14.39"	"0.27"	"1.51"	"9.78"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3958592"	""	"None"	"402.50"	"0"	"2.75"	"BDBM223927"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ncccc2-4)CC1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"391029"	"UO_0000065"	"17.29"	"0.32"	"4.21"	"10.18"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3952127"	""	"None"	"478.54"	"1"	"5.19"	"BDBM223928"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"391030"	"UO_0000065"	"15.14"	"0.28"	"2.05"	"10.00"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3937521"	""	"None"	"390.42"	"0"	"3.93"	"BDBM223931"	"CN1Cc2c(C3=CCN4C(=O)OC[C@H]4C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"391033"	"UO_0000065"	"18.39"	"0.34"	"3.25"	"11.68"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3900994"	""	"None"	"442.56"	"0"	"4.91"	"BDBM223949"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"391051"	"UO_0000065"	"15.42"	"0.28"	"1.91"	"9.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3901136"	""	"None"	"486.59"	"1"	"5.75"	"BDBM223962"	"CN1Cc2c(C3=CCCN(C4CCC(=CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"391064"	"UO_0000065"	"14.15"	"0.26"	"1.14"	"9.50"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3673512"	""	"None"	"398.51"	"0"	"4.44"	"BDBM167830"	"CN1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"311611"	"UO_0000065"	"20.07"	"0.36"	"3.56"	"11.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL524629"	""	"None"	"366.56"	"0"	"4.13"	"2"	"CC(C)(C)c1cnc(CSc2cnc(NCC3CCNCC3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3668350"	""	"None"	"339.41"	"0"	"4.15"	"BDBM167591"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCNCC3)c(C)c12"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311373"	"UO_0000065"	"22.89"	"0.42"	"3.62"	"15.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3901726"	""	"None"	"321.36"	"0"	"3.64"	"BDBM223792"	"Fc1ccc2c(c1)-c1ccnc3[nH]c(C4=CCNCC4)c(c13)CO2"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	"390894"	"UO_0000065"	"23.96"	"0.44"	"4.06"	"15.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3986185"	""	"None"	"505.59"	"1"	"2.47"	"BDBM223863"	"CN(CC(O)CO)C(=O)CN1CC2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2C1"	"IC50"	"'='"	"99.0"	"nM"	"7.00"	""	"390965"	"UO_0000065"	"13.85"	"0.26"	"4.53"	"7.30"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3942621"	""	"None"	"348.43"	"0"	"4.09"	"BDBM223865"	"CN1Cc2c(C3=CCCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	"390967"	"UO_0000065"	"20.22"	"0.37"	"2.96"	"16.03"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3960117"	""	"None"	"503.62"	"1"	"4.03"	"BDBM223893"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"950.0"	"nM"	"6.02"	""	"390995"	"UO_0000065"	"11.96"	"0.22"	"1.99"	"7.96"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3953907"	""	"None"	"374.45"	"0"	"3.00"	"BDBM223917"	"CNC(=O)N1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ncccc2-4)CC1"	"IC50"	"'='"	"94.0"	"nM"	"7.03"	""	"391019"	"UO_0000065"	"18.77"	"0.34"	"4.03"	"9.11"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3694400"	""	"None"	"330.36"	"0"	"2.23"	"BDBM120934"	"COc1ccc(F)cc1-c1cc(NC(=O)C2CCCNC2)ncn1"	"IC50"	"'='"	"0.018"	"nM"	"10.74"	""	"249033"	"UO_0000065"	"32.52"	"0.61"	"8.51"	"14.11"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3673435"	""	"None"	"371.41"	"0"	"3.14"	"BDBM164884"	"COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"308357"	"UO_0000065"	"21.54"	"0.40"	"4.86"	"9.96"	"0"	"CHEMBL3707939"	"In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638701"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4434871"	""	"None"	"606.73"	"2"	"5.59"	"YKL-1-116"	"C=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3n[nH]c4c3CN(C(=O)N[C@H](CN(C)C)c3ccccc3)C4(C)C)c2)cc1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL3668358"	""	"None"	"524.09"	"2"	"5.81"	"BDBM167599"	"CC(C)S(=O)(=O)N1CCCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)c(Cl)cnc3[nH]2)C1"	"IC50"	"'='"	"600.0"	"nM"	"6.22"	""	"311381"	"UO_0000065"	"11.87"	"0.24"	"0.41"	"6.84"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327603"	"UO_0000065"	"17.27"	"0.33"	"2.38"	"9.44"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3932928"	""	"None"	"462.57"	"1"	"5.34"	"BDBM223814"	"CN1Cc2c(C3=CCC(N[C@H](C(=O)O)C(C)(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	"390916"	"UO_0000065"	"15.55"	"0.29"	"1.85"	"8.85"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3980578"	""	"None"	"418.47"	"0"	"4.02"	"BDBM223836"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4CC(=O)O)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"170.0"	"nM"	"6.77"	""	"390938"	"UO_0000065"	"16.18"	"0.30"	"2.75"	"9.34"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3958055"	""	"None"	"330.37"	"0"	"4.38"	"BDBM223838"	"CN1Cc2c(-c3cccnc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	"390940"	"UO_0000065"	"21.57"	"0.39"	"2.74"	"15.90"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3984185"	""	"None"	"410.42"	"0"	"3.63"	"BDBM223845"	"CN1Cc2c(C3=CCN(CC(=O)O)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"390947"	"UO_0000065"	"17.83"	"0.33"	"3.69"	"10.10"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3927646"	""	"None"	"387.41"	"0"	"4.61"	"BDBM223860"	"CN1Cc2c(-c3cccc(CC(=O)O)c3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"390962"	"UO_0000065"	"18.07"	"0.33"	"2.39"	"10.11"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3897049"	""	"None"	"515.63"	"1"	"4.31"	"BDBM223884"	"CN1Cc2c(C3=CC4CCCC(C3)N4CC(=O)N(C)C3CC(O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"390986"	"UO_0000065"	"13.93"	"0.26"	"2.87"	"9.49"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL455450"	""	"None"	"394.57"	"0"	"3.91"	"18"	"C[C@H]1CNC[C@@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1"	"IC50"	"'='"	"3200.0"	"nM"	"5.50"	""	""	"UO_0000065"	"13.93"	"0.29"	"1.58"	"6.86"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3668487"	""	"None"	"470.55"	"1"	"5.63"	"BDBM167730"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(Cc4ccc(NC(C)=O)cc4)CC3)cc12"	"IC50"	"'='"	"56.0"	"nM"	"7.25"	""	"311511"	"UO_0000065"	"15.41"	"0.28"	"1.62"	"10.32"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668488"	""	"None"	"502.57"	"1"	"4.49"	"BDBM167731"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(=O)(=O)N(C(=O)O)C(C)(C)C)CC3)cc12"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	"311512"	"UO_0000065"	"14.31"	"0.28"	"2.70"	"6.21"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663747"	""	"None"	"323.40"	"0"	"2.68"	"BDBM167521"	"COc1ccc(N)nc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"6900.0"	"nM"	"5.16"	""	"311303"	"UO_0000065"	"15.96"	"0.29"	"2.48"	"5.81"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668345"	""	"None"	"355.41"	"0"	"3.82"	"BDBM167586"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CNC(C)(C)CO3)cc12"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"311368"	"UO_0000065"	"20.26"	"0.38"	"3.38"	"12.17"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668349"	""	"None"	"339.41"	"0"	"4.36"	"BDBM167590"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCC(N)C3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311372"	"UO_0000065"	"22.50"	"0.42"	"3.28"	"11.95"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668376"	""	"None"	"325.39"	"0"	"4.14"	"BDBM167617"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN3C)cc12"	"IC50"	"'='"	"430.0"	"nM"	"6.37"	""	"311399"	"UO_0000065"	"19.57"	"0.36"	"2.23"	"15.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4635959"	""	"None"	"497.64"	"0"	"2.89"	"Fig 7, Cpd II"	"Cc1cc(NC2CCN(C(=O)O[C@H]3CCN(C(=O)/C=C/CN(C)C)C3)CC2)n2ncc(C(C)C)c2n1"	"IC50"	"'='"	"6320.0"	"nM"	"5.20"	""	""	"UO_0000065"	"10.45"	"0.20"	"2.31"	"5.46"	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL3301610"	"ABEMACICLIB"	"4.0"	"506.61"	"1"	"4.94"	"6; LY2835219"	"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	""	"UO_0000065"	"14.30"	"0.27"	"2.30"	"9.66"	"0"	"CHEMBL4348721"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346699"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL14762"	"SELICICLIB"	"2.0"	"354.46"	"0"	"3.20"	"2"	"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	""	"UO_0000065"	"18.73"	"0.35"	"3.44"	"7.55"	"0"	"CHEMBL4348721"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346699"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL452602"	""	"None"	"394.57"	"0"	"3.91"	"20"	"C[C@@H]1CNC[C@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	""	"UO_0000065"	"17.54"	"0.36"	"3.01"	"8.65"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL4225966"	"SEL-120 FREE BASE"	"1.0"	"414.14"	"0"	"3.23"	"2; SEL120-34A"	"Cc1c(Br)c(Br)c2c3c1nc(N1CCNCC1)n3CCC2"	"IC50"	"'='"	"1070.0"	"nM"	"5.97"	""	""	"UO_0000065"	"14.42"	"0.39"	"2.74"	"18.04"	"0"	"CHEMBL4220232"	"Inhibition of CDK9 (unknown origin) in presence of [gamma33P]ATP by radiometric method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4219051"	"1"	"Scientific Literature"	"J Med Chem"	"2018"	"None"	""	""	""
"CHEMBL3923419"	""	"None"	"461.47"	"0"	"4.78"	"BDBM180831"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327499"	"UO_0000065"	"17.99"	"0.35"	"3.52"	"8.28"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668404"	""	"None"	"341.85"	"0"	"3.67"	"BDBM167645"	"CN1CCC(c2cc3c(-c4nc(N)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"311427"	"UO_0000065"	"20.14"	"0.39"	"3.22"	"9.72"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668410"	""	"None"	"397.53"	"0"	"4.75"	"BDBM167651"	"c1ccc(CCNc2cccc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311433"	"UO_0000065"	"18.82"	"0.34"	"2.73"	"11.40"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668475"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167718"	"Clc1cnc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311499"	"UO_0000065"	"18.28"	"0.35"	"2.28"	"11.64"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668502"	""	"None"	"410.49"	"0"	"3.65"	"BDBM167745"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"311526"	"UO_0000065"	"18.08"	"0.34"	"3.77"	"12.07"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668504"	""	"None"	"492.50"	"0"	"3.85"	"BDBM167747"	"CCN(C(=O)O)S(=O)(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)c(F)cnc3[nH]2)CC1"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"311528"	"UO_0000065"	"13.98"	"0.28"	"3.04"	"5.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663760"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167534"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311316"	"UO_0000065"	"23.73"	"0.44"	"3.88"	"15.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663770"	""	"None"	"339.41"	"0"	"4.19"	"BDBM167545"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311327"	"UO_0000065"	"22.50"	"0.42"	"3.45"	"18.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668530"	""	"None"	"444.46"	"0"	"3.44"	"BDBM167774"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)c(C#N)c12"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	"311555"	"UO_0000065"	"16.45"	"0.32"	"3.87"	"7.38"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673498"	""	"None"	"494.02"	"0"	"4.94"	"BDBM167816"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4cccc(NCc5ccccc5Cl)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"490.0"	"nM"	"6.31"	""	"311597"	"UO_0000065"	"12.77"	"0.25"	"1.37"	"6.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673541"	""	"None"	"458.50"	"0"	"4.17"	"BDBM167859"	"CNC(=O)N1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"311640"	"UO_0000065"	"18.97"	"0.35"	"4.53"	"9.06"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673528"	""	"None"	"445.50"	"0"	"4.46"	"BDBM167846"	"CC(=O)N1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"24.0"	"nM"	"7.62"	""	"311627"	"UO_0000065"	"17.10"	"0.32"	"3.16"	"9.07"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673530"	""	"None"	"400.46"	"0"	"4.15"	"BDBM167848"	"Fc1cccc(CNc2cncc(-c3ccnc4[nH]c(C5=CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"311629"	"UO_0000065"	"20.09"	"0.37"	"3.90"	"10.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327482"	"UO_0000065"	"18.99"	"0.37"	"3.90"	"8.13"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327502"	"UO_0000065"	"19.02"	"0.38"	"3.42"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3947123"	""	"None"	"460.55"	"1"	"5.22"	"BDBM223965"	"CC[C@H]1c2c(C3=CCN([C@H]4C[C@@H](C(=O)O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"391067"	"UO_0000065"	"15.11"	"0.28"	"1.74"	"9.60"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL424696"	""	"None"	"353.45"	"0"	"4.45"	"1"	"c1ccc(Nc2ncc(-c3ccnc(OC4CCCCC4)n3)s2)nc1"	"IC50"	"'='"	"2.5"	"nM"	"8.60"	""	""	"UO_0000065"	"24.34"	"0.47"	"4.15"	"11.81"	"0"	"CHEMBL870945"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1137419"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2006"	"None"	""	""	""
"CHEMBL3668474"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167717"	"Fc1ccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCCNC5)cc34)n2)cc1"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"311498"	"UO_0000065"	"17.36"	"0.33"	"2.07"	"11.53"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668417"	""	"None"	"437.52"	"0"	"4.71"	"BDBM167658"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@H]3CC[C@H](NCC4CC4C(=O)O)CC3)cc12"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"311440"	"UO_0000065"	"17.23"	"0.32"	"2.83"	"8.64"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668427"	""	"None"	"387.49"	"0"	"3.77"	"BDBM167669"	"CN1CCC(c2cc3c(-c4cccc(NCc5cc[nH]n5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311451"	"UO_0000065"	"20.19"	"0.37"	"4.05"	"9.15"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668441"	""	"None"	"395.48"	"0"	"4.20"	"BDBM167683"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(CC4CCOCC4)C3)cc12"	"IC50"	"'='"	"290.0"	"nM"	"6.54"	""	"311465"	"UO_0000065"	"16.53"	"0.31"	"2.34"	"12.98"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668495"	""	"None"	"381.41"	"0"	"3.55"	"BDBM167738"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)O)CC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311519"	"UO_0000065"	"19.62"	"0.36"	"3.93"	"9.54"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668395"	""	"None"	"413.49"	"0"	"3.35"	"BDBM167636"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@H]3CC[C@H](NCC(O)CO)CC3)cc12"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"311418"	"UO_0000065"	"18.27"	"0.34"	"4.20"	"8.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668536"	""	"None"	"429.52"	"0"	"4.20"	"BDBM167780"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC(C)(C)N(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"104.0"	"nM"	"6.98"	""	"311561"	"UO_0000065"	"16.26"	"0.32"	"2.78"	"9.27"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327476"	"UO_0000065"	"16.85"	"0.33"	"2.18"	"9.21"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327486"	"UO_0000065"	"19.49"	"0.38"	"3.41"	"9.27"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"327634"	"UO_0000065"	"16.83"	"0.33"	"2.47"	"8.35"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3949630"	""	"None"	"473.48"	"0"	"4.92"	"BDBM180845"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=O)(=NC#N)C3CC3)c2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327513"	"UO_0000065"	"17.36"	"0.34"	"3.30"	"8.20"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3892881"	""	"None"	"498.53"	"1"	"6.06"	"BDBM180850"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccc(F)cc3)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327518"	"UO_0000065"	"16.65"	"0.32"	"2.24"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"327614"	"UO_0000065"	"17.34"	"0.35"	"3.01"	"8.68"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3971492"	""	"None"	"496.61"	"0"	"4.16"	"BDBM223785"	"CS(=O)(=O)N1CC=C(c2[nH]c3nccc4c3c2CN(CC2CCOCC2)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"800.0"	"nM"	"6.10"	""	"390887"	"UO_0000065"	"12.28"	"0.24"	"1.94"	"7.76"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4582951"	""	"None"	"587.13"	"2"	"5.27"	"SY-1365"	"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N[C@@]2(C)CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)nc1"	"IC50"	"'='"	"914.0"	"nM"	"6.04"	""	""	"UO_0000065"	"10.29"	"0.20"	"0.77"	"4.72"	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL4749580"	""	"None"	"385.49"	"0"	"2.66"	"THZ-CE-B-19"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCN(CC)CC3)s2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4644893"	""	"None"	"553.71"	"2"	"5.34"	"B5"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"1.79"	"nM"	"8.75"	""	""	"UO_0000065"	"15.80"	"0.31"	"3.41"	"7.45"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4074103"	""	"None"	"303.37"	"0"	"2.51"	"3"	"N#Cc1ccnc2[nH]c(-c3ccc(N4CCNCC4)cc3)cc12"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	""	"UO_0000065"	"22.49"	"0.41"	"4.31"	"10.07"	"0"	"CHEMBL4047696"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4043256"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2017"	"None"	""	""	""
"CHEMBL3955479"	""	"None"	"364.42"	"0"	"3.06"	"BDBM223932"	"CN1Cc2c(C3=C[C@H](CO)NCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"391034"	"UO_0000065"	"20.73"	"0.38"	"4.49"	"11.77"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3892893"	""	"None"	"442.56"	"0"	"4.91"	"BDBM223950"	"CN1Cc2c(C3=CCN(C4CCC(C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"391052"	"UO_0000065"	"15.64"	"0.29"	"2.01"	"9.55"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3911825"	""	"None"	"436.49"	"0"	"3.29"	"BDBM223816"	"CN1Cc2c(C3=CCC(N[C@@H](CO)C(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"91.0"	"nM"	"7.04"	""	"390918"	"UO_0000065"	"16.13"	"0.30"	"3.75"	"6.94"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3940113"	""	"None"	"377.42"	"0"	"4.59"	"BDBM223819"	"CN1Cc2c(C3=CCC(C(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"390921"	"UO_0000065"	"18.08"	"0.33"	"2.23"	"9.86"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3982411"	""	"None"	"330.37"	"0"	"4.38"	"BDBM223822"	"CN1Cc2c(-c3ccncc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"390924"	"UO_0000065"	"20.84"	"0.38"	"2.51"	"15.37"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3909010"	""	"None"	"408.46"	"0"	"3.78"	"BDBM223823"	"CN1Cc2c(-c3ccc(S(C)(=O)=O)nc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390925"	"UO_0000065"	"17.04"	"0.33"	"3.18"	"8.81"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3954733"	""	"None"	"346.37"	"0"	"3.36"	"BDBM223824"	"CN1Cc2c(-c3cnc(N)nc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"3300.0"	"nM"	"5.48"	""	"390926"	"UO_0000065"	"15.83"	"0.29"	"2.12"	"6.55"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3942947"	""	"None"	"479.56"	"0"	"2.22"	"BDBM223831"	"CN1Cc2c(C3=CCN(CC(=O)N(CCO)CCO)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"390933"	"UO_0000065"	"15.11"	"0.28"	"5.02"	"7.55"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3952232"	""	"None"	"466.53"	"0"	"4.89"	"BDBM223843"	"CN1Cc2c(C3=CCN(CC(=O)OC(C)(C)C)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"390945"	"UO_0000065"	"15.00"	"0.28"	"2.11"	"11.39"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3949735"	""	"None"	"501.61"	"1"	"3.64"	"BDBM223872"	"CN1Cc2c(C3=CC4CN(CC(=O)N(C)C5CC(O)C5)CC4C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"390974"	"UO_0000065"	"13.96"	"0.26"	"3.36"	"9.25"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3944411"	""	"None"	"391.45"	"0"	"3.75"	"BDBM223874"	"CNC(=O)N1CCC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C1"	"IC50"	"'='"	"180.0"	"nM"	"6.75"	""	"390976"	"UO_0000065"	"17.23"	"0.32"	"2.99"	"10.50"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3673529"	""	"None"	"460.51"	"0"	"4.26"	"BDBM167847"	"CNC(=O)N1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311628"	"UO_0000065"	"15.95"	"0.30"	"3.09"	"7.65"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673536"	""	"None"	"443.51"	"0"	"2.73"	"BDBM167854"	"O=C(CO)N1CCC(c2cc3c(-c4cncc(NCc5cccnc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"81.0"	"nM"	"7.09"	""	"311635"	"UO_0000065"	"15.99"	"0.29"	"4.36"	"5.91"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673542"	""	"None"	"459.48"	"0"	"3.35"	"BDBM167860"	"O=C(CO)N1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"311641"	"UO_0000065"	"18.93"	"0.35"	"5.35"	"8.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673543"	""	"None"	"513.55"	"1"	"4.70"	"BDBM167861"	"CS(=O)(=O)N1CC=C(c2cc3c(-c4nc(NCc5cccc(F)c5)c(F)cc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"311642"	"UO_0000065"	"13.55"	"0.26"	"2.26"	"7.65"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668344"	""	"None"	"419.92"	"0"	"4.55"	"BDBM167585"	"Clc1ccc(NCc2ccccc2)nc1-c1ccnc2[nH]c(C3CNCCO3)cc12"	"IC50"	"'='"	"65.0"	"nM"	"7.19"	""	"311367"	"UO_0000065"	"17.12"	"0.33"	"2.64"	"9.60"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3967588"	""	"None"	"463.90"	"0"	"4.91"	"BDBM180851"	"COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327645"	"UO_0000065"	"18.75"	"0.38"	"3.79"	"8.68"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4078893"	""	"None"	"427.81"	"0"	"4.43"	"7"	"FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4007695"	"Inhibition of CDK9 (unknown origin) after 60 mins by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4007384"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2016"	"None"	""	""	""
"CHEMBL4069365"	""	"None"	"421.38"	"0"	"4.14"	"13"	"CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4007695"	"Inhibition of CDK9 (unknown origin) after 60 mins by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4007384"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2016"	"None"	""	""	""
"CHEMBL4084410"	""	"None"	"312.80"	"0"	"3.29"	"1"	"Clc1ccnc2[nH]c(-c3ccc(N4CCNCC4)cc3)cc12"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"24.61"	"0.48"	"4.41"	"17.52"	"0"	"CHEMBL4047696"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4043256"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2017"	"None"	""	""	""
"CHEMBL3655767"	""	"None"	"318.43"	"0"	"2.55"	"BDBM106955"	"CC[C@H](Nc1nc(NC2CC2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	"226143"	"UO_0000065"	"20.63"	"0.39"	"4.02"	"7.47"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3663774"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167549"	"Fc1cccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311331"	"UO_0000065"	"17.95"	"0.34"	"2.32"	"11.92"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663793"	""	"None"	"416.96"	"1"	"5.96"	"BDBM167568"	"Clc1ccc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311350"	"UO_0000065"	"18.23"	"0.35"	"1.64"	"14.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663806"	""	"None"	"327.36"	"0"	"3.04"	"BDBM167581"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CNCCO3)cc12"	"IC50"	"'='"	"42.0"	"nM"	"7.38"	""	"311363"	"UO_0000065"	"22.53"	"0.42"	"4.34"	"12.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668343"	""	"None"	"341.39"	"0"	"3.38"	"BDBM167584"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(C)CCO3)cc12"	"IC50"	"'='"	"250.0"	"nM"	"6.60"	""	"311366"	"UO_0000065"	"19.34"	"0.36"	"3.22"	"13.10"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3800585"	""	"None"	"471.57"	"0"	"2.17"	"9"	"C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1"	"IC50"	"'>'"	"25000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3803172"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3797138"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3663765"	""	"None"	"341.84"	"0"	"4.36"	"BDBM167539"	"COc1ccc(Cl)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"77.0"	"nM"	"7.11"	""	"311321"	"UO_0000065"	"20.81"	"0.40"	"2.75"	"14.24"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663766"	""	"None"	"321.42"	"0"	"4.01"	"BDBM167540"	"COc1ccc(C)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"68.0"	"nM"	"7.17"	""	"311322"	"UO_0000065"	"22.30"	"0.41"	"3.16"	"14.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673514"	""	"None"	"458.57"	"0"	"3.16"	"BDBM167832"	"OCC(O)CN1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"311613"	"UO_0000065"	"16.47"	"0.30"	"4.39"	"6.85"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668494"	""	"None"	"446.49"	"0"	"4.43"	"BDBM167737"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)Nc4cnn(C)c4)CC3)cc12"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	"311518"	"UO_0000065"	"16.64"	"0.31"	"3.00"	"8.44"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668557"	""	"None"	"449.53"	"1"	"5.11"	"BDBM167801"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C4CCC(C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"139.0"	"nM"	"6.86"	""	"311582"	"UO_0000065"	"15.25"	"0.28"	"1.75"	"8.74"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673500"	""	"None"	"462.58"	"0"	"3.77"	"BDBM167818"	"CS(=O)(=O)N1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311599"	"UO_0000065"	"16.91"	"0.32"	"4.05"	"7.53"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673522"	""	"None"	"461.50"	"0"	"3.44"	"BDBM167840"	"O=C(CO)N1CCC(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"311621"	"UO_0000065"	"16.40"	"0.30"	"4.13"	"7.26"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673533"	""	"None"	"457.51"	"0"	"4.20"	"BDBM167851"	"CNC(=O)N1CC=C(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"17.0"	"nM"	"7.77"	""	"311632"	"UO_0000065"	"16.98"	"0.31"	"3.57"	"7.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673538"	""	"None"	"458.50"	"0"	"3.38"	"BDBM167856"	"O=C(CO)N1CC=C(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"311637"	"UO_0000065"	"17.55"	"0.32"	"4.67"	"7.52"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673549"	""	"None"	"444.47"	"1"	"5.01"	"BDBM167867"	"O=C(O)C1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"18.0"	"nM"	"7.75"	""	"311648"	"UO_0000065"	"17.42"	"0.32"	"2.73"	"7.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3919796"	""	"None"	"508.35"	"2"	"5.02"	"BDBM180823"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327617"	"UO_0000065"	"17.11"	"0.38"	"3.68"	"8.68"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934141"	""	"None"	"459.48"	"0"	"4.26"	"BDBM180827"	"COc1cc(CS(C)(=O)=NC#N)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"1.0"	"nM"	"9.00"	""	"327621"	"UO_0000065"	"19.59"	"0.38"	"4.74"	"8.22"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3923934"	""	"None"	"446.53"	"0"	"4.66"	"BDBM223918"	"CN1Cc2c(C3=CCN(C4CC(CC(=O)O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"42.0"	"nM"	"7.38"	""	"391020"	"UO_0000065"	"16.52"	"0.31"	"2.72"	"10.18"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3951638"	""	"None"	"460.55"	"1"	"5.05"	"BDBM223919"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"391021"	"UO_0000065"	"15.83"	"0.29"	"2.24"	"10.06"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3932161"	""	"None"	"362.45"	"0"	"4.65"	"BDBM223921"	"CC[C@@H]1c2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"417.0"	"nM"	"6.38"	""	"391023"	"UO_0000065"	"17.60"	"0.32"	"1.73"	"14.52"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3901731"	""	"None"	"528.67"	"2"	"6.62"	"BDBM223953"	"CN1Cc2c(C3=CCN(C4CCC(=CC(=O)OC(C)(C)C)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"391055"	"UO_0000065"	"13.09"	"0.24"	"0.30"	"11.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3343037"	""	"None"	"430.46"	"0"	"4.01"	"7a"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCO"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343038"	""	"None"	"444.45"	"0"	"4.10"	"7b"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCC(=O)O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343051"	""	"None"	"427.42"	"0"	"2.63"	"24b"	"O=C(Nc1ccc(NC(=O)c2ccccn2)cc1)c1cccc(-c2c[nH]c(=O)[nH]c2=O)c1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3959283"	""	"None"	"443.48"	"0"	"4.64"	"BDBM180815"	"CCS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1)=NC#N"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327609"	"UO_0000065"	"18.14"	"0.35"	"3.41"	"8.02"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668512"	""	"None"	"382.44"	"0"	"3.04"	"BDBM167755"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(N)=O)CC3)cc12"	"IC50"	"'='"	"32.0"	"nM"	"7.50"	""	"311536"	"UO_0000065"	"19.60"	"0.37"	"4.45"	"8.90"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668517"	""	"None"	"488.54"	"0"	"4.15"	"BDBM167760"	"CCN(C(=O)O)S(=O)(=O)NC1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	"311541"	"UO_0000065"	"15.00"	"0.29"	"3.18"	"5.88"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4292930"	""	"None"	"382.47"	"0"	"2.02"	"Dinacicilib"	"Cc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.96"	"0.41"	"6.38"	"9.07"	"0"	"CHEMBL4271332"	"Inhibition of recombinant CDK9 (unknown origin) expressed in Sf9 cells using histone H1 derived biotinylated peptide and 33P-ATP incubated for 1 hr by liquid scintillation counting method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4270504"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL3899222"	""	"None"	"398.46"	"0"	"3.34"	"BDBM223783"	"CS(=O)(=O)N1CC=C(c2[nH]c3nccc4c3c2CNc2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"62.0"	"nM"	"7.21"	""	"390885"	"UO_0000065"	"18.09"	"0.35"	"3.87"	"9.23"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"Dinaciclib"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL3877186"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3875233"	"1"	"Scientific Literature"	"Nat Rev Drug Discov"	"2017"	"None"	""	""	""
"CHEMBL496567"	""	"None"	"366.56"	"0"	"4.40"	"4"	"CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@H](N)CC3)s2)o1"	"IC50"	"'='"	"355.0"	"nM"	"6.45"	""	""	"UO_0000065"	"17.60"	"0.37"	"2.05"	"8.38"	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL509772"	""	"None"	"352.53"	"0"	"3.88"	"10"	"CC(C)(C)c1cnc(CSc2cnc(NC3CCNCC3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3343057"	""	"None"	"463.49"	"0"	"2.07"	"27"	"COc1cc(C(=O)Nc2ccc(NC(=O)C3CCCCN3)cc2)cc(-c2c[nH]c(=O)[nH]c2=O)c1"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343047"	""	"None"	"377.40"	"0"	"3.49"	"16b"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)c(N)cc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL402272"	""	"None"	"229.24"	"0"	"0.34"	"5"	"Nc1nccc(-c2cc3c([nH]2)CCNC3=O)n1"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	""	"UO_0000065"	"32.88"	"0.61"	"7.20"	"7.80"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"9, FP"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"0"	"CHEMBL1226911"	"Inhibition of cdk9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1221210"	"1"	"Scientific Literature"	"Nat Chem Biol"	"2008"	"None"	""	""	""
"CHEMBL452601"	""	"None"	"394.57"	"0"	"3.91"	"19"	"C[C@H]1CNC[C@H](C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)C1"	"IC50"	"'='"	"770.0"	"nM"	"6.11"	""	""	"UO_0000065"	"15.49"	"0.32"	"2.20"	"7.64"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL455194"	""	"None"	"394.57"	"0"	"4.05"	"3"	"CC1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	""	"UO_0000065"	"14.76"	"0.31"	"1.77"	"7.28"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL1615221"	""	"None"	"431.54"	"0"	"4.26"	"56; (S)-CR8"	"CC[C@@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"16.13"	"0.30"	"2.70"	"6.90"	"0"	"CHEMBL4613379"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4613207"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4082469"	""	"None"	"282.42"	"0"	"2.79"	"29a"	"CSc1sc(C(N)=O)c2c1-c1sncc1CC2"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"29.74"	"0.67"	"5.61"	"15.00"	"0"	"CHEMBL4029555"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4028808"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2017"	"None"	""	""	""
"CHEMBL4102376"	""	"None"	"326.83"	"0"	"3.30"	"2"	"Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(Cl)ccnc21"	"IC50"	"'='"	"5000.0"	"nM"	"5.30"	""	""	"UO_0000065"	"16.22"	"0.31"	"2.00"	"16.02"	"0"	"CHEMBL4047696"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4043256"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2017"	"None"	""	""	""
"CHEMBL454645"	""	"None"	"394.57"	"0"	"4.05"	"8"	"CC1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CN1"	"IC50"	"'='"	"370.0"	"nM"	"6.43"	""	""	"UO_0000065"	"16.30"	"0.34"	"2.38"	"8.03"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL212049"	""	"None"	"367.48"	"0"	"4.76"	"2"	"Cc1cnc(OC2CCCCC2)nc1-c1cnc(Nc2ccccn2)s1"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	""	"UO_0000065"	"20.64"	"0.40"	"2.83"	"10.42"	"0"	"CHEMBL870945"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1137419"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2006"	"None"	""	""	""
"CHEMBL3694402"	""	"None"	"326.36"	"0"	"1.62"	"BDBM120936"	"COc1ccccc1-c1cc(NC(=O)C2CCC(=O)NC2)ncn1"	"IC50"	"'='"	"0.019"	"nM"	"10.72"	""	"249035"	"UO_0000065"	"32.85"	"0.61"	"9.10"	"11.50"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL1922219"	""	"None"	"369.47"	"0"	"2.99"	"alphaSbetaR-21, CCT68127"	"CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"107.0"	"nM"	"6.97"	""	""	"UO_0000065"	"18.87"	"0.35"	"3.98"	"6.92"	"0"	"CHEMBL1926149"	"Inhibition of CDK9 in human HT29 cells assessed as reduction in RNA polymerase 2 expression"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HT-29"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1921760"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2011"	"CHEMBL3307768"	""	""	""
"CHEMBL495557"	""	"None"	"367.54"	"0"	"4.44"	"6"	"CC(C)(C)c1cnc(CSc2cnc(N[C@H]3CC[C@H](O)CC3)s2)o1"	"IC50"	"'='"	"3500.0"	"nM"	"5.46"	""	""	"UO_0000065"	"14.84"	"0.31"	"1.02"	"7.66"	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3694399"	""	"None"	"326.40"	"0"	"2.11"	"BDBM120933"	"COc1ccccc1-c1cc(N(C)C(=O)[C@@H]2CCCNC2)ncn1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"249032"	"UO_0000065"	"24.51"	"0.46"	"5.89"	"11.88"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL455195"	""	"None"	"408.59"	"0"	"4.44"	"4"	"CCC1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1"	"IC50"	"'='"	"680.0"	"nM"	"6.17"	""	""	"UO_0000065"	"15.09"	"0.31"	"1.73"	"7.70"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL1944698"	"ZOTIRACICLIB"	"2.0"	"372.47"	"0"	"4.66"	"50"	"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	""	"UO_0000065"	"22.88"	"0.42"	"3.86"	"16.95"	"0"	"CHEMBL3856553"	"Inhibition of human GST-tagged CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3856187"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3976153"	""	"None"	"482.58"	"0"	"3.63"	"BDBM223847"	"COCCS(=O)(=O)N1CC2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2C1"	"IC50"	"'='"	"80.0"	"nM"	"7.10"	""	"390949"	"UO_0000065"	"14.71"	"0.29"	"3.47"	"9.04"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3959305"	""	"None"	"475.57"	"0"	"3.10"	"BDBM223864"	"CN(CCO)C(=O)CN1CC2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2C1"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	"390966"	"UO_0000065"	"15.49"	"0.29"	"4.27"	"9.73"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4113920"	""	"None"	"501.61"	"1"	"3.92"	"BDBM223876"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4CC(=O)N(C)C3CC(O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"73.0"	"nM"	"7.14"	""	"390978"	"UO_0000065"	"14.23"	"0.26"	"3.22"	"9.43"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3943576"	""	"None"	"503.62"	"1"	"4.03"	"BDBM223896"	"CN1Cc2c(C3=CCN(CC(=O)N(C)C4CC(O)C4)CC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	"390998"	"UO_0000065"	"11.76"	"0.22"	"1.89"	"7.82"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3945173"	""	"None"	"465.50"	"0"	"2.75"	"BDBM223915"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"52.0"	"nM"	"7.28"	""	"391017"	"UO_0000065"	"15.65"	"0.29"	"4.53"	"9.62"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3983369"	""	"None"	"373.39"	"0"	"4.68"	"BDBM223825"	"CN1Cc2c(-c3ccc(C(=O)O)cc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"390927"	"UO_0000065"	"18.28"	"0.33"	"2.14"	"9.86"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL297570"	""	"None"	"380.54"	"0"	"3.66"	"6"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCCNC3)s2)o1"	"IC50"	"'='"	"550.0"	"nM"	"6.26"	""	""	"UO_0000065"	"16.45"	"0.34"	"2.60"	"7.82"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL509012"	""	"None"	"422.62"	"0"	"4.68"	"5"	"CC(C)C1CC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CCN1"	"IC50"	"'='"	"810.0"	"nM"	"6.09"	""	""	"UO_0000065"	"14.41"	"0.30"	"1.41"	"7.61"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL3924252"	""	"None"	"395.43"	"0"	"2.70"	"BDBM223942"	"OCC(O)CN1CC=C(c2[nH]c3nccc4c3c2COc2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"391044"	"UO_0000065"	"17.41"	"0.32"	"4.19"	"8.44"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3343048"	""	"None"	"420.42"	"0"	"3.66"	"17a"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1OCC(=O)O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL3343052"	""	"None"	"457.45"	"0"	"2.64"	"24c"	"COc1ccc(C(=O)Nc2ccc(NC(=O)c3ccccn3)cc2)cc1-c1c[nH]c(=O)[nH]c1=O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL215205"	""	"None"	"218.22"	"0"	"1.70"	"CAN508"	"Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1"	"IC50"	"'='"	"350.0"	"nM"	"6.46"	""	""	"UO_0000065"	"29.58"	"0.55"	"4.76"	"5.14"	"0"	"CHEMBL1825642"	"Inhibition of CDK9 by [33P]gamma-ATP incorporation assay"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1821675"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2011"	"None"	""	""	""
"CHEMBL2397315"	""	"None"	"344.36"	"0"	"3.62"	"31d-2"	"Cc1nc(NC(=O)[C@@H](C)CC(F)(F)F)sc1-c1ccc(N)nc1"	"IC50"	"'='"	"5300.0"	"nM"	"5.28"	""	""	"UO_0000065"	"15.32"	"0.31"	"1.66"	"6.52"	"0"	"CHEMBL2399034"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2396517"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2013"	"None"	""	""	""
"CHEMBL3924904"	""	"None"	"429.52"	"0"	"3.76"	"BDBM60459"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3C[C@@H]4CN(S(C)(=O)=O)C[C@@H]4C3)cc12"	"IC50"	"'='"	"70.0"	"nM"	"7.16"	""	"217646"	"UO_0000065"	"16.66"	"0.33"	"3.39"	"9.50"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL2035185"	"CT-1578"	"1.0"	"462.55"	"0"	"4.56"	"14l, SB1578, 67:33 trans/Cis mixture"	"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	""	"UO_0000065"	"16.09"	"0.30"	"2.88"	"9.09"	"0"	"CHEMBL2040159"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2034857"	"1"	"Scientific Literature"	"J Med Chem"	"2012"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"SCH-727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"178.0"	"nM"	"6.75"	""	""	"UO_0000065"	"17.02"	"0.32"	"4.47"	"7.29"	"0"	"CHEMBL3777660"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3774312"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3589673"	""	"None"	"326.74"	"0"	"4.23"	"5u"	"COc1ccc2nc(C(=O)O)c3c4cccc(Cl)c4[nH]c3c2c1"	"IC50"	"'='"	"210.0"	"nM"	"6.68"	""	""	"UO_0000065"	"20.44"	"0.40"	"2.45"	"8.88"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL296468"	"BMS-387032"	"1.0"	"380.54"	"0"	"3.66"	"1, SNS-032"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"	"IC50"	"'='"	"458.0"	"nM"	"6.34"	""	""	"UO_0000065"	"16.66"	"0.35"	"2.68"	"7.92"	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL498200"	""	"None"	"325.29"	"0"	"2.22"	"93-1"	"Nc1nccc(-c2cc3c([nH]2)C(CCC(F)(F)F)CNC3=O)n1"	"IC50"	"'='"	"218.0"	"nM"	"6.66"	""	""	"UO_0000065"	"20.48"	"0.40"	"4.44"	"6.89"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL497995"	""	"None"	"283.34"	"0"	"1.68"	"88-1"	"Nc1nccc(-c2cc3c([nH]2)C(C2CCC2)CNC3=O)n1"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	""	"UO_0000065"	"24.77"	"0.46"	"5.34"	"7.26"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL497995"	""	"None"	"283.34"	"0"	"1.68"	"88-1"	"Nc1nccc(-c2cc3c([nH]2)C(C2CCC2)CNC3=O)n1"	"IC50"	"'='"	"83.0"	"nM"	"7.08"	""	""	"UO_0000065"	"24.99"	"0.46"	"5.40"	"7.32"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL225519"	""	"None"	"213.24"	"0"	"1.36"	"1"	"O=C1NCCc2[nH]c(-c3ccncc3)cc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"35.02"	"0.64"	"6.11"	"12.93"	"1"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL3905910"	"VORUCICLIB"	"2.0"	"469.84"	"0"	"4.32"	"31"	"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO"	"IC50"	"'<'"	"100.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4370707"	"Inhibition of human CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4368927"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4850143"	""	"None"	"474.51"	"0"	"3.46"	"8"	"CCOC(=O)NS(=O)(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	""	"UO_0000065"	"16.02"	"0.31"	"4.14"	"6.69"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4851229"	""	"None"	"467.52"	"1"	"5.25"	"15"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"14.88"	"0.28"	"1.71"	"8.87"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL1980297"	"ILORASERTIB"	"2.0"	"488.55"	"1"	"5.18"	"2, ABT-348"	"Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL2024911"	"Inhibition of CDK9 by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2021801"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2012"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"Dinaciclib"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4738665"	"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 cells using biotinylated Histone H1 peptide as substrate incubated for 1 hr in presence of [33P]ATP by liquid scintillation counting method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4732230"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2021"	"None"	"TIME = 1.0 hr"	"INHIBITOR"	""
"CHEMBL189963"	"PALBOCICLIB"	"4.0"	"447.54"	"0"	"2.97"	"Palbociclib"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'='"	"892.0"	"nM"	"6.05"	""	""	"UO_0000065"	"13.52"	"0.25"	"3.08"	"5.76"	"0"	"CHEMBL3777660"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3774312"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL2205766"	""	"None"	"346.42"	"0"	"1.45"	"14, CZC24758"	"CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL2211476"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2203257"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2012"	"None"	""	""	""
"CHEMBL4763202"	""	"None"	"565.02"	"2"	"5.66"	"MFH-3-107-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CNc4cc(C(F)(F)F)c(Cl)cn4)s3)C2)cc1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL5169987"	""	"None"	"315.42"	"0"	"4.00"	"50; FIT-039"	"Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1"	"IC50"	"'='"	"5800.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.60"	"0.33"	"1.24"	"18.60"	"1"	"CHEMBL5131646"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131375"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4855187"	""	"None"	"443.50"	"0"	"3.64"	"7"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C(=O)NS(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"89.0"	"nM"	"7.05"	""	""	"UO_0000065"	"15.90"	"0.31"	"3.41"	"6.97"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668495"	""	"None"	"381.41"	"0"	"3.55"	"6"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)O)CC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	""	"UO_0000065"	"19.62"	"0.36"	"3.93"	"9.54"	"1"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"1"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	""	"UO_0000065"	"21.21"	"0.42"	"5.22"	"9.05"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4777981"	""	"None"	"467.52"	"1"	"5.25"	"63; A-1592668"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"2.6"	"nM"	"8.59"	""	""	"UO_0000065"	"18.36"	"0.34"	"3.34"	"10.94"	"0"	"CHEMBL4701442"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3668457"	""	"None"	"397.45"	"0"	"2.82"	"62; A-1467729"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12"	"IC50"	"'='"	"27.6"	"nM"	"7.56"	""	""	"UO_0000065"	"19.02"	"0.36"	"4.74"	"9.26"	"0"	"CHEMBL4701455"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4088216"	"TP-030-1"	"None"	"402.45"	"0"	"2.35"	"EUB0000719"	"CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21"	"IC50"	""	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4884661"	"CDK9(CDK9CGS1) Takeda global kinase panel"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4507327"	"54"	"Donated Chemical Probes - SGC Frankfurt"	""	"2021"	"None"	"Compound concentration None 1.0 µM"	""	""
"CHEMBL4860767"	""	"None"	"501.59"	"1"	"3.39"	"A1"	"C=CC(=O)N1CCN(c2ccc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)nc2)CC1"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5256395"	"Covalent inhibition of CDK9 (unknown origin) using histone H1 as substrate incubated for 10 mins in presence of [gamma-32P]ATP by radioactivity based kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5252647"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2023"	"None"	"TIME = 0.1667 hr"	""	""
"CHEMBL495754"	""	"None"	"365.57"	"1"	"5.71"	"3"	"CC(C)(C)c1cnc(CSc2cnc(NCC3CCCCC3)s2)o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL1002042"	"Inhibition of CDK9 in human HCT116 cells assessed as phosphor-ser2 level of RNA polymerase 2 after 16 hrs by high content cellular assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1143434"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL296468"	"BMS-387032"	"1.0"	"380.54"	"0"	"3.66"	"1, SNS-032, BMS-387032"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"	"IC50"	"'='"	"550.0"	"nM"	"6.26"	""	""	"UO_0000065"	"16.45"	"0.34"	"2.60"	"7.82"	"0"	"CHEMBL965586"	"Inhibition of CDK9-mediated RNA pol 2 phosphorylation at ser2 in human HCT116 cells after 16 hrs by HCS assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1152130"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2008"	"CHEMBL3308372"	""	""	""
"CHEMBL4794338"	""	"None"	"507.66"	"2"	"5.06"	"MFH-3-116-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(CCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4643754"	""	"None"	"486.66"	"0"	"4.50"	"MFH-4-4-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCC4CCOCC4)s3)C2)cc1"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4777844"	""	"None"	"491.68"	"0"	"4.02"	"B1"	"CN(C)C/C=C/C(=O)N1CCC(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)CC1"	"IC50"	"'='"	"0.495"	"nM"	"9.30"	""	""	"UO_0000065"	"18.93"	"0.39"	"5.29"	"10.16"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5170524"	""	"None"	"404.51"	"0"	"3.94"	"9"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"20.76"	"0.38"	"4.46"	"11.95"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL1944698"	"ZOTIRACICLIB"	"2.0"	"372.47"	"0"	"4.66"	"9; TG-02"	"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	""	"UO_0000065"	"23.35"	"0.42"	"4.04"	"17.30"	"0"	"CHEMBL4701411"	"Inhibition of human CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5188442"	""	"None"	"418.47"	"0"	"4.27"	"3"	"COc1cc(F)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc12"	"IC50"	"'='"	"2300.0"	"nM"	"5.64"	""	""	"UO_0000065"	"13.47"	"0.25"	"1.37"	"8.91"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4878465"	""	"None"	"449.53"	"1"	"5.11"	"19"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCC(C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	""	"UO_0000065"	"15.40"	"0.29"	"1.81"	"8.82"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4865444"	""	"None"	"463.55"	"1"	"5.50"	"20"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCC(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	""	"UO_0000065"	"15.24"	"0.28"	"1.57"	"9.01"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL5202522"	""	"None"	"358.42"	"0"	"3.47"	"46; MC180295"	"Nc1nc(N[C@H]2CC3CCC2C3)sc1C(=O)c1ccccc1[N+](=O)[O-]"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"23.16"	"0.45"	"4.83"	"7.47"	"0"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4781539"	""	"None"	"525.70"	"2"	"5.56"	"MFH-2-90-1; B12"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"98.0"	"nM"	"7.01"	""	""	"UO_0000065"	"13.33"	"0.27"	"1.45"	"6.98"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4786324"	""	"None"	"499.69"	"0"	"4.55"	"MFH-3-191-1"	"C=CC(=O)Nc1ccc([S+]([O-])N2CCCC(Nc3ncc(SCc4cccnc4)s3)C2)cc1"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL3668553"	""	"None"	"463.55"	"1"	"5.50"	"13"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"220.0"	"nM"	"6.66"	""	""	"UO_0000065"	"14.36"	"0.27"	"1.16"	"8.49"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4853678"	""	"None"	"481.54"	"1"	"5.64"	"18"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	""	"UO_0000065"	"14.17"	"0.27"	"1.18"	"8.70"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4870276"	""	"None"	"464.54"	"0"	"4.02"	"23"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"12.75"	"0.24"	"1.90"	"7.25"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"12"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3589665"	""	"None"	"326.74"	"0"	"4.23"	"5m"	"COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Cl)c3[nH]c21"	"IC50"	"'='"	"1000.0"	"nM"	"6.00"	""	""	"UO_0000065"	"18.36"	"0.36"	"1.77"	"7.98"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589675"	""	"None"	"402.84"	"1"	"5.90"	"5w"	"COc1ccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)cc1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589774"	""	"None"	"302.74"	"0"	"4.28"	"6"	"O=C(O)c1nc2ccsc2c2[nH]c3c(Cl)cccc3c12"	"IC50"	"'='"	"350.0"	"nM"	"6.46"	""	""	"UO_0000065"	"21.33"	"0.44"	"2.18"	"9.78"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL4579344"	""	"None"	"383.50"	"0"	"3.21"	"CYC065"	"Cc1cc(C)c(CNc2nc(N[C@@H](C)[C@@H](C)O)nc3c2ncn3C(C)C)cn1"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	""	"UO_0000065"	"19.78"	"0.37"	"4.38"	"7.53"	"0"	"CHEMBL4346799"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346652"	"1"	"Scientific Literature"	"J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL225519"	""	"None"	"213.24"	"0"	"1.36"	"1, PHA-767491"	"O=C1NCCc2[nH]c(-c3ccncc3)cc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"35.02"	"0.64"	"6.11"	"12.93"	"0"	"CHEMBL1226911"	"Inhibition of cdk9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1221210"	"1"	"Scientific Literature"	"Nat Chem Biol"	"2008"	"None"	""	""	""
"CHEMBL4761602"	""	"None"	"357.44"	"0"	"3.84"	"71"	"Nc1nc(C[C@H]2CC3CCC2C3)sc1C(=O)c1ccccc1[N+](=O)[O-]"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"23.22"	"0.45"	"4.46"	"8.37"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5207813"	""	"None"	"393.49"	"0"	"2.20"	"21"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"1000.0"	"nM"	"6.00"	""	""	"UO_0000065"	"15.25"	"0.28"	"3.80"	"8.08"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL3663760"	""	"None"	"325.39"	"0"	"3.84"	"8"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"22.95"	"0.42"	"3.63"	"14.95"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5204473"	""	"None"	"422.53"	"0"	"2.64"	"32"	"CC(C)n1nc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	""	"UO_0000065"	"18.17"	"0.34"	"5.04"	"8.81"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5201044"	""	"None"	"467.57"	"0"	"4.36"	"2"	"O=C(c1ccc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)cc1)N1CCCC1"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"15.97"	"0.29"	"3.11"	"10.05"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL3663760"	""	"None"	"325.39"	"0"	"3.84"	"8"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"25.27"	"0.47"	"4.38"	"16.46"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5207146"	""	"None"	"446.55"	"0"	"4.20"	"14"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	""	"UO_0000065"	"17.82"	"0.33"	"3.76"	"10.13"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5192311"	""	"None"	"448.57"	"0"	"3.65"	"17"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCN(CCO)CC3)cc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"18.72"	"0.35"	"4.75"	"10.28"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5192909"	""	"None"	"463.58"	"0"	"3.01"	"28"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"12.77"	"0.24"	"2.91"	"7.09"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5179773"	""	"None"	"422.53"	"0"	"2.64"	"33"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)cnc1=O"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"19.88"	"0.37"	"5.76"	"9.64"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5173041"	""	"None"	"497.60"	"0"	"4.37"	"4"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc12"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	""	"UO_0000065"	"11.70"	"0.21"	"1.45"	"6.97"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5207813"	""	"None"	"393.49"	"0"	"2.20"	"21"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C)c4)ccnc3[nH]2)CC1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL5198372"	""	"None"	"453.61"	"0"	"3.02"	"27"	"CSCCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"50.0"	"nM"	"7.30"	""	""	"UO_0000065"	"16.10"	"0.31"	"4.28"	"9.84"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5179773"	""	"None"	"422.53"	"0"	"2.64"	"33"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)cnc1=O"	"IC50"	"'='"	"650.0"	"nM"	"6.19"	""	""	"UO_0000065"	"14.64"	"0.27"	"3.55"	"7.10"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5277376"	""	"None"	"555.61"	"1"	"4.80"	"A4"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(C/C=C/C(F)(F)F)CC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5256395"	"Covalent inhibition of CDK9 (unknown origin) using histone H1 as substrate incubated for 10 mins in presence of [gamma-32P]ATP by radioactivity based kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5252647"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2023"	"None"	"TIME = 0.1667 hr"	""	""
"CHEMBL189963"	"PALBOCICLIB"	"4.0"	"447.54"	"0"	"2.97"	"Palbociclib"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5256395"	"Covalent inhibition of CDK9 (unknown origin) using histone H1 as substrate incubated for 10 mins in presence of [gamma-32P]ATP by radioactivity based kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5252647"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2023"	"None"	"TIME = 0.1667 hr"	""	""
"CHEMBL3922015"	""	"None"	"426.52"	"0"	"3.93"	"BDBM223798"	"CC1c2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390900"	"UO_0000065"	"16.31"	"0.32"	"3.03"	"10.04"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3967032"	""	"None"	"477.58"	"0"	"3.48"	"BDBM223804"	"CN1Cc2c(C3CCN(CC(=O)N4CCC[C@H]4CO)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"93.0"	"nM"	"7.03"	""	"390906"	"UO_0000065"	"14.72"	"0.27"	"3.55"	"9.29"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3892247"	""	"None"	"451.55"	"0"	"2.95"	"BDBM223805"	"CN(CCO)C(=O)CN1CCC(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"91.0"	"nM"	"7.04"	""	"390907"	"UO_0000065"	"15.59"	"0.29"	"4.09"	"9.30"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3947668"	""	"None"	"378.41"	"0"	"3.32"	"BDBM223811"	"CN1c2ccc(F)cc2-c2ccnc3[nH]c(C4=CCNCC4)c(c23)C1C(=O)O"	"IC50"	"'='"	"540.0"	"nM"	"6.27"	""	"390913"	"UO_0000065"	"16.56"	"0.31"	"2.95"	"7.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3969304"	""	"None"	"515.63"	"1"	"4.31"	"BDBM223882"	"CN1Cc2c(C3=CC4CCCC(C3)N4CC(=O)N3CCC[C@H]3CO)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"390984"	"UO_0000065"	"14.05"	"0.26"	"2.93"	"9.57"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4097778"	"TP-030n"	"None"	"458.54"	"0"	"1.13"	"TP-030n"	"CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21"	"IC50"	""	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4885243"	"CDK9(CDK9CGS1) Takeda global kinase panel"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4507327"	"54"	"Donated Chemical Probes - SGC Frankfurt"	""	"2021"	"None"	"Compound concentration None 1.0 µM"	""	""
"CHEMBL5275973"	""	"None"	"249.70"	"0"	"1.36"	"PHA-767491"	"Cl.O=C1NCCc2[nH]c(-c3ccncc3)cc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"35.02"	"0.64"	"6.11"	"12.93"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"Flavopiridol"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"Dinaciclib"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL16171"	"WOGONIN"	"None"	"284.27"	"0"	"2.88"	"44"	"COc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12"	"IC50"	"'='"	"190.0"	"nM"	"6.72"	""	""	"UO_0000065"	"23.64"	"0.44"	"3.84"	"8.41"	"1"	"CHEMBL5217356"	"Inhibition of CDK9 (unknown origin) using [33-p]-ATP as substrate incubated for 40 mins by Western blot analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5214967"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 0.6667 hr"	"INHIBITOR"	""
"CHEMBL5198038"	""	"None"	"421.55"	"0"	"3.24"	"24"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4753717"	""	"None"	"624.83"	"2"	"5.66"	"B4"	"CN(C)CC/C=C/C(=O)Nc1ccc(C(=O)N2CCCC(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"4.4"	"nM"	"8.36"	""	""	"UO_0000065"	"13.37"	"0.27"	"2.70"	"6.93"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3937565"	""	"None"	"445.54"	"0"	"4.03"	"BDBM223833"	"CN(C)C(=O)CN1[C@H]2CC[C@@H]1C=C(c1[nH]c3nccc4c3c1CN(C)c1ccc(F)cc1-4)C2"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"390935"	"UO_0000065"	"15.25"	"0.28"	"2.77"	"12.25"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3982622"	""	"None"	"417.49"	"0"	"3.99"	"BDBM223854"	"CNC(=O)N1CC2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2C1"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	"390956"	"UO_0000065"	"17.69"	"0.33"	"3.40"	"11.50"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3920469"	""	"None"	"461.54"	"0"	"3.00"	"BDBM223869"	"CN1Cc2c(C3=CCCN(CC(=O)N4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"180.0"	"nM"	"6.75"	""	"390971"	"UO_0000065"	"14.61"	"0.27"	"3.74"	"8.91"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3976427"	""	"None"	"474.58"	"1"	"5.44"	"BDBM223908"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	"391010"	"UO_0000065"	"15.16"	"0.28"	"1.75"	"9.93"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3973391"	""	"None"	"430.48"	"0"	"3.51"	"BDBM223909"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"391011"	"UO_0000065"	"17.29"	"0.34"	"3.93"	"10.74"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3949793"	""	"None"	"438.55"	"0"	"3.89"	"BDBM60455"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CCN4CCOCC4)CC3)cc12"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	"217635"	"UO_0000065"	"16.87"	"0.32"	"3.51"	"13.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3823659"	""	"None"	"436.91"	"0"	"3.57"	"7"	"CC(=O)N1CCC(n2cc(Nc3ncc(Cl)c(-c4cnc5ccccn45)n3)cn2)CC1"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	""	"UO_0000065"	"17.01"	"0.33"	"3.86"	"7.97"	"0"	"CHEMBL3825313"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3822394"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3929678"	""	"None"	"399.45"	"0"	"3.31"	"BDBM223793"	"CS(=O)(=O)N1CC=C(c2[nH]c3nccc4c3c2COc2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"94.0"	"nM"	"7.03"	""	"390895"	"UO_0000065"	"17.59"	"0.34"	"3.72"	"9.33"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3899955"	""	"None"	"407.47"	"0"	"4.39"	"BDBM223821"	"CN1Cc2c(-c3ccc(S(C)(=O)=O)cc3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"390923"	"UO_0000065"	"17.62"	"0.34"	"2.79"	"10.87"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3981660"	""	"None"	"493.56"	"0"	"3.53"	"BDBM223853"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@@H]4CO)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"390955"	"UO_0000065"	"14.78"	"0.28"	"3.76"	"9.63"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3959178"	""	"None"	"501.61"	"1"	"3.92"	"BDBM223857"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4CC(=O)N3CCC[C@H]3CO)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"72.0"	"nM"	"7.14"	""	"390959"	"UO_0000065"	"14.24"	"0.26"	"3.22"	"9.44"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3906050"	""	"None"	"447.51"	"0"	"2.61"	"BDBM223899"	"CN1Cc2c(C3=CCCN(CC(=O)N4CC(O)C4)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"391001"	"UO_0000065"	"15.19"	"0.28"	"4.19"	"8.98"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3935996"	""	"None"	"479.56"	"0"	"2.22"	"BDBM223901"	"CN(CC(O)CO)C(=O)CN1CCC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C1"	"IC50"	"'='"	"540.0"	"nM"	"6.27"	""	"391003"	"UO_0000065"	"13.07"	"0.24"	"4.05"	"6.53"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3917273"	""	"None"	"492.57"	"1"	"5.58"	"BDBM223914"	"CN1Cc2c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"58.0"	"nM"	"7.24"	""	"391016"	"UO_0000065"	"14.69"	"0.27"	"1.66"	"9.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3924439"	""	"None"	"390.42"	"0"	"3.93"	"BDBM223929"	"CN1Cc2c(C3=C[C@@H]4COC(=O)N4CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	"391031"	"UO_0000065"	"19.04"	"0.35"	"3.50"	"12.09"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3928730"	""	"None"	"364.42"	"0"	"3.06"	"BDBM223933"	"CN1Cc2c(C3=C[C@@H](CO)NCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	"391035"	"UO_0000065"	"20.27"	"0.37"	"4.33"	"11.51"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3942903"	""	"None"	"334.40"	"0"	"3.70"	"BDBM223937"	"CN1Cc2c(C3=CCNCC3)[nH]c3ncc(F)c(c23)-c2ccccc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	"391039"	"UO_0000065"	"22.33"	"0.41"	"3.77"	"16.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3919070"	""	"None"	"434.93"	"0"	"3.99"	"BDBM60453"	"[O-][n+]1cccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"60.0"	"nM"	"7.22"	""	"217630"	"UO_0000065"	"16.60"	"0.32"	"3.23"	"7.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327477"	"UO_0000065"	"16.85"	"0.33"	"2.18"	"9.21"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327478"	"UO_0000065"	"19.46"	"0.39"	"3.73"	"9.35"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327489"	"UO_0000065"	"18.67"	"0.37"	"3.59"	"9.35"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327508"	"UO_0000065"	"19.02"	"0.38"	"3.42"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3984385"	""	"None"	"547.46"	"2"	"5.91"	"BDBM180841"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"327509"	"UO_0000065"	"13.89"	"0.28"	"1.69"	"7.58"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3921855"	""	"None"	"430.48"	"0"	"4.88"	"BDBM180844"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"327512"	"UO_0000065"	"18.24"	"0.36"	"2.97"	"8.93"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327514"	"UO_0000065"	"17.94"	"0.35"	"3.03"	"9.15"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3923419"	""	"None"	"461.47"	"0"	"4.78"	"BDBM180831"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327625"	"UO_0000065"	"17.55"	"0.35"	"3.32"	"8.08"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"327632"	"UO_0000065"	"17.05"	"0.34"	"2.56"	"8.46"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327649"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327650"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3951695"	""	"None"	"360.44"	"0"	"3.94"	"BDBM223837"	"CN1Cc2c(C3=CC4CNCC4C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"88.0"	"nM"	"7.06"	""	"390939"	"UO_0000065"	"19.57"	"0.36"	"3.12"	"16.05"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3969125"	""	"None"	"475.57"	"0"	"3.39"	"BDBM223900"	"CN1Cc2c(C3=CCCN(CC(=O)N(C)C4CC(O)C4)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"420.0"	"nM"	"6.38"	""	"391002"	"UO_0000065"	"13.41"	"0.25"	"2.99"	"8.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327474"	"UO_0000065"	"20.52"	"0.40"	"3.95"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3900262"	""	"None"	"552.60"	"2"	"6.50"	"BDBM180798"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"327592"	"UO_0000065"	"14.33"	"0.28"	"1.42"	"7.71"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3916775"	""	"None"	"461.49"	"0"	"4.11"	"BDBM180803"	"CNC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"327597"	"UO_0000065"	"16.55"	"0.33"	"3.53"	"7.24"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4850687"	""	"None"	"524.03"	"1"	"3.44"	"C-13"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(C(=O)CCl)CC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'='"	"1834.0"	"nM"	"5.74"	""	""	"UO_0000065"	"10.95"	"0.21"	"2.30"	"5.06"	"0"	"CHEMBL4821740"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4819081"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL4864688"	""	"None"	"683.77"	"1"	"3.43"	"2"	"O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O"	"IC50"	"'='"	"530.0"	"nM"	"6.28"	""	""	"UO_0000065"	"9.18"	"0.17"	"2.85"	"3.27"	"0"	"CHEMBL4822305"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4819106"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL4521241"	""	"None"	"305.33"	"0"	"1.29"	"Rohitukine"	"Cc1cc(=O)c2c(O)cc(O)c([C@@H]3CCN(C)C[C@@H]3O)c2o1"	"IC50"	"'='"	"300.0"	"nM"	"6.52"	""	""	"UO_0000065"	"21.36"	"0.40"	"5.23"	"6.93"	"0"	"CHEMBL4338272"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4334516"	"1"	"Scientific Literature"	"J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4442620"	"RONICICLIB"	"2.0"	"430.45"	"0"	"3.96"	"10; BAY 1000394"	"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"19.28"	"0.39"	"4.34"	"7.67"	"1"	"CHEMBL5096590"	"Inhibition of CDK9 (unknown origin) expressed in baculovirus-infected Sf9 insect cells"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096150"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL445813"	"AT-7519"	"2.0"	"382.25"	"0"	"2.45"	"AT7519"	"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"20.93"	"0.44"	"5.55"	"8.09"	"1"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3905335"	""	"None"	"472.44"	"1"	"5.37"	"BDBM180836"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327504"	"UO_0000065"	"18.41"	"0.37"	"3.33"	"9.89"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327507"	"UO_0000065"	"19.24"	"0.38"	"3.52"	"9.55"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3892285"	""	"None"	"505.55"	"2"	"5.82"	"BDBM180802"	"CS(=O)(Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1)=NC#N"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"327596"	"UO_0000065"	"15.04"	"0.29"	"1.78"	"7.58"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	"327605"	"UO_0000065"	"17.59"	"0.35"	"2.94"	"8.45"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663780"	""	"None"	"453.92"	"1"	"5.64"	"BDBM167555"	"Fc1ccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1F"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311337"	"UO_0000065"	"17.01"	"0.33"	"2.08"	"11.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663789"	""	"None"	"425.96"	"0"	"4.58"	"BDBM167564"	"Clc1ccc(NCC2CCCOC2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"87.0"	"nM"	"7.06"	""	"311346"	"UO_0000065"	"16.58"	"0.32"	"2.48"	"9.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668374"	""	"None"	"381.41"	"0"	"2.99"	"BDBM167615"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)CO)CC3)cc12"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"311397"	"UO_0000065"	"19.52"	"0.36"	"4.45"	"9.49"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668377"	""	"None"	"411.55"	"1"	"5.61"	"BDBM167618"	"C[C@H](Nc1cccc(-c2ccnc3[nH]c(C4CCN(C)CC4)cc23)n1)c1ccccc1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311400"	"UO_0000065"	"17.88"	"0.32"	"1.75"	"12.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668392"	""	"None"	"401.46"	"0"	"3.43"	"BDBM167633"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"37.0"	"nM"	"7.43"	""	"311415"	"UO_0000065"	"18.51"	"0.36"	"4.00"	"9.87"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"327627"	"UO_0000065"	"17.27"	"0.34"	"2.66"	"8.57"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL5094822"	""	"None"	"239.28"	"0"	"2.97"	"33"	"Cc1cc2cc(-c3cc(N)nc(N)c3)ccc2o1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL5092736"	""	"None"	"310.41"	"0"	"3.02"	"37"	"CCCCn1c(CC)nc2ccc(-c3cc(N)nc(N)c3)nc21"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL5084504"	""	"None"	"308.39"	"0"	"3.08"	"41"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C1CCCC1"	"IC50"	"'='"	"314.0"	"nM"	"6.50"	""	""	"UO_0000065"	"21.09"	"0.39"	"3.42"	"6.80"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5071425"	""	"None"	"374.45"	"0"	"3.43"	"52"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C[C@H](C)Oc1ccccc1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL5077422"	""	"None"	"361.41"	"0"	"2.44"	"53"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCOc1ccccn1"	"IC50"	"'='"	"881.0"	"nM"	"6.05"	""	""	"UO_0000065"	"16.75"	"0.31"	"3.62"	"5.14"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5079873"	""	"None"	"375.44"	"0"	"2.83"	"55"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C[C@H](C)Oc1ccccn1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL3343046"	""	"None"	"362.39"	"0"	"3.91"	"16a"	"COc1cc(C(=O)Nc2ccc(NC(=O)c3ccccc3)cc2)ccc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL524266"	""	"None"	"275.29"	"0"	"1.24"	"S-89"	"Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	""	"UO_0000065"	"27.44"	"0.52"	"6.31"	"7.81"	"0"	"CHEMBL1019786"	"Inhibition of CDK9"	"B"	"BAO_0000357"	"single protein format"	"None"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL1139384"	"1"	"Scientific Literature"	"J Med Chem"	"2009"	"None"	""	""	""
"CHEMBL4760844"	""	"None"	"402.50"	"0"	"4.05"	"20"	"CC(C)N1c2cc(Nc3nccc(-c4ccccc4N)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"39.2"	"nM"	"7.41"	""	""	"UO_0000065"	"18.40"	"0.34"	"3.36"	"8.48"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4793212"	""	"None"	"435.50"	"0"	"4.61"	"23"	"COc1cc(F)ccc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1"	"IC50"	"'='"	"46.9"	"nM"	"7.33"	""	""	"UO_0000065"	"16.83"	"0.31"	"2.72"	"10.38"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4764023"	""	"None"	"416.53"	"0"	"4.51"	"25"	"CNc1cccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)c1"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	""	"UO_0000065"	"18.38"	"0.34"	"3.15"	"10.43"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4789072"	""	"None"	"416.53"	"0"	"4.36"	"31"	"Cc1c(N)cccc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1"	"IC50"	"'='"	"182.9"	"nM"	"6.74"	""	""	"UO_0000065"	"16.18"	"0.30"	"2.38"	"7.71"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3663751"	""	"None"	"339.41"	"0"	"4.19"	"BDBM167525"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN(C)C3)cc12"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"311307"	"UO_0000065"	"21.97"	"0.41"	"3.27"	"18.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663759"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167533"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"311315"	"UO_0000065"	"24.46"	"0.45"	"4.12"	"15.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668364"	""	"None"	"398.51"	"0"	"4.44"	"BDBM167605"	"CN1CCC(c2cc3c(-c4cccc(NCc5cccnc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"311387"	"UO_0000065"	"18.91"	"0.34"	"3.10"	"10.81"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668365"	""	"None"	"443.62"	"1"	"5.64"	"BDBM167606"	"CN1CCC(c2cc3c(-c4cccc(NCCSc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"311388"	"UO_0000065"	"16.44"	"0.31"	"1.65"	"12.83"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668381"	""	"None"	"353.40"	"0"	"3.71"	"BDBM167622"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(C)=O)C3)cc12"	"IC50"	"'='"	"74.0"	"nM"	"7.13"	""	"311404"	"UO_0000065"	"20.18"	"0.37"	"3.42"	"12.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327651"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3962241"	""	"None"	"422.43"	"0"	"4.49"	"BDBM180805"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327479"	"UO_0000065"	"19.05"	"0.38"	"3.56"	"9.15"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934755"	""	"None"	"494.50"	"1"	"5.07"	"BDBM180804"	"CCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"327598"	"UO_0000065"	"16.02"	"0.32"	"2.85"	"7.71"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3960677"	""	"None"	"434.47"	"0"	"4.36"	"BDBM180828"	"COc1cc(CS(C)(=N)=O)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327624"	"UO_0000065"	"18.92"	"0.37"	"3.86"	"8.46"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115908"	""	"None"	"None"	"None"	"None"	"BDBM180855"	""	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"327648"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4074015"	""	"None"	"314.33"	"0"	"0.73"	"24"	"C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12"	"IC50"	"'='"	"41300.0"	"nM"	"4.38"	""	""	"UO_0000065"	"13.95"	"0.27"	"3.65"	"3.46"	"0"	"CHEMBL4700171"	"Inhibition of human CDK9 by kinase-profiling analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699418"	"1"	"Scientific Literature"	"RSC Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3894563"	""	"None"	"440.54"	"0"	"4.32"	"BDBM223789"	"CCC1c2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"390891"	"UO_0000065"	"15.71"	"0.30"	"2.60"	"9.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3975721"	""	"None"	"390.46"	"0"	"4.25"	"BDBM223830"	"CNC(=O)C1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"390932"	"UO_0000065"	"18.44"	"0.34"	"2.95"	"11.80"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3901001"	""	"None"	"438.53"	"0"	"3.90"	"BDBM223834"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4S(C)(=O)=O)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	"390936"	"UO_0000065"	"16.00"	"0.31"	"3.12"	"10.13"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3960860"	""	"None"	"475.57"	"0"	"3.39"	"BDBM223842"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@@H]4CO)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"62.0"	"nM"	"7.21"	""	"390944"	"UO_0000065"	"15.16"	"0.28"	"3.82"	"9.52"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3892477"	""	"None"	"406.46"	"0"	"3.88"	"BDBM223868"	"CN1Cc2c(C3=CCCN(CC(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"170.0"	"nM"	"6.77"	""	"390970"	"UO_0000065"	"16.65"	"0.31"	"2.89"	"9.34"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3952466"	""	"None"	"460.55"	"1"	"5.22"	"BDBM223967"	"CC[C@H]1c2c(C3=CCN([C@H]4C[C@H](C(=O)O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"391069"	"UO_0000065"	"15.11"	"0.28"	"1.74"	"9.60"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3933775"	""	"None"	"473.55"	"0"	"2.86"	"BDBM223862"	"CN1Cc2c(C3=CC4CN(CC(=O)N5CC(O)C5)CC4C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"94.0"	"nM"	"7.03"	""	"390964"	"UO_0000065"	"14.84"	"0.27"	"4.17"	"9.28"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3930577"	""	"None"	"408.41"	"0"	"4.07"	"BDBM223903"	"CN1Cc2c(C3=C[C@@H]4COC(=O)N4CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"54.0"	"nM"	"7.27"	""	"391005"	"UO_0000065"	"17.79"	"0.33"	"3.20"	"11.82"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3946513"	""	"None"	"493.56"	"0"	"3.53"	"BDBM223925"	"CN1Cc2c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"391027"	"UO_0000065"	"14.89"	"0.28"	"3.82"	"9.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3951656"	""	"None"	"467.52"	"0"	"3.00"	"BDBM223935"	"CN(CCO)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2cc(F)c(F)cc2-4)CC1"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"391037"	"UO_0000065"	"15.69"	"0.29"	"4.34"	"9.69"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3977776"	""	"None"	"486.59"	"1"	"5.75"	"BDBM223954"	"CC(C(=O)O)=C1CCC(N2CC=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2)CC1"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	"391056"	"UO_0000065"	"14.54"	"0.27"	"1.33"	"9.77"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3911547"	""	"None"	"497.55"	"0"	"2.36"	"BDBM223888"	"CN(CC(O)CO)C(=O)CN1CC=C(c2[nH]c3ncc(F)c4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"390990"	"UO_0000065"	"14.77"	"0.28"	"4.99"	"7.66"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3922076"	""	"None"	"477.58"	"0"	"3.49"	"BDBM223894"	"CN(CCO)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C(C)(C)C1"	"IC50"	"'='"	"890.0"	"nM"	"6.05"	""	"390996"	"UO_0000065"	"12.67"	"0.24"	"2.56"	"7.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3976415"	""	"None"	"474.58"	"1"	"5.31"	"BDBM223964"	"CC[C@H]1c2c(C3=CCN([C@H]4C[C@@H](C(=O)OC)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	"391066"	"UO_0000065"	"15.16"	"0.28"	"1.88"	"11.70"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3981911"	""	"None"	"438.89"	"1"	"5.00"	"BDBM180852"	"COc1cc(F)ccc1-c1nc(Nc2cc(Cl)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327520"	"UO_0000065"	"18.91"	"0.39"	"3.30"	"9.44"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3915267"	""	"None"	"449.53"	"0"	"2.86"	"BDBM223797"	"CN(CCO)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"390899"	"UO_0000065"	"16.28"	"0.30"	"4.46"	"9.67"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3936047"	""	"None"	"420.49"	"0"	"4.32"	"BDBM223808"	"C[C@H](NC1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1)C(=O)O"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"390910"	"UO_0000065"	"16.65"	"0.31"	"2.68"	"8.62"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3971127"	""	"None"	"461.54"	"0"	"3.00"	"BDBM223820"	"CN1Cc2c(C3=CCN(CC(=O)N4CC[C@H](O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"390922"	"UO_0000065"	"15.86"	"0.29"	"4.32"	"9.67"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3915748"	""	"None"	"362.45"	"0"	"4.33"	"BDBM223870"	"CN1Cc2c(C3=CCNCC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"420.0"	"nM"	"6.38"	""	"390972"	"UO_0000065"	"17.59"	"0.32"	"2.05"	"14.51"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3655772"	""	"None"	"437.47"	"0"	"4.00"	"BDBM106960"	"CC[C@H](Nc1nc(NCc2ccc(C(F)(F)F)nc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"250.0"	"nM"	"6.60"	""	"226148"	"UO_0000065"	"15.09"	"0.29"	"2.60"	"6.55"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3663783"	""	"None"	"424.98"	"0"	"4.16"	"BDBM167558"	"Clc1ccc(NCC2CCCNC2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"170.0"	"nM"	"6.77"	""	"311340"	"UO_0000065"	"15.93"	"0.31"	"2.61"	"8.72"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663787"	""	"None"	"446.00"	"1"	"5.77"	"BDBM167562"	"CCN(Cc1ccccc1)c1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"311344"	"UO_0000065"	"16.41"	"0.31"	"1.55"	"12.88"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3905335"	""	"None"	"472.44"	"1"	"5.37"	"BDBM180836"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327630"	"UO_0000065"	"18.04"	"0.36"	"3.15"	"9.69"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3917892"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180838"	"CCS(=N)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"327633"	"UO_0000065"	"17.08"	"0.34"	"2.58"	"8.48"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3921855"	""	"None"	"430.48"	"0"	"4.88"	"BDBM180844"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"279.0"	"nM"	"6.55"	""	"327638"	"UO_0000065"	"15.23"	"0.30"	"1.67"	"7.45"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	"327616"	"UO_0000065"	"16.45"	"0.33"	"2.61"	"8.24"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668511"	""	"None"	"477.54"	"0"	"2.94"	"BDBM167754"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N4CCC[C@H]4C(N)=O)CC3)cc12"	"IC50"	"'='"	"118.0"	"nM"	"6.93"	""	"311535"	"UO_0000065"	"14.51"	"0.27"	"3.99"	"6.63"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668524"	""	"None"	"415.49"	"0"	"3.81"	"BDBM167768"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=C[C@H](C)N(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"85.0"	"nM"	"7.07"	""	"311549"	"UO_0000065"	"17.02"	"0.33"	"3.26"	"9.39"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668403"	""	"None"	"425.50"	"0"	"4.86"	"BDBM167644"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@H]3CC[C@H](NCCCC(=O)O)CC3)cc12"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	"311426"	"UO_0000065"	"16.91"	"0.32"	"2.33"	"8.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668432"	""	"None"	"511.05"	"1"	"4.35"	"BDBM167674"	"CN1CCC(c2cc3c(-c4nc(NCc5ccc(S(N)(=O)=O)cc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311456"	"UO_0000065"	"14.38"	"0.29"	"3.00"	"6.28"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4594423"	"TP-1287"	"1.0"	"481.83"	"0"	"3.07"	"TP-1287"	"CN1CC[C@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	""	"UO_0000065"	"14.69"	"0.30"	"4.01"	"5.03"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3655762"	""	"None"	"397.53"	"0"	"3.60"	"CYC065"	"CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"26.0"	"nM"	"7.58"	""	""	"UO_0000065"	"19.08"	"0.36"	"3.99"	"7.53"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3668439"	""	"None"	"339.37"	"0"	"3.32"	"BDBM167681"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(C(C)=O)C3)cc12"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"311463"	"UO_0000065"	"20.02"	"0.37"	"3.48"	"11.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668443"	""	"None"	"341.39"	"0"	"2.77"	"BDBM167685"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(CCO)C3)cc12"	"IC50"	"'='"	"76.0"	"nM"	"7.12"	""	"311467"	"UO_0000065"	"20.85"	"0.39"	"4.35"	"11.60"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668447"	""	"None"	"506.01"	"2"	"5.16"	"BDBM167689"	"CN1CCC(c2cc3c(-c4nc(NCc5ccc(OCC(=O)O)cc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"311471"	"UO_0000065"	"14.73"	"0.28"	"2.30"	"7.21"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668456"	""	"None"	"375.43"	"0"	"2.74"	"BDBM167698"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CN(S(C)(=O)=O)C3)cc12"	"IC50"	"'='"	"140.0"	"nM"	"6.85"	""	"311480"	"UO_0000065"	"18.26"	"0.36"	"4.11"	"9.10"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668497"	""	"None"	"474.51"	"0"	"3.71"	"BDBM167740"	"CCN(C(=O)O)S(=O)(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311521"	"UO_0000065"	"16.27"	"0.32"	"4.01"	"6.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673510"	""	"None"	"442.52"	"0"	"3.33"	"BDBM167828"	"O=C(CO)N1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	"311609"	"UO_0000065"	"16.72"	"0.31"	"4.07"	"6.91"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3655769"	""	"None"	"332.45"	"0"	"2.94"	"BDBM106957"	"CC[C@H](Nc1nc(NC2CCC2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"500.0"	"nM"	"6.30"	""	"226145"	"UO_0000065"	"18.95"	"0.36"	"3.36"	"7.17"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3589662"	""	"None"	"388.16"	"0"	"4.17"	"5j"	"O=C(O)c1nc2ccccc2c2[nH]c3c(I)cccc3c12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589664"	""	"None"	"310.28"	"0"	"3.72"	"5l"	"COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(F)c3[nH]c21"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589775"	""	"None"	"342.15"	"0"	"3.73"	"7"	"O=C(O)c1nc2cccnc2c2[nH]c3c(Br)cccc3c12"	"IC50"	"'='"	"2000.0"	"nM"	"5.70"	""	""	"UO_0000065"	"16.66"	"0.37"	"1.97"	"7.23"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3668429"	""	"None"	"404.56"	"0"	"3.80"	"BDBM167671"	"CN1CCC(c2cc3c(-c4cccc(NCC5CCN(C)C5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"91.0"	"nM"	"7.04"	""	"311453"	"UO_0000065"	"17.40"	"0.32"	"3.24"	"11.72"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL5287796"	""	"None"	"450.54"	"0"	"2.34"	"LZT-106"	"COc1cc(O)c2c(=O)cc(-c3ccc(N4CCN(C)CC4)cc3)oc2c1N1CCNCC1"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	""	"UO_0000065"	"16.70"	"0.31"	"5.18"	"9.24"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3668457"	""	"None"	"397.45"	"0"	"2.82"	"A-1467729"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12"	"IC50"	"'='"	"1.2"	"nM"	"8.92"	""	""	"UO_0000065"	"22.45"	"0.42"	"6.10"	"10.93"	"1"	"CHEMBL5224480"	"Inhibition of CDK9 (unknown origin) by LANCE ULight TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4555799"	""	"None"	"327.82"	"0"	"3.44"	"20a"	"Clc1cnc(N[C@H]2CCCNC2)nc1-c1c[nH]c2ccccc12"	"IC50"	"'>'"	"200.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL3589666"	""	"None"	"371.19"	"0"	"4.34"	"5n"	"COc1ccc2c(c1)nc(C(=O)O)c1c3cccc(Br)c3[nH]c21"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	""	"UO_0000065"	"15.69"	"0.35"	"1.48"	"7.74"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589670"	""	"None"	"406.15"	"0"	"4.31"	"5r"	"O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(F)cccc3c12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589671"	""	"None"	"422.61"	"0"	"4.83"	"5s"	"O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Cl)cccc3c12"	"IC50"	"'='"	"2200.0"	"nM"	"5.66"	""	""	"UO_0000065"	"13.39"	"0.35"	"0.83"	"8.57"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589672"	""	"None"	"467.06"	"0"	"4.93"	"5t"	"O=C(O)c1nc2ccc(I)cc2c2[nH]c3c(Br)cccc3c12"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	""	"UO_0000065"	"12.47"	"0.36"	"0.89"	"8.83"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3589674"	""	"None"	"402.84"	"1"	"5.90"	"5v"	"COc1cccc(-c2ccc3nc(C(=O)O)c4c5cccc(Cl)c5[nH]c4c3c2)c1"	"IC50"	"'='"	"3100.0"	"nM"	"5.51"	""	""	"UO_0000065"	"13.67"	"0.26"	"-0.39"	"7.32"	"0"	"CHEMBL3591180"	"Inhibition of human recombinant CDK9 expressed in insect cells using CDK7/9 tide as substrate after 30 mins by scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3588821"	"1"	"Scientific Literature"	"J Med Chem"	"2015"	"None"	""	""	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327494"	"UO_0000065"	"17.37"	"0.40"	"3.29"	"9.55"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3979266"	""	"None"	"461.47"	"0"	"4.78"	"BDBM180837"	"CCS(=O)(Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1)=NC#N"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327505"	"UO_0000065"	"18.85"	"0.37"	"3.92"	"8.68"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327524"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3932396"	""	"None"	"524.52"	"1"	"4.69"	"BDBM180859"	"COCCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327526"	"UO_0000065"	"16.25"	"0.32"	"3.83"	"7.61"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668529"	""	"None"	"451.48"	"0"	"3.57"	"BDBM167773"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N(C)C)CC3)c(C#N)c12"	"IC50"	"'='"	"101.0"	"nM"	"7.00"	""	"311554"	"UO_0000065"	"15.49"	"0.29"	"3.43"	"8.21"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668551"	""	"None"	"424.45"	"0"	"4.19"	"BDBM167795"	"CNC(=O)N1CC2C=C(c3cc4c(-c5cc(F)ccc5OC)c(F)cnc4[nH]3)CC2C1"	"IC50"	"'='"	"201.0"	"nM"	"6.70"	""	"311576"	"UO_0000065"	"15.78"	"0.30"	"2.51"	"9.53"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673491"	""	"None"	"447.51"	"0"	"4.01"	"BDBM167809"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CN(C(=O)C5CC(O)C5)CC4C3)cc12"	"IC50"	"'='"	"115.0"	"nM"	"6.94"	""	"311590"	"UO_0000065"	"15.51"	"0.29"	"2.93"	"8.85"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673493"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167811"	"Fc1cccc(CNc2cc(-c3ccnc4[nH]c(C5CCNCC5)cc34)c(Cl)cn2)c1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311592"	"UO_0000065"	"17.95"	"0.34"	"2.32"	"11.92"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668425"	""	"None"	"468.05"	"1"	"5.70"	"BDBM167667"	"CN1CCC(c2cc3c(-c4nc(NCC5CCOC(C)(C)C5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"311449"	"UO_0000065"	"14.58"	"0.28"	"1.12"	"10.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3906489"	""	"None"	"476.51"	"0"	"4.93"	"BDBM180796"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"327590"	"UO_0000065"	"15.57"	"0.31"	"2.49"	"7.22"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3694405"	""	"None"	"398.44"	"0"	"2.78"	"BDBM120940"	"COc1ccccc1-c1cc(NC(=O)c2cccc(NS(C)(=O)=O)c2)ncn1"	"IC50"	"'='"	"1.08"	"nM"	"8.97"	""	"249039"	"UO_0000065"	"22.50"	"0.44"	"6.19"	"8.13"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3694402"	""	"None"	"326.36"	"0"	"1.62"	"BDBM120936"	"COc1ccccc1-c1cc(NC(=O)C2CCC(=O)NC2)ncn1"	"IC50"	"'='"	"0.173"	"nM"	"9.76"	""	"249036"	"UO_0000065"	"29.91"	"0.56"	"8.14"	"10.47"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3673515"	""	"None"	"535.63"	"1"	"4.06"	"BDBM167833"	"CCN(C(=O)O)S(=O)(=O)N1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311614"	"UO_0000065"	"14.61"	"0.28"	"3.76"	"5.42"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673521"	""	"None"	"382.47"	"0"	"4.01"	"BDBM167839"	"C1=C(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CCNC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311620"	"UO_0000065"	"20.46"	"0.37"	"3.81"	"9.96"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4846069"	""	"None"	"285.35"	"0"	"2.87"	"11"	"COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1"	"IC50"	"'='"	"1080.0"	"nM"	"5.97"	""	""	"UO_0000065"	"20.91"	"0.39"	"3.10"	"8.90"	"0"	"CHEMBL4822305"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4819106"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL4853678"	""	"None"	"481.54"	"1"	"5.64"	"18"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	""	"UO_0000065"	"14.54"	"0.27"	"1.36"	"8.92"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4792521"	""	"None"	"447.97"	"0"	"3.32"	"24-M2"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cn[nH]c3CC(C)(C)CO)c(Cl)cn2)C1"	"IC50"	"'>'"	"2300.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL4764938"	""	"None"	"412.88"	"0"	"3.08"	"12"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3nnn4ccccc34)c(Cl)cn2)C1"	"IC50"	"'>'"	"2600.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL3918885"	""	"None"	"434.52"	"0"	"4.09"	"BDBM60458"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CCC(C3)N4CC(=O)N(C)C)cc12"	"IC50"	"'='"	"114.0"	"nM"	"6.94"	""	"217644"	"UO_0000065"	"15.98"	"0.30"	"2.85"	"11.30"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3943237"	""	"None"	"459.53"	"0"	"3.96"	"BDBM60460"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CC4CCC(C3)N4CC(=O)N(C)C)cc12"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"217650"	"UO_0000065"	"15.06"	"0.28"	"2.96"	"8.12"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4752747"	""	"None"	"438.54"	"1"	"5.02"	"38"	"CC(C)N1c2cc(Nc3nccc(-c4cccc5ncccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"81.6"	"nM"	"7.09"	""	""	"UO_0000065"	"16.16"	"0.29"	"2.07"	"9.55"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3932396"	""	"None"	"524.52"	"1"	"4.69"	"BDBM180859"	"COCCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327652"	"UO_0000065"	"16.25"	"0.32"	"3.83"	"7.61"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4459754"	""	"None"	"394.52"	"0"	"2.85"	"8; CT7001, ICEC0942"	"CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@@H]3CCNC[C@H]3O)nc12"	"IC50"	"'='"	"1100.0"	"nM"	"5.96"	""	""	"UO_0000065"	"15.10"	"0.28"	"3.11"	"6.89"	"0"	"CHEMBL4403351"	"Inhibition of CDK9 (unknown origin) by luciferase reporter gene assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4747992"	""	"None"	"537.66"	"1"	"4.86"	"GD29"	"NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1"	"IC50"	"'='"	"108.2"	"nM"	"6.97"	""	""	"UO_0000065"	"12.96"	"0.25"	"2.11"	"6.31"	"0"	"CHEMBL4688588"	"Inhibition of CDK9 (unknown origin) by ATP competitive based analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4680314"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL4798556"	""	"None"	"426.52"	"0"	"4.95"	"35"	"CC(C)N1c2cc(Nc3nccc(-c4cccc5[nH]ccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"13.8"	"nM"	"7.86"	""	""	"UO_0000065"	"18.43"	"0.34"	"2.91"	"10.19"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3908787"	""	"None"	"419.50"	"0"	"3.50"	"BDBM223941"	"CN(C)C(=O)CN1CC=C(c2[nH]c3ncc(F)c4c3c2CN(C)c2ccccc2-4)CC1"	"IC50"	"'='"	"56.0"	"nM"	"7.25"	""	"391043"	"UO_0000065"	"17.29"	"0.32"	"3.75"	"13.07"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3918837"	""	"None"	"478.54"	"1"	"5.19"	"BDBM223944"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	"391046"	"UO_0000065"	"14.89"	"0.28"	"1.93"	"9.83"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3925516"	""	"None"	"456.59"	"1"	"5.30"	"BDBM223948"	"CN1Cc2c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"391050"	"UO_0000065"	"15.24"	"0.28"	"1.66"	"9.60"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3921585"	""	"None"	"519.62"	"1"	"3.14"	"BDBM223885"	"CN(CC(O)CO)C(=O)CN1C2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC1CCC2"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390987"	"UO_0000065"	"13.39"	"0.25"	"3.82"	"7.25"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4294976"	""	"None"	"374.45"	"0"	"3.92"	"74"	"CCOc1ccccc1CNc1nc(C)nc2[nH]cc(-c3ccnc(N)c3)c12"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"21.36"	"0.39"	"4.08"	"7.86"	"0"	"CHEMBL4266675"	"Inhibition of human full-length N-terminal GST-fused CDK9 (1 to 372 residues) expressed in baculovirus expression system using MBP as substrate after 100 mins by TR-FRET assay"	"B"	"BAO_0000019"	"assay format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4265878"	"1"	"Scientific Literature"	"J Med Chem"	"2018"	"None"	""	""	""
"CHEMBL1801932"	""	"None"	"380.54"	"0"	"4.40"	"BS-181"	"CC(C)c1cnn2c(NCc3ccccc3)cc(NCCCCCCN)nc12"	"IC50"	"'='"	"2180.0"	"nM"	"5.66"	""	""	"UO_0000065"	"14.88"	"0.28"	"1.26"	"7.05"	"0"	"CHEMBL3777660"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3774312"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL3655774"	""	"None"	"383.50"	"0"	"3.29"	"BDBM106962"	"CC[C@H](Nc1nc(NCc2ncccc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"5840.0"	"nM"	"5.23"	""	"226150"	"UO_0000065"	"13.65"	"0.26"	"1.94"	"5.19"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3923769"	""	"None"	"412.49"	"0"	"3.37"	"BDBM223782"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"390884"	"UO_0000065"	"18.43"	"0.36"	"4.23"	"10.97"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4533453"	""	"None"	"327.82"	"0"	"3.44"	"20b"	"Clc1cnc(N[C@@H]2CCCNC2)nc1-c1c[nH]c2ccccc12"	"IC50"	"'>'"	"200.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4465061"	""	"None"	"327.82"	"0"	"4.42"	"22"	"Clc1cnc(NC2CCCCC2)nc1-c1c[nH]c2cccnc12"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"23.49"	"0.46"	"3.28"	"11.58"	"0"	"CHEMBL4403354"	"Inhibition of CDK9 (unknown origin) after 4 hrs"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4787309"	""	"None"	"417.90"	"0"	"2.76"	"16"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3COCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"2100.0"	"nM"	"5.68"	""	""	"UO_0000065"	"13.59"	"0.27"	"2.92"	"5.79"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4754081"	""	"None"	"413.50"	"0"	"3.30"	"23"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	""	"UO_0000065"	"18.38"	"0.35"	"4.30"	"8.55"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4740586"	""	"None"	"402.50"	"0"	"4.05"	"22"	"CC(C)N1c2cc(Nc3nccc(-c4ccc(N)cc4)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"48.9"	"nM"	"7.31"	""	""	"UO_0000065"	"18.16"	"0.33"	"3.26"	"8.37"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4786023"	""	"None"	"430.56"	"0"	"4.90"	"26"	"CCNc1cccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)c1"	"IC50"	"'='"	"37.8"	"nM"	"7.42"	""	""	"UO_0000065"	"17.24"	"0.32"	"2.52"	"10.11"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3673519"	""	"None"	"444.51"	"0"	"4.50"	"BDBM167837"	"CC(=O)N1CCC(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311618"	"UO_0000065"	"17.27"	"0.32"	"3.18"	"8.85"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668397"	""	"None"	"380.47"	"0"	"3.53"	"BDBM167638"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C4CCNC4)C3)cc12"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"311420"	"UO_0000065"	"19.28"	"0.36"	"3.81"	"13.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668402"	""	"None"	"383.47"	"0"	"4.20"	"BDBM167643"	"COCCN1CCCC(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)C1"	"IC50"	"'='"	"50.0"	"nM"	"7.30"	""	"311425"	"UO_0000065"	"19.04"	"0.36"	"3.10"	"14.49"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673492"	""	"None"	"515.59"	"1"	"3.57"	"BDBM167810"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CC4CN(CC(=O)N5CCC[C@H]5CO)CC4C3)cc12"	"IC50"	"'='"	"138.0"	"nM"	"6.86"	""	"311591"	"UO_0000065"	"13.31"	"0.25"	"3.29"	"6.50"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673545"	""	"None"	"495.51"	"0"	"4.35"	"BDBM167863"	"O=C(CO)N1CCC(c2cc3c(-c4nc(NCc5cccc(F)c5)c(F)cc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"311644"	"UO_0000065"	"16.59"	"0.31"	"3.87"	"8.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4793573"	""	"None"	"531.75"	"1"	"4.98"	"MFH-2-95-1"	"C=CC(=O)NC1CCC(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)CC1"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	""	"UO_0000065"	"14.40"	"0.29"	"2.68"	"7.63"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4746993"	""	"None"	"555.73"	"2"	"5.57"	"MFH-3-81-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c(OC)c1"	"IC50"	"'='"	"164.0"	"nM"	"6.79"	""	""	"UO_0000065"	"12.21"	"0.24"	"1.22"	"6.19"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4789917"	""	"None"	"548.62"	"2"	"5.09"	"MFH-3-201-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(SCc4cnc(C(F)(F)F)nc4)s3)C2)cc1"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4758168"	""	"None"	"568.77"	"2"	"5.10"	"MFH-4-73-1"	"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CC[C@@H](Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"54.5"	"nM"	"7.26"	""	""	"UO_0000065"	"12.77"	"0.25"	"2.16"	"7.01"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4643057"	""	"None"	"442.57"	"1"	"5.10"	"B6"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(SCc3ncc(C(C)(C)C)o3)s2)c1"	"IC50"	"'='"	"24.6"	"nM"	"7.61"	""	""	"UO_0000065"	"17.19"	"0.35"	"2.51"	"7.83"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4761637"	""	"None"	"561.69"	"2"	"6.35"	"B9"	"C=CC(=O)Nc1ccc(C(=O)Nc2cccc(C(=O)Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)c2)cc1"	"IC50"	"'='"	"23.7"	"nM"	"7.62"	""	""	"UO_0000065"	"13.58"	"0.27"	"1.28"	"6.04"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4757918"	""	"None"	"456.53"	"1"	"5.15"	"41"	"CC(C)N1c2cc(Nc3ncc(F)c(-c4cncc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"23.9"	"nM"	"7.62"	""	""	"UO_0000065"	"16.69"	"0.31"	"2.47"	"10.26"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5090552"	""	"None"	"259.70"	"0"	"3.31"	"34"	"Nc1cc(-c2ccc3oc(Cl)cc3c2)cc(N)n1"	"IC50"	"'='"	"5430.0"	"nM"	"5.26"	""	""	"UO_0000065"	"20.27"	"0.40"	"1.96"	"6.74"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5073976"	""	"None"	"334.38"	"0"	"2.80"	"45"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCc1ccco1"	"IC50"	"'='"	"1952.0"	"nM"	"5.71"	""	""	"UO_0000065"	"17.07"	"0.31"	"2.91"	"5.25"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5073869"	""	"None"	"253.30"	"0"	"3.28"	"50"	"Cc1oc2ccc(-c3cc(N)nc(N)c3)cc2c1C"	"IC50"	"'='"	"8835.0"	"nM"	"5.05"	""	""	"UO_0000065"	"19.95"	"0.36"	"1.77"	"6.47"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4777761"	""	"None"	"358.42"	"0"	"2.36"	"THZ-CE-B-17"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCOCC3)s2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4848653"	""	"None"	"481.54"	"1"	"5.64"	"17"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"180.0"	"nM"	"6.75"	""	""	"UO_0000065"	"14.01"	"0.26"	"1.10"	"8.60"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4874984"	""	"None"	"463.55"	"1"	"5.36"	"21"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"2400.0"	"nM"	"5.62"	""	""	"UO_0000065"	"12.12"	"0.23"	"0.26"	"7.16"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4549667"	"TP-030-2"	"None"	"481.35"	"0"	"3.12"	"EUB0000720"	"CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21"	"IC50"	""	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4884952"	"CDK9(CDK9CGS1) Takeda global kinase panel"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4507326"	"54"	"Donated Chemical Probes - SGC Frankfurt"	""	"2021"	"None"	"Compound concentration None 1.0 µM"	""	""
"CHEMBL3663778"	""	"None"	"436.92"	"0"	"4.89"	"BDBM167553"	"Fc1cncc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)c1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"311335"	"UO_0000065"	"18.31"	"0.35"	"3.11"	"10.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663779"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167554"	"Fc1ccccc1CNc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311336"	"UO_0000065"	"17.16"	"0.33"	"1.98"	"11.40"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668430"	""	"None"	"436.56"	"1"	"5.53"	"BDBM167672"	"CN1CCC(c2cc3c(-c4cccc(NCc5ccc6cc[nH]c6c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	"311454"	"UO_0000065"	"16.18"	"0.29"	"1.54"	"9.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668477"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167720"	"Fc1ccccc1CNc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCCNC4)cc23)n1"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"311501"	"UO_0000065"	"16.47"	"0.32"	"1.68"	"10.94"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668491"	""	"None"	"390.42"	"0"	"3.91"	"BDBM167734"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)CC#N)CC3)cc12"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311515"	"UO_0000065"	"19.67"	"0.36"	"3.77"	"9.36"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668559"	""	"None"	"454.48"	"0"	"2.81"	"BDBM167803"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"42.0"	"nM"	"7.38"	""	"311584"	"UO_0000065"	"16.23"	"0.31"	"4.57"	"9.03"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663757"	""	"None"	"524.09"	"2"	"5.81"	"BDBM167531"	"CC(C)S(=O)(=O)N1CCCC(c2cc3c(-c4nc(NCc5ccccc5)ccc4Cl)ccnc3[nH]2)C1"	"IC50"	"'='"	"1400.0"	"nM"	"5.85"	""	"311313"	"UO_0000065"	"11.17"	"0.22"	"0.04"	"6.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663764"	""	"None"	"343.38"	"0"	"3.98"	"BDBM167538"	"COc1cc(F)c(F)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"311320"	"UO_0000065"	"23.07"	"0.43"	"3.94"	"15.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663785"	""	"None"	"431.93"	"0"	"5.00"	"BDBM167560"	"O=C(Nc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1)c1ccccc1"	"IC50"	"'='"	"19000.0"	"nM"	"4.72"	""	"311342"	"UO_0000065"	"10.93"	"0.21"	"-0.28"	"5.71"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668352"	""	"None"	"329.81"	"0"	"4.49"	"BDBM167593"	"Fc1cccc(-c2c(Cl)cnc3[nH]c(C4CCCNC4)cc23)c1"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"311375"	"UO_0000065"	"21.83"	"0.43"	"2.71"	"17.69"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4756595"	"ENITOCICLIB"	"1.0"	"404.44"	"0"	"4.35"	"8; BAY-1251152"	"COc1cc(F)ccc1-c1cc(Nc2cc(CS(C)(=N)=O)ccn2)ncc1F"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	""	"UO_0000065"	"21.07"	"0.42"	"4.17"	"9.69"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3663808"	""	"None"	"341.39"	"0"	"3.38"	"BDBM167583"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CN(C)CCO3)cc12"	"IC50"	"'='"	"510.0"	"nM"	"6.29"	""	"311365"	"UO_0000065"	"18.43"	"0.34"	"2.91"	"12.49"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668505"	""	"None"	"436.49"	"0"	"2.67"	"BDBM167748"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"62.0"	"nM"	"7.21"	""	"311529"	"UO_0000065"	"16.51"	"0.31"	"4.54"	"8.82"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668541"	""	"None"	"466.56"	"0"	"3.54"	"BDBM167785"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C4CC(O)C4)CC3)cc12"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"311566"	"UO_0000065"	"15.39"	"0.29"	"3.64"	"8.79"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL5199352"	""	"None"	"405.50"	"0"	"4.37"	"12"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCOCC3)cc12"	"IC50"	"'='"	"650.0"	"nM"	"6.19"	""	""	"UO_0000065"	"15.26"	"0.28"	"1.82"	"9.17"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5192311"	""	"None"	"448.57"	"0"	"3.65"	"17"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCN(CCO)CC3)cc12"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	""	"UO_0000065"	"15.35"	"0.28"	"3.24"	"8.43"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5181511"	""	"None"	"378.48"	"0"	"3.70"	"37"	"CC(=O)N1CCC(c2cc3c(-c4ccc(=O)n(C(C)C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"350.0"	"nM"	"6.46"	""	""	"UO_0000065"	"17.06"	"0.31"	"2.76"	"9.09"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4440386"	""	"None"	"420.52"	"0"	"2.88"	"16b; VII33"	"CC(C)c1cnn2c(NCc3cccc4c3cnn4C)nc(OC3CCCNC3)nc12"	"IC50"	"'<'"	"50.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4741442"	""	"None"	"402.27"	"0"	"1.42"	"ZK 304709"	"C[C@H](CO)Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ncc1Br"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"20.64"	"0.49"	"6.88"	"6.37"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL133342"	"(S)-ROSCOVITINE"	"None"	"354.46"	"0"	"3.20"	"CYC202"	"CC[C@@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	""	"UO_0000065"	"18.73"	"0.35"	"3.44"	"7.55"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"SCH 727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL296468"	"BMS-387032"	"1.0"	"380.54"	"0"	"3.66"	"SNS-032, BMS-387032"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"22.07"	"0.46"	"4.74"	"10.49"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5089171"	""	"None"	"440.31"	"0"	"3.20"	"56"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCOc1cccc(Br)n1"	"IC50"	"'='"	"289.0"	"nM"	"6.54"	""	""	"UO_0000065"	"14.85"	"0.32"	"3.34"	"5.55"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL14762"	"SELICICLIB"	"2.0"	"354.46"	"0"	"3.20"	"2"	"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1"	"IC50"	"'='"	"1050.0"	"nM"	"5.98"	""	""	"UO_0000065"	"16.87"	"0.31"	"2.78"	"6.80"	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"4"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4303287"	""	"None"	"566.07"	"2"	"6.33"	"24; THZ2"	"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1"	"IC50"	"'='"	"134.0"	"nM"	"6.87"	""	""	"UO_0000065"	"12.14"	"0.23"	"0.54"	"5.97"	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL488436"	"AZD-5438"	"1.0"	"371.47"	"0"	"3.38"	"AZD5438"	"Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"20.73"	"0.40"	"4.32"	"8.58"	"0"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5285499"	""	"None"	"259.36"	"0"	"1.97"	"KI-ARv-03"	"CCCc1cc(N[C@@H]2CC[C@@H](N)C2)n2nccc2n1"	"IC50"	"'='"	"50.0"	"nM"	"7.30"	""	""	"UO_0000065"	"28.15"	"0.52"	"5.33"	"10.70"	"0"	"CHEMBL5224454"	"Inhibition of CDK9 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	"TIME = 2.0 hr"	"INHIBITOR"	""
"CHEMBL3655773"	""	"None"	"383.50"	"0"	"3.29"	"BDBM106961"	"CC[C@H](Nc1nc(NCc2cccc(C)n2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"2040.0"	"nM"	"5.69"	""	"226149"	"UO_0000065"	"14.84"	"0.28"	"2.40"	"5.65"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3898182"	""	"None"	"394.50"	"0"	"3.23"	"BDBM223938"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"85.0"	"nM"	"7.07"	""	"391040"	"UO_0000065"	"17.92"	"0.34"	"3.84"	"10.20"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3916153"	""	"None"	"441.53"	"0"	"2.70"	"BDBM223957"	"CN1Cc2c(C3=CCN(CCS(N)(=O)=O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"24.0"	"nM"	"7.62"	""	"391059"	"UO_0000065"	"17.26"	"0.34"	"4.92"	"7.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3975453"	""	"None"	"502.63"	"2"	"6.08"	"BDBM223963"	"CN1Cc2c(C3=CCN(C4CCC(C(C)(C)C(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"391065"	"UO_0000065"	"13.70"	"0.25"	"0.81"	"9.50"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3903886"	""	"None"	"441.51"	"0"	"4.77"	"BDBM223880"	"CN1Cc2c(C3=CC4CCCC(C3)N4C(=O)CC#N)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"390982"	"UO_0000065"	"16.66"	"0.30"	"2.59"	"9.68"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3907123"	""	"None"	"489.60"	"0"	"3.78"	"BDBM223881"	"CN(CCO)C(=O)CN1C2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC1CCC2"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	"390983"	"UO_0000065"	"14.43"	"0.27"	"3.29"	"9.33"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3928559"	""	"None"	"402.50"	"0"	"3.50"	"BDBM60457"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCNCC3S(C)(=N)=O)cc12"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"217641"	"UO_0000065"	"19.03"	"0.37"	"4.16"	"8.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3343034"	""	"None"	"400.44"	"0"	"4.65"	"5a"	"COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)nc(C)nc2cc1O"	"IC50"	"'>'"	"30000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3380808"	"Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3351874"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2014"	"None"	""	""	""
"CHEMBL4079206"	""	"None"	"462.33"	"0"	"4.46"	"32; IIIM-290"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(/C=C/c4c(Cl)cccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"1.9"	"nM"	"8.72"	""	""	"UO_0000065"	"18.86"	"0.38"	"4.26"	"9.26"	"0"	"CHEMBL4370707"	"Inhibition of human CDK9"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4368927"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2019"	"None"	""	""	""
"CHEMBL3953940"	""	"None"	"445.54"	"0"	"3.74"	"BDBM223855"	"CN(C)C(=O)CN1CC2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC2C1"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"390957"	"UO_0000065"	"16.47"	"0.30"	"3.60"	"13.23"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4448572"	""	"None"	"426.40"	"0"	"2.38"	"1"	"COCCNC(=O)Nc1nc2cc(OS(=O)(=O)c3c(F)cccc3F)ccc2[nH]1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"19.28"	"0.39"	"5.84"	"6.72"	"0"	"CHEMBL4426791"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4425133"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL4094627"	""	"None"	"317.40"	"0"	"2.52"	"4"	"Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(C#N)ccnc21"	"IC50"	"'='"	"6100.0"	"nM"	"5.21"	""	""	"UO_0000065"	"16.43"	"0.30"	"2.69"	"9.17"	"0"	"CHEMBL4047696"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4043256"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2017"	"None"	""	""	""
"CHEMBL4753256"	""	"None"	"415.93"	"0"	"3.42"	"27"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"77.0"	"nM"	"7.11"	""	""	"UO_0000065"	"17.10"	"0.34"	"3.69"	"8.00"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3976491"	""	"None"	"362.45"	"0"	"4.65"	"BDBM223787"	"CCC1c2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"390889"	"UO_0000065"	"20.19"	"0.37"	"2.67"	"16.65"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3976471"	""	"None"	"394.45"	"0"	"3.58"	"BDBM223801"	"CN1Cc2c(C3CCN(CC(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"390903"	"UO_0000065"	"17.30"	"0.32"	"3.24"	"9.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3952541"	""	"None"	"406.46"	"0"	"3.80"	"BDBM223806"	"CCOC(=O)C1c2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"390908"	"UO_0000065"	"16.79"	"0.31"	"3.02"	"9.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3969174"	""	"None"	"406.46"	"0"	"3.93"	"BDBM223809"	"CN1Cc2c(C3=CCC(NCC(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"86.0"	"nM"	"7.07"	""	"390911"	"UO_0000065"	"17.38"	"0.32"	"3.14"	"8.70"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3976947"	""	"None"	"482.56"	"1"	"5.67"	"BDBM223810"	"CN1Cc2c(C3=CCC(N[C@H](C(=O)O)c4ccccc4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"56.0"	"nM"	"7.25"	""	"390912"	"UO_0000065"	"15.03"	"0.28"	"1.58"	"8.93"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3961213"	""	"None"	"404.49"	"0"	"4.59"	"BDBM223828"	"CN(C)C(=O)C1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"390930"	"UO_0000065"	"17.11"	"0.32"	"2.33"	"13.25"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3668387"	""	"None"	"409.51"	"0"	"4.59"	"BDBM167628"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC4CCCOC4)C3)cc12"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	"311410"	"UO_0000065"	"18.18"	"0.34"	"2.85"	"14.78"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668411"	""	"None"	"425.58"	"1"	"5.11"	"BDBM167652"	"CN1CCC(c2cc3c(-c4cccc(N(C)CCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"311434"	"UO_0000065"	"16.26"	"0.30"	"1.81"	"14.40"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673526"	""	"None"	"459.53"	"0"	"4.29"	"BDBM167844"	"CNC(=O)N1CCC(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311625"	"UO_0000065"	"16.80"	"0.31"	"3.43"	"7.81"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673537"	""	"None"	"442.53"	"0"	"3.55"	"BDBM167855"	"CNC(=O)N1CCC(c2cc3c(-c4cncc(NCc5cccnc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"66.0"	"nM"	"7.18"	""	"311636"	"UO_0000065"	"16.23"	"0.30"	"3.63"	"6.43"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3655768"	""	"None"	"332.45"	"0"	"2.80"	"BDBM106956"	"CC[C@H](Nc1nc(NCC2CC2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"380.0"	"nM"	"6.42"	""	"226144"	"UO_0000065"	"19.31"	"0.37"	"3.62"	"7.30"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL4538461"	""	"None"	"416.24"	"0"	"3.82"	"2"	"COC(=O)Nc1nc2cc(OS(=O)(=O)c3c(Cl)cccc3Cl)ccc2[nH]1"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"14.22"	"0.31"	"2.10"	"5.36"	"0"	"CHEMBL4426791"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4425133"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	""	""
"CHEMBL4780912"	""	"None"	"381.48"	"0"	"2.91"	"4"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)ccn2)C1"	"IC50"	"'='"	"520.0"	"nM"	"6.28"	""	""	"UO_0000065"	"16.47"	"0.31"	"3.37"	"7.07"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4760601"	""	"None"	"383.50"	"0"	"3.47"	"3"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc(C)n3C(C)C)ccn2)C1"	"IC50"	"'='"	"920.0"	"nM"	"6.04"	""	""	"UO_0000065"	"15.74"	"0.29"	"2.57"	"6.79"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3668426"	""	"None"	"432.96"	"1"	"5.09"	"BDBM167668"	"CN1CCC(c2cc3c(-c4nc(NCc5ccncc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"311450"	"UO_0000065"	"16.84"	"0.32"	"2.20"	"10.46"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3976450"	""	"None"	"418.47"	"0"	"4.74"	"BDBM180816"	"CCS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"135.0"	"nM"	"6.87"	""	"327610"	"UO_0000065"	"16.42"	"0.32"	"2.13"	"7.81"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3937866"	""	"None"	"497.45"	"1"	"5.27"	"BDBM180835"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327629"	"UO_0000065"	"16.88"	"0.34"	"3.13"	"8.38"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"104.0"	"nM"	"6.98"	""	"327640"	"UO_0000065"	"15.57"	"0.31"	"1.96"	"7.94"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4796500"	""	"None"	"417.90"	"0"	"3.01"	"19"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3OCCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"350.0"	"nM"	"6.46"	""	""	"UO_0000065"	"15.45"	"0.30"	"3.45"	"6.58"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4450322"	""	"None"	"515.62"	"1"	"3.85"	"TKL-5-124"	"C=CC(=O)Nc1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)cc1"	"IC50"	"'>'"	"3020.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL3944304"	""	"None"	"455.49"	"0"	"4.79"	"BDBM180843"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(=O)(=NC#N)C3CC3)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327637"	"UO_0000065"	"18.22"	"0.35"	"3.51"	"8.28"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"327465"	"UO_0000065"	"19.35"	"0.38"	"3.47"	"8.89"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934755"	""	"None"	"494.50"	"1"	"5.07"	"BDBM180804"	"CCOC(=O)N=S(C)(=O)Cc1cc(F)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327472"	"UO_0000065"	"16.37"	"0.33"	"3.03"	"7.88"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663802"	""	"None"	"311.36"	"0"	"3.45"	"BDBM167577"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@@H]3CCNC3)cc12"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311359"	"UO_0000065"	"25.13"	"0.46"	"4.37"	"15.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668351"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167592"	"Clc1cnc2[nH]c(C3CCNCC3)cc2c1-c1cccc(NCc2ccccc2)n1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311374"	"UO_0000065"	"18.19"	"0.35"	"2.24"	"11.58"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668353"	""	"None"	"330.79"	"0"	"3.88"	"BDBM167594"	"Fc1cccc(-c2c(Cl)cnc3[nH]c(C4CCCNC4)cc23)n1"	"IC50"	"'='"	"840.0"	"nM"	"6.08"	""	"311376"	"UO_0000065"	"18.37"	"0.36"	"2.20"	"11.34"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668368"	""	"None"	"433.60"	"1"	"5.05"	"BDBM167609"	"CN1CCC(c2cc3c(-c4cccc(NCC5CCOC(C)(C)C5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"311391"	"UO_0000065"	"15.74"	"0.29"	"1.77"	"10.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668393"	""	"None"	"439.53"	"0"	"4.95"	"BDBM167634"	"COC(=O)CCCN[C@H]1CC[C@H](c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"311416"	"UO_0000065"	"17.42"	"0.33"	"2.71"	"10.04"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668413"	""	"None"	"431.97"	"1"	"5.70"	"BDBM167654"	"CN1CCC(c2cc3c(-c4cccc(NCc5ccccc5Cl)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"24.0"	"nM"	"7.62"	""	"311436"	"UO_0000065"	"17.64"	"0.34"	"1.92"	"13.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668419"	""	"None"	"466.56"	"0"	"3.54"	"BDBM167660"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CN4CCC(O)CC4)CC3)cc12"	"IC50"	"'='"	"31.0"	"nM"	"7.51"	""	"311442"	"UO_0000065"	"16.09"	"0.30"	"3.97"	"9.19"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668422"	""	"None"	"418.55"	"0"	"3.47"	"BDBM167664"	"CN1CCC(c2cc3c(-c4cccc(NCCN5CCCC5=O)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"340.0"	"nM"	"6.47"	""	"311446"	"UO_0000065"	"15.45"	"0.28"	"3.00"	"8.38"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668423"	""	"None"	"395.94"	"0"	"4.91"	"BDBM167665"	"CN1CCC(c2cc3c(-c4nc(NCC5CC5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	"311447"	"UO_0000065"	"17.72"	"0.34"	"2.11"	"12.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668445"	""	"None"	"488.06"	"0"	"4.32"	"BDBM167687"	"CN1CCC(c2cc3c(-c4nc(NCC5CCS(=O)(=O)CC5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311469"	"UO_0000065"	"15.58"	"0.31"	"3.28"	"8.36"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668452"	""	"None"	"452.53"	"0"	"3.42"	"BDBM167694"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CN4CCOCC4)CC3)cc12"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311476"	"UO_0000065"	"17.06"	"0.32"	"4.30"	"10.92"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668482"	""	"None"	"401.49"	"0"	"4.84"	"BDBM167725"	"Fc1cc(NCc2ccccc2)nc(-c2ccnc3[nH]c(C4CCCNC4)cc23)c1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311506"	"UO_0000065"	"19.12"	"0.35"	"2.84"	"11.70"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4759074"	""	"None"	"429.95"	"0"	"3.81"	"31"	"CC(=O)NC1CCCC(C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"2400.0"	"nM"	"5.62"	""	""	"UO_0000065"	"13.07"	"0.26"	"1.81"	"6.32"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4855780"	""	"None"	"449.53"	"1"	"5.11"	"12"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"83.0"	"nM"	"7.08"	""	""	"UO_0000065"	"15.75"	"0.29"	"1.97"	"9.03"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4777981"	""	"None"	"467.52"	"1"	"5.25"	"16"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"78.0"	"nM"	"7.11"	""	""	"UO_0000065"	"15.20"	"0.29"	"1.86"	"9.06"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4848653"	""	"None"	"481.54"	"1"	"5.64"	"17"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	""	"UO_0000065"	"14.37"	"0.27"	"1.28"	"8.82"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4855187"	""	"None"	"443.50"	"0"	"3.64"	"7"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C(=O)NS(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"660.0"	"nM"	"6.18"	""	""	"UO_0000065"	"13.94"	"0.27"	"2.54"	"6.11"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4777981"	""	"None"	"467.52"	"1"	"5.25"	"16"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"14.88"	"0.28"	"1.71"	"8.87"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4878465"	""	"None"	"449.53"	"1"	"5.11"	"19"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCC(C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"680.0"	"nM"	"6.17"	""	""	"UO_0000065"	"13.72"	"0.26"	"1.06"	"7.86"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3984563"	""	"None"	"485.54"	"0"	"3.40"	"BDBM223781"	"CCOC(=O)NS(=O)(=O)N1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	"390883"	"UO_0000065"	"15.09"	"0.29"	"3.93"	"6.81"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3914190"	""	"None"	"419.50"	"0"	"3.50"	"BDBM223790"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"51.0"	"nM"	"7.29"	""	"390892"	"UO_0000065"	"17.38"	"0.32"	"3.79"	"13.15"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3985050"	""	"None"	"447.51"	"0"	"2.61"	"BDBM223796"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"390898"	"UO_0000065"	"16.44"	"0.30"	"4.75"	"9.72"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3938400"	""	"None"	"475.57"	"0"	"3.39"	"BDBM223802"	"CN1Cc2c(C3=CCN(CC(=O)N(C)C4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	"390904"	"UO_0000065"	"15.56"	"0.29"	"4.01"	"9.77"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3967958"	""	"None"	"469.54"	"0"	"2.48"	"BDBM223803"	"CNS(=O)(=O)CC(=O)N1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"22.0"	"nM"	"7.66"	""	"390905"	"UO_0000065"	"16.31"	"0.32"	"5.18"	"7.78"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3981309"	""	"None"	"448.54"	"0"	"4.95"	"BDBM223807"	"CC(C)[C@@H](NC1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1)C(=O)O"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"390909"	"UO_0000065"	"16.36"	"0.30"	"2.39"	"9.03"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3953020"	""	"None"	"496.59"	"1"	"5.54"	"BDBM223813"	"CN1Cc2c(C3=CCC(N[C@@H](Cc4ccccc4)C(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"61.0"	"nM"	"7.21"	""	"390915"	"UO_0000065"	"14.53"	"0.27"	"1.67"	"8.88"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3892232"	""	"None"	"432.50"	"0"	"3.71"	"BDBM223829"	"CN1Cc2c(C3=CCC(C(=O)N4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"390931"	"UO_0000065"	"16.09"	"0.30"	"3.25"	"9.60"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3967245"	""	"None"	"467.50"	"0"	"3.89"	"BDBM223832"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(F)(F)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"63.0"	"nM"	"7.20"	""	"390934"	"UO_0000065"	"15.40"	"0.29"	"3.31"	"12.98"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3970274"	""	"None"	"479.53"	"0"	"3.14"	"BDBM223851"	"CN1Cc2c(C3=CCN(CC(=O)N4CC[C@H](O)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"52.0"	"nM"	"7.28"	""	"390953"	"UO_0000065"	"15.19"	"0.28"	"4.14"	"9.62"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3908119"	""	"None"	"479.53"	"0"	"3.00"	"BDBM223852"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(CO)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"89.0"	"nM"	"7.05"	""	"390954"	"UO_0000065"	"14.70"	"0.28"	"4.05"	"9.31"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3927123"	""	"None"	"433.53"	"0"	"3.89"	"BDBM223866"	"CN(C)C(=O)CN1CCC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"390968"	"UO_0000065"	"15.74"	"0.29"	"2.93"	"12.30"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3921963"	""	"None"	"412.49"	"0"	"3.37"	"BDBM223873"	"CN1Cc2c(C3=CCCN(S(C)(=O)=O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"390975"	"UO_0000065"	"16.69"	"0.32"	"3.52"	"9.94"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3950866"	""	"None"	"431.52"	"0"	"4.67"	"BDBM223878"	"CNC(=O)N1C2C=C(c3[nH]c4nccc5c4c3CN(C)c3ccc(F)cc3-5)CC1CCC2"	"IC50"	"'='"	"83.0"	"nM"	"7.08"	""	"390980"	"UO_0000065"	"16.41"	"0.30"	"2.41"	"11.02"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3941567"	""	"None"	"487.58"	"0"	"3.53"	"BDBM223883"	"CN1Cc2c(C3=CC4CCCC(C3)N4CC(=O)N3CC(O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"98.0"	"nM"	"7.01"	""	"390985"	"UO_0000065"	"14.37"	"0.27"	"3.48"	"9.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3912612"	""	"None"	"493.56"	"0"	"3.53"	"BDBM223887"	"CN1Cc2c(C3=CCN(CC(=O)N(C)C4CC(O)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	"390989"	"UO_0000065"	"14.93"	"0.28"	"3.84"	"9.73"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3963396"	""	"None"	"475.57"	"0"	"3.39"	"BDBM223898"	"CN1Cc2c(C3=CCCN(CC(=O)N4CCC[C@H]4CO)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"480.0"	"nM"	"6.32"	""	"391000"	"UO_0000065"	"13.29"	"0.25"	"2.93"	"8.35"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3931677"	""	"None"	"437.49"	"0"	"3.64"	"BDBM223910"	"CN(C)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2cc(F)c(F)cc2-4)CC1"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	"391012"	"UO_0000065"	"16.91"	"0.32"	"3.76"	"13.34"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3944130"	""	"None"	"506.60"	"2"	"5.67"	"BDBM223912"	"COC(=O)CC1CCC(N2CC=C(c3[nH]c4nccc5c4c3CN(C)c3cc(F)c(F)cc3-5)CC2)CC1"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	"391014"	"UO_0000065"	"14.46"	"0.27"	"1.66"	"11.92"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3937675"	""	"None"	"410.42"	"0"	"3.63"	"BDBM223923"	"CN1Cc2c(C3=CCN(CC(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"42.0"	"nM"	"7.38"	""	"391025"	"UO_0000065"	"17.97"	"0.34"	"3.75"	"10.18"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4740254"	""	"None"	"360.85"	"0"	"2.89"	"34"	"CC1(C)Cc2c(-c3cc(NC(=O)[C@H]4C[C@@H](O)C4)ncc3Cl)cnn2C1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	""	"UO_0000065"	"20.39"	"0.40"	"4.47"	"9.19"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4462530"	"AZD-4573"	"2.0"	"429.95"	"0"	"3.81"	"24"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"13.4"	"nM"	"7.87"	""	""	"UO_0000065"	"18.31"	"0.36"	"4.06"	"8.85"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4756050"	""	"None"	"401.90"	"0"	"3.18"	"14"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc4n3CCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"760.0"	"nM"	"6.12"	""	""	"UO_0000065"	"15.23"	"0.30"	"2.94"	"6.88"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3668522"	""	"None"	"433.49"	"0"	"3.43"	"BDBM167766"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)N(C)C)CC3)c(C#N)c12"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"311547"	"UO_0000065"	"16.95"	"0.31"	"3.92"	"8.62"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673494"	""	"None"	"415.52"	"1"	"5.36"	"BDBM167812"	"NC1CCCC(c2cc3c(-c4cccc(NCc5cccc(F)c5)n4)ccnc3[nH]2)C1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"311593"	"UO_0000065"	"19.36"	"0.35"	"2.69"	"10.11"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673495"	""	"None"	"294.33"	"0"	"3.14"	"BDBM167813"	"Fc1cccc(-c2ccnc3[nH]c(C4=CCNCC4)cc23)n1"	"IC50"	"'='"	"240.0"	"nM"	"6.62"	""	"311594"	"UO_0000065"	"22.49"	"0.41"	"3.48"	"12.35"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673508"	""	"None"	"478.50"	"0"	"3.61"	"BDBM167826"	"O=C(CO)N1CCC(c2cc3c(-c4cncc(NCc5cc(F)cc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"31.0"	"nM"	"7.51"	""	"311607"	"UO_0000065"	"15.69"	"0.29"	"3.90"	"7.02"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3894072"	""	"None"	"475.57"	"0"	"3.25"	"BDBM223895"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(O)C4)CC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"960.0"	"nM"	"6.02"	""	"390997"	"UO_0000065"	"12.65"	"0.23"	"2.77"	"7.95"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3923572"	""	"None"	"362.45"	"0"	"4.65"	"BDBM223920"	"CC[C@H]1c2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"391022"	"UO_0000065"	"20.76"	"0.38"	"2.87"	"17.12"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3970723"	""	"None"	"352.39"	"0"	"3.83"	"BDBM223922"	"CN1Cc2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"29.0"	"nM"	"7.54"	""	"391024"	"UO_0000065"	"21.39"	"0.40"	"3.71"	"17.15"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3983849"	""	"None"	"493.56"	"0"	"3.53"	"BDBM223926"	"CN1Cc2c(C3=CCN(CC(=O)N(C)C4CC(O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"53.0"	"nM"	"7.28"	""	"391028"	"UO_0000065"	"14.74"	"0.28"	"3.75"	"9.61"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3668515"	""	"None"	"426.47"	"0"	"3.30"	"BDBM167758"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)c(C#N)c12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311539"	"UO_0000065"	"17.91"	"0.35"	"4.34"	"7.71"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668533"	""	"None"	"507.54"	"1"	"3.46"	"BDBM167777"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN(CC(=O)N4CCC[C@@H]4CO)CC3)c(C#N)c12"	"IC50"	"'='"	"149.0"	"nM"	"6.83"	""	"311558"	"UO_0000065"	"13.45"	"0.25"	"3.37"	"6.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668547"	""	"None"	"445.49"	"0"	"3.81"	"BDBM167791"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CC4CN(S(C)(=O)=O)CC4C3)cc12"	"IC50"	"'='"	"117.0"	"nM"	"6.93"	""	"311572"	"UO_0000065"	"15.56"	"0.31"	"3.12"	"9.21"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3655776"	""	"None"	"395.39"	"0"	"2.75"	"BDBM106964"	"CC(C)n1cnc2c(NCc3cccnc3)nc(NCC(O)C(F)(F)F)nc21"	"IC50"	"'='"	"7400.0"	"nM"	"5.13"	""	"226152"	"UO_0000065"	"12.98"	"0.25"	"2.38"	"5.09"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327481"	"UO_0000065"	"18.85"	"0.37"	"3.85"	"8.08"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3897217"	""	"None"	"440.42"	"0"	"4.63"	"BDBM180820"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)c(F)c(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327488"	"UO_0000065"	"19.07"	"0.38"	"3.77"	"9.55"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3950787"	""	"None"	"334.40"	"0"	"3.70"	"BDBM223779"	"CN1Cc2c(C3=CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"390881"	"UO_0000065"	"22.96"	"0.42"	"3.98"	"17.47"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3914925"	""	"None"	"316.41"	"0"	"3.56"	"BDBM223936"	"CN1Cc2c(C3=CCNCC3)[nH]c3nccc(c23)-c2ccccc21"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	"391038"	"UO_0000065"	"22.18"	"0.40"	"3.46"	"15.97"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3668478"	""	"None"	"418.93"	"0"	"4.75"	"BDBM167721"	"Clc1ccc(NCc2cccnc2)nc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	"311502"	"UO_0000065"	"17.58"	"0.34"	"2.62"	"9.38"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668483"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167726"	"Clc1cnc2[nH]c(C3CCCNC3)cc2c1-c1ccnc(NCc2ccccc2)c1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311507"	"UO_0000065"	"18.19"	"0.35"	"2.24"	"11.58"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3655764"	""	"None"	"402.93"	"0"	"4.24"	"BDBM106952"	"CC[C@H](Nc1nc(NCc2cccc(Cl)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"60.0"	"nM"	"7.22"	""	"226140"	"UO_0000065"	"17.92"	"0.35"	"2.98"	"8.22"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3960058"	""	"None"	"352.39"	"0"	"3.83"	"BDBM223826"	"CN1Cc2c(C3=CCNCC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"27.0"	"nM"	"7.57"	""	"390928"	"UO_0000065"	"21.48"	"0.40"	"3.74"	"17.22"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3975203"	""	"None"	"360.44"	"0"	"4.23"	"BDBM223840"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"390942"	"UO_0000065"	"20.36"	"0.37"	"3.11"	"16.69"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3900836"	""	"None"	"479.56"	"0"	"2.22"	"BDBM223841"	"CN(CC(O)CO)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"390943"	"UO_0000065"	"15.47"	"0.29"	"5.20"	"7.74"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3906898"	""	"None"	"473.55"	"0"	"3.14"	"BDBM223858"	"CN1Cc2c(C3=C[C@H]4CC[C@@H](C3)N4CC(=O)N3CC(O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"97.0"	"nM"	"7.01"	""	"390960"	"UO_0000065"	"14.81"	"0.27"	"3.87"	"9.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3934364"	""	"None"	"334.40"	"0"	"3.70"	"BDBM223871"	"CN1Cc2c(C3=CCCNC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"46.0"	"nM"	"7.34"	""	"390973"	"UO_0000065"	"21.94"	"0.40"	"3.64"	"16.69"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3978141"	""	"None"	"440.54"	"0"	"4.00"	"BDBM223891"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3(C)C)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"650.0"	"nM"	"6.19"	""	"390993"	"UO_0000065"	"14.04"	"0.27"	"2.19"	"8.93"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3982368"	""	"None"	"382.41"	"0"	"3.20"	"BDBM223904"	"CN1Cc2c(C3=C[C@H](CO)NCC3)[nH]c3nccc(c23)-c2cc(F)c(F)cc21"	"IC50"	"'='"	"58.0"	"nM"	"7.24"	""	"391006"	"UO_0000065"	"18.92"	"0.35"	"4.04"	"11.28"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3944130"	""	"None"	"506.60"	"2"	"5.67"	"BDBM223911"	"COC(=O)CC1CCC(N2CC=C(c3[nH]c4nccc5c4c3CN(C)c3cc(F)c(F)cc3-5)CC2)CC1"	"IC50"	"'='"	"58.0"	"nM"	"7.24"	""	"391013"	"UO_0000065"	"14.28"	"0.27"	"1.57"	"11.77"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3922725"	""	"None"	"395.49"	"0"	"2.62"	"BDBM223916"	"CN1Cc2c(C3=CCN(S(C)(=O)=O)CC3)[nH]c3nccc(c23)-c2cccnc21"	"IC50"	"'='"	"69.0"	"nM"	"7.16"	""	"391018"	"UO_0000065"	"18.11"	"0.35"	"4.54"	"8.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3927462"	""	"None"	"364.42"	"0"	"3.06"	"BDBM223934"	"CN1Cc2c(C3=CCN[C@@H](CO)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"391036"	"UO_0000065"	"20.64"	"0.38"	"4.46"	"11.72"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3896241"	""	"None"	"461.54"	"1"	"5.38"	"BDBM223943"	"O=C(O)CC1CCC(N2CC=C(c3[nH]c4nccc5c4c3COc3ccc(F)cc3-5)CC2)CC1"	"IC50"	"'='"	"390.0"	"nM"	"6.41"	""	"391045"	"UO_0000065"	"13.89"	"0.26"	"1.03"	"8.17"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3984474"	""	"None"	"446.53"	"0"	"4.31"	"BDBM223966"	"CN1CCc2c(C3=CCN([C@H]4C[C@@H](C(=O)O)C4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	"391068"	"UO_0000065"	"15.28"	"0.28"	"2.51"	"9.42"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4743840"	""	"None"	"399.52"	"0"	"3.05"	"THZ-CE-B-22"	"C=CC(=O)Nc1cccc(C(=O)Nc2ncc(N3CCC(N(C)C)CC3)s2)c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4764719"	""	"None"	"523.66"	"1"	"4.99"	"MFH-3-128-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(COCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	""	""
"CHEMBL4752989"	""	"None"	"582.80"	"2"	"5.49"	"B16; THZ-CE-B-16"	"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c1"	"IC50"	"'='"	"177.0"	"nM"	"6.75"	""	""	"UO_0000065"	"11.59"	"0.23"	"1.26"	"6.52"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3909386"	""	"None"	"462.57"	"1"	"6.29"	"BDBM223786"	"CCC1c2c(C3=CCN(C(=O)OC(C)(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc2N1C"	"IC50"	"'='"	"1400.0"	"nM"	"5.85"	""	"390888"	"UO_0000065"	"12.66"	"0.24"	"-0.44"	"9.52"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3946356"	""	"None"	"336.41"	"0"	"3.79"	"BDBM223799"	"CN1Cc2c(C3CCNCC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"400.0"	"nM"	"6.40"	""	"390901"	"UO_0000065"	"19.02"	"0.35"	"2.61"	"14.56"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3975945"	""	"None"	"448.54"	"1"	"5.10"	"BDBM223817"	"CCC[C@H](NC1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1)C(=O)O"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"390919"	"UO_0000065"	"15.35"	"0.28"	"1.79"	"8.48"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4083249"	""	"None"	"409.42"	"1"	"5.54"	"25"	"C[C@@H](c1ccc(F)cc1)n1nnc2cnc3ccc(-c4ccc5ocnc5c4)cc3c21"	"IC50"	"'='"	"1430.0"	"nM"	"5.84"	""	""	"UO_0000065"	"14.28"	"0.26"	"0.30"	"8.39"	"0"	"CHEMBL4014123"	"Inhibition of recombinant human CDK9 expressed in fall armyworm sf21 cells using PDKtide as substrate in presence of [gamma-32]-ATP"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4011657"	"1"	"Scientific Literature"	"J Med Chem"	"2017"	"None"	""	""	""
"CHEMBL3668392"	""	"None"	"401.46"	"0"	"3.43"	"2"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(S(C)(=O)=O)CC3)cc12"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	""	"UO_0000065"	"16.54"	"0.32"	"3.21"	"8.82"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3668495"	""	"None"	"381.41"	"0"	"3.55"	"6"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(=O)O)CC3)cc12"	"IC50"	"'='"	"87.0"	"nM"	"7.06"	""	""	"UO_0000065"	"18.51"	"0.34"	"3.51"	"9.00"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4855780"	""	"None"	"449.53"	"1"	"5.11"	"12"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"270.0"	"nM"	"6.57"	""	""	"UO_0000065"	"14.61"	"0.27"	"1.46"	"8.37"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3925253"	""	"None"	"464.54"	"0"	"3.45"	"BDBM60465"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CCC(C3)N4CC(=O)N(C)CCO)cc12"	"IC50"	"'='"	"114.0"	"nM"	"6.94"	""	"218881"	"UO_0000065"	"14.95"	"0.28"	"3.49"	"8.50"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4877117"	""	"None"	"499.37"	"0"	"3.18"	"5"	"Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1"	"IC50"	"'='"	"10000.0"	"nM"	"5.00"	""	""	"UO_0000065"	"10.01"	"0.20"	"1.82"	"4.36"	"0"	"CHEMBL4806304"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4804285"	"38"	"Patent Bioactivity Data"	""	"2019"	"None"	""	"INHIBITOR"	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327492"	"UO_0000065"	"18.00"	"0.41"	"3.59"	"9.89"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663794"	""	"None"	"431.97"	"1"	"5.70"	"BDBM167569"	"CN1CCC(c2cc3c(-c4nc(NCc5ccccc5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	"311351"	"UO_0000065"	"17.87"	"0.34"	"2.02"	"13.58"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668462"	""	"None"	"457.55"	"0"	"4.89"	"BDBM167704"	"CN1CCC(c2cc3c(-c4cc(NCc5ccc(C(N)=O)cc5)ccc4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	"311486"	"UO_0000065"	"16.61"	"0.31"	"2.71"	"8.73"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668496"	""	"None"	"380.42"	"0"	"2.95"	"BDBM167739"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(N)=O)CC3)cc12"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	"311520"	"UO_0000065"	"19.85"	"0.37"	"4.60"	"8.97"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663784"	""	"None"	"388.90"	"1"	"5.41"	"BDBM167559"	"Clc1ccc(-c2ccccc2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"5100.0"	"nM"	"5.29"	""	"311341"	"UO_0000065"	"13.61"	"0.26"	"-0.12"	"9.87"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	"327467"	"UO_0000065"	"16.74"	"0.32"	"2.13"	"9.15"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668359"	""	"None"	"343.83"	"1"	"5.01"	"BDBM167600"	"NC1CCCC(c2cc3c(-c4cccc(F)c4)c(Cl)cnc3[nH]2)C1"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"311382"	"UO_0000065"	"20.36"	"0.40"	"1.99"	"12.80"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663782"	""	"None"	"424.98"	"0"	"4.16"	"BDBM167557"	"Clc1ccc(NCC2CCNCC2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"550.0"	"nM"	"6.26"	""	"311339"	"UO_0000065"	"14.73"	"0.28"	"2.10"	"8.06"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668418"	""	"None"	"297.33"	"0"	"3.06"	"BDBM167659"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CNC3)cc12"	"IC50"	"'='"	"12.0"	"nM"	"7.92"	""	"311441"	"UO_0000065"	"26.64"	"0.49"	"4.86"	"15.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668424"	""	"None"	"484.65"	"0"	"4.99"	"BDBM167666"	"CN(C)CCOc1ccc(CNc2cccc(-c3ccnc4[nH]c(C5CCN(C)CC5)cc34)n2)cc1"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	"311448"	"UO_0000065"	"15.12"	"0.28"	"2.34"	"10.57"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668458"	""	"None"	"310.38"	"0"	"3.42"	"BDBM167700"	"Nc1ccc(F)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)c1"	"IC50"	"'='"	"67.0"	"nM"	"7.17"	""	"311482"	"UO_0000065"	"23.11"	"0.43"	"3.75"	"10.75"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668518"	""	"None"	"440.52"	"0"	"3.01"	"BDBM167761"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)CCO)CC3)cc12"	"IC50"	"'='"	"56.0"	"nM"	"7.25"	""	"311542"	"UO_0000065"	"16.46"	"0.31"	"4.24"	"8.88"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668550"	""	"None"	"406.46"	"0"	"4.05"	"BDBM167794"	"CNC(=O)N1C[C@H]2CC(c3cc4c(-c5cc(F)ccc5OC)ccnc4[nH]3)=C[C@H]2C1"	"IC50"	"'='"	"93.0"	"nM"	"7.03"	""	"311575"	"UO_0000065"	"17.30"	"0.32"	"2.98"	"10.01"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673501"	""	"None"	"384.49"	"0"	"4.10"	"BDBM167819"	"c1ccc(CNc2cncc(-c3ccnc4[nH]c(C5CCNCC5)cc34)n2)cc1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"311600"	"UO_0000065"	"21.59"	"0.39"	"4.20"	"10.57"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4582624"	""	"None"	"504.60"	"2"	"2.68"	"13"	"COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1"	"IC50"	"'='"	"13000.0"	"nM"	"4.89"	""	""	"UO_0000065"	"9.68"	"0.18"	"2.21"	"3.56"	"0"	"CHEMBL4323546"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4321825"	"1"	"Scientific Literature"	"J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL3663750"	""	"None"	"339.41"	"0"	"4.19"	"BDBM167524"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCCN(C)C3)cc12"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	"311306"	"UO_0000065"	"21.54"	"0.40"	"3.12"	"17.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663753"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167527"	"Clc1ccc(NCc2ccccc2)nc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311309"	"UO_0000065"	"17.90"	"0.34"	"2.12"	"11.40"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663754"	""	"None"	"431.97"	"1"	"5.70"	"BDBM167528"	"CN1CCCC(c2cc3c(-c4nc(NCc5ccccc5)ccc4Cl)ccnc3[nH]2)C1"	"IC50"	"'='"	"93.0"	"nM"	"7.03"	""	"311310"	"UO_0000065"	"16.28"	"0.31"	"1.33"	"12.37"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668370"	""	"None"	"431.97"	"1"	"5.70"	"BDBM167611"	"CN1CCC(c2cc3c(-c4cccc(NCc5cccc(Cl)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311393"	"UO_0000065"	"18.18"	"0.35"	"2.15"	"13.82"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668372"	""	"None"	"353.40"	"0"	"4.06"	"BDBM167613"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN3C(C)=O)cc12"	"IC50"	"'='"	"1300.0"	"nM"	"5.89"	""	"311395"	"UO_0000065"	"16.66"	"0.31"	"1.83"	"10.11"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668373"	""	"None"	"365.41"	"0"	"4.01"	"BDBM167614"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"33.0"	"nM"	"7.48"	""	"311396"	"UO_0000065"	"20.47"	"0.38"	"3.47"	"12.85"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668390"	""	"None"	"409.51"	"0"	"4.59"	"BDBM167631"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CC4CCOCC4)C3)cc12"	"IC50"	"'='"	"61.0"	"nM"	"7.21"	""	"311413"	"UO_0000065"	"17.62"	"0.33"	"2.62"	"14.32"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673535"	""	"None"	"459.55"	"0"	"2.56"	"BDBM167853"	"OCC(O)CN1CCC(c2cc3c(-c4cncc(NCc5cccnc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"43.0"	"nM"	"7.37"	""	"311634"	"UO_0000065"	"16.03"	"0.30"	"4.81"	"5.99"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673551"	""	"None"	"443.48"	"0"	"4.41"	"BDBM167869"	"NC(=O)C1CC=C(c2cc3c(-c4cncc(OCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"87.0"	"nM"	"7.06"	""	"311650"	"UO_0000065"	"15.92"	"0.29"	"2.65"	"6.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668498"	""	"None"	"414.87"	"0"	"4.46"	"BDBM167741"	"CNC(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)c(Cl)cnc3[nH]2)CC1"	"IC50"	"'='"	"101.0"	"nM"	"7.00"	""	"311522"	"UO_0000065"	"16.86"	"0.33"	"2.54"	"9.96"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3892764"	""	"None"	"392.43"	"0"	"3.49"	"BDBM223794"	"CN1Cc2c(C3=CCN(CC(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"61.0"	"nM"	"7.21"	""	"390896"	"UO_0000065"	"18.38"	"0.34"	"3.72"	"9.96"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3961728"	""	"None"	"446.53"	"0"	"4.80"	"BDBM223815"	"CN1Cc2c(C3=CCC(N4CCC[C@H]4C(=O)O)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	"390917"	"UO_0000065"	"15.22"	"0.28"	"2.00"	"9.38"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3952162"	""	"None"	"437.49"	"0"	"3.64"	"BDBM223844"	"CN(C)C(=O)CN1CC=C(c2[nH]c3ncc(F)c4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"390946"	"UO_0000065"	"16.82"	"0.31"	"3.72"	"13.26"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3673518"	""	"None"	"416.50"	"0"	"4.58"	"BDBM167836"	"CN1CCC(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"311617"	"UO_0000065"	"18.86"	"0.35"	"3.27"	"11.26"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673552"	""	"None"	"442.50"	"0"	"4.44"	"BDBM167870"	"NC(=O)C1CC=C(c2cc3c(-c4cncc(NCc5cccc(F)c5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311651"	"UO_0000065"	"16.62"	"0.30"	"2.92"	"6.71"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663746"	""	"None"	"325.39"	"0"	"3.84"	"BDBM167520"	"COc1ccc(F)cc1-c1ccnc2[nH]c([C@@H]3CCCNC3)cc12"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311302"	"UO_0000065"	"24.04"	"0.45"	"3.98"	"15.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663749"	""	"None"	"347.46"	"0"	"4.58"	"BDBM167523"	"COc1ccc(C2CC2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'='"	"4700.0"	"nM"	"5.33"	""	"311305"	"UO_0000065"	"15.33"	"0.28"	"0.75"	"10.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663752"	""	"None"	"367.42"	"0"	"4.10"	"BDBM167526"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN(C(C)=O)C3)cc12"	"IC50"	"'='"	"320.0"	"nM"	"6.50"	""	"311308"	"UO_0000065"	"17.68"	"0.33"	"2.39"	"11.16"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668367"	""	"None"	"311.36"	"0"	"3.80"	"BDBM167608"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCCN3)cc12"	"IC50"	"'='"	"580.0"	"nM"	"6.24"	""	"311390"	"UO_0000065"	"20.03"	"0.37"	"2.44"	"12.49"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4788016"	""	"None"	"401.90"	"0"	"3.18"	"13"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"530.0"	"nM"	"6.28"	""	""	"UO_0000065"	"15.62"	"0.31"	"3.10"	"7.06"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3965720"	""	"None"	"427.50"	"0"	"3.96"	"BDBM60456"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CCC(C3)N4S(C)(=O)=O)cc12"	"IC50"	"'='"	"38.0"	"nM"	"7.42"	""	"217636"	"UO_0000065"	"17.36"	"0.34"	"3.46"	"9.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"7.0"	"nM"	"8.15"	""	"327475"	"UO_0000065"	"20.16"	"0.40"	"3.80"	"9.27"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4750372"	""	"None"	"431.92"	"0"	"3.06"	"6-M1"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4O)c(Cl)cn2)C1"	"IC50"	"'='"	"720.0"	"nM"	"6.14"	""	""	"UO_0000065"	"14.22"	"0.28"	"3.08"	"5.63"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4751230"	""	"None"	"399.47"	"0"	"3.05"	"5"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(F)cn2)C1"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	""	"UO_0000065"	"17.52"	"0.33"	"3.95"	"7.87"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3673434"	""	"None"	"385.44"	"0"	"3.53"	"2; AZ5576"	"COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	""	"UO_0000065"	"17.87"	"0.34"	"3.36"	"8.57"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4861217"	""	"None"	"449.53"	"1"	"5.11"	"11"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"64.0"	"nM"	"7.19"	""	""	"UO_0000065"	"16.00"	"0.30"	"2.08"	"9.17"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668473"	""	"None"	"435.93"	"1"	"5.50"	"BDBM167716"	"Fc1cccc(CNc2ccc(Cl)c(-c3ccnc4[nH]c(C5CCCNC5)cc34)n2)c1"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"311497"	"UO_0000065"	"18.57"	"0.36"	"2.60"	"12.34"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663762"	""	"None"	"308.39"	"0"	"3.10"	"BDBM167536"	"COc1cccnc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"31.0"	"nM"	"7.51"	""	"311318"	"UO_0000065"	"24.35"	"0.45"	"4.41"	"11.95"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668414"	""	"None"	"446.00"	"1"	"5.72"	"BDBM167655"	"CN1CCC(c2cc3c(-c4cccc(N(C)Cc5ccccc5Cl)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"69.0"	"nM"	"7.16"	""	"311437"	"UO_0000065"	"16.06"	"0.31"	"1.44"	"14.90"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3694406"	""	"None"	"338.34"	"0"	"2.87"	"BDBM120941"	"COc1ccc(F)cc1-c1cc(NC(=O)Cc2cccnc2)ncn1"	"IC50"	"'='"	"0.015"	"nM"	"10.82"	""	"249040"	"UO_0000065"	"31.99"	"0.59"	"7.95"	"14.06"	"0"	"CHEMBL3706262"	"In Vitro Kinase Inhibition Assays: All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixture was pipetted in four steps in the following order:20 μl of assay buffer (standard buffer),5 μl of ATP solution (in H2O),5 μl of test compound (in 10% DMSO),10 μl of substrate/10 μl of enzyme solution (premixed),The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-Orthovanadate, 1.2 mM DTT, 50 μg/ml PEG20000, 1 μM [-33P]-ATP (approx. 5×1005 cpm per well)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638952"	"37"	"BindingDB Database"	""	"2014"	"None"	""	""	""
"CHEMBL3663791"	""	"None"	"400.50"	"1"	"5.45"	"BDBM167566"	"Fc1ccc(NCc2ccccc2)cc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"49.0"	"nM"	"7.31"	""	"311348"	"UO_0000065"	"18.25"	"0.33"	"1.86"	"13.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668405"	""	"None"	"468.39"	"1"	"5.46"	"BDBM167646"	"CN1CCC(c2cc3c(-c4nc(Nc5nc(N)ccc5Cl)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	"311428"	"UO_0000065"	"12.43"	"0.25"	"0.36"	"6.08"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668408"	""	"None"	"383.42"	"0"	"3.08"	"BDBM167649"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(C(=O)CO)CC3)cc12"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311431"	"UO_0000065"	"19.92"	"0.37"	"4.56"	"9.74"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668546"	""	"None"	"416.46"	"0"	"4.15"	"BDBM167790"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CN(C(=O)CC#N)CC4C3)cc12"	"IC50"	"'='"	"77.0"	"nM"	"7.11"	""	"311571"	"UO_0000065"	"17.08"	"0.31"	"2.96"	"8.67"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL5187219"	""	"None"	"326.37"	"0"	"4.27"	"11"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCOCC3)cc12"	"IC50"	"'='"	"400.0"	"nM"	"6.40"	""	""	"UO_0000065"	"19.60"	"0.36"	"2.13"	"13.57"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5192022"	""	"None"	"432.59"	"1"	"5.41"	"35"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(Cc5cccs5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	""	"UO_0000065"	"18.16"	"0.35"	"2.44"	"14.57"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5169987"	""	"None"	"315.42"	"0"	"4.00"	"50; FIT-039"	"Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1"	"IC50"	"'='"	"5800.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.60"	"0.33"	"1.24"	"18.60"	"1"	"CHEMBL5131669"	"Inhibition of CDK9 (unknown origin) incubated for 2 hrs by measuring remaining ATP"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131375"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 2.0 hr"	"INHIBITOR"	""
"CHEMBL3912866"	""	"None"	"522.45"	"2"	"6.00"	"BDBM180842"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=N)=O)cc(C(F)(F)C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	"327636"	"UO_0000065"	"15.89"	"0.32"	"2.30"	"9.44"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934257"	""	"None"	"448.47"	"1"	"5.02"	"BDBM180846"	"COc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(=N)(=O)C3CC3)c2)ncc1F"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	"327641"	"UO_0000065"	"15.52"	"0.31"	"1.94"	"7.91"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3972796"	""	"None"	"470.53"	"0"	"4.72"	"BDBM180849"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCC4)n2)c1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	"327643"	"UO_0000065"	"17.00"	"0.33"	"3.28"	"7.78"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327523"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4115909"	""	"None"	"None"	"None"	"None"	"BDBM180856"	""	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	"327525"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3949057"	""	"None"	"484.55"	"1"	"5.11"	"BDBM180800"	"CCOC(=O)N=S(C)(=O)Cc1cccc(Nc2ncc(F)c(-c3cccc4c3OCCC4)n2)c1"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	"327594"	"UO_0000065"	"16.21"	"0.32"	"2.74"	"7.64"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3965161"	""	"None"	"404.44"	"0"	"4.35"	"BDBM180797"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"106.0"	"nM"	"6.97"	""	"327601"	"UO_0000065"	"17.25"	"0.34"	"2.62"	"7.93"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668500"	""	"None"	"398.41"	"0"	"3.95"	"BDBM167743"	"CNC(=O)N1CC=C(c2cc3c(-c4cc(F)c(F)cc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	"311524"	"UO_0000065"	"19.17"	"0.36"	"3.69"	"10.87"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663773"	""	"None"	"417.94"	"1"	"5.36"	"BDBM167548"	"Clc1ccc(NCc2ccccc2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311330"	"UO_0000065"	"18.37"	"0.35"	"2.32"	"11.70"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663775"	""	"None"	"418.93"	"0"	"4.75"	"BDBM167550"	"Clc1ccc(NCc2cccnc2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"18.0"	"nM"	"7.75"	""	"311332"	"UO_0000065"	"18.49"	"0.35"	"2.99"	"9.86"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668484"	""	"None"	"418.49"	"1"	"5.59"	"BDBM167727"	"Fc1cccc(CNc2ccc(F)c(-c3ccnc4[nH]c(C5CCCNC5)cc34)c2)c1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	"311508"	"UO_0000065"	"18.35"	"0.34"	"2.09"	"14.56"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668492"	""	"None"	"368.39"	"0"	"3.94"	"BDBM167735"	"CNC(=O)N1CC=C(c2cc3c(-c4cccc(F)c4F)ccnc3[nH]2)CC1"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	"311516"	"UO_0000065"	"19.21"	"0.36"	"3.14"	"11.60"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4562323"	""	"None"	"432.53"	"0"	"3.18"	"15; LDC4297"	"CC(C)c1cnn2c(NCc3ccccc3-n3cccn3)nc(OC3CCCNC3)nc12"	"IC50"	"'='"	"1711.0"	"nM"	"5.77"	""	""	"UO_0000065"	"13.33"	"0.25"	"2.59"	"6.12"	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4648857"	""	"None"	"558.09"	"2"	"5.05"	"57; THZ531"	"CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCC[C@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1"	"IC50"	"'='"	"10500.0"	"nM"	"4.98"	""	""	"UO_0000065"	"8.92"	"0.17"	"-0.07"	"4.69"	"0"	"CHEMBL4613379"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4613207"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL5199065"	""	"None"	"287.41"	"0"	"2.92"	"31; KB-0742"	"CCC(CC)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"28.61"	"0.53"	"5.30"	"12.05"	"1"	"CHEMBL5146295"	"Inhibition of CDK9 (unknown origin) by hotspot kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4865444"	""	"None"	"463.55"	"1"	"5.50"	"20"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCC(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"980.0"	"nM"	"6.01"	""	""	"UO_0000065"	"12.96"	"0.24"	"0.51"	"7.66"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4758996"	""	"None"	"442.57"	"0"	"4.83"	"33"	"CC(C)N1c2cc(Nc3nccc(-c4cccc5c4CCCN5)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"67.0"	"nM"	"7.17"	""	""	"UO_0000065"	"16.21"	"0.30"	"2.34"	"9.78"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4764361"	""	"None"	"430.94"	"0"	"2.68"	"17"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CN(C)CC4)c(Cl)cn2)C1"	"IC50"	"'='"	"800.0"	"nM"	"6.10"	""	""	"UO_0000065"	"14.15"	"0.28"	"3.42"	"6.62"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4765079"	""	"None"	"411.89"	"0"	"3.68"	"11"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc4ccccn34)c(Cl)cn2)C1"	"IC50"	"'='"	"1600.0"	"nM"	"5.80"	""	""	"UO_0000065"	"14.07"	"0.27"	"2.12"	"6.56"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5090676"	""	"None"	"338.40"	"0"	"2.95"	"27"	"Cc1nc(OCc2cncs2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5073598"	""	"None"	"367.36"	"0"	"3.20"	"35"	"Cc1nc(NCc2c(F)cccc2F)c2c(-c3ccnc(N)n3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL4762677"	""	"None"	"438.54"	"1"	"5.02"	"39"	"CC(C)N1c2cc(Nc3nccc(-c4ccnc5ccccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"19.8"	"nM"	"7.70"	""	""	"UO_0000065"	"17.57"	"0.32"	"2.68"	"10.37"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3668527"	""	"None"	"438.50"	"0"	"2.92"	"BDBM167771"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=C[C@@H](CO)N(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"93.0"	"nM"	"7.03"	""	"311552"	"UO_0000065"	"16.04"	"0.30"	"4.11"	"8.61"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3959867"	""	"None"	"436.46"	"0"	"4.88"	"BDBM180832"	"CCOc1cc(F)ccc1-c1nc(Nc2cc(F)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	"327500"	"UO_0000065"	"18.84"	"0.37"	"3.34"	"9.35"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3937866"	""	"None"	"497.45"	"1"	"5.27"	"BDBM180835"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327503"	"UO_0000065"	"16.88"	"0.34"	"3.13"	"8.38"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3655763"	""	"None"	"383.50"	"0"	"3.29"	"BDBM106951"	"CC[C@H](Nc1nc(NCc2ccc(C)nc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"3630.0"	"nM"	"5.44"	""	"226139"	"UO_0000065"	"14.19"	"0.27"	"2.15"	"5.40"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3668457"	""	"None"	"397.45"	"0"	"2.82"	"62; A-1467729"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(CC(O)CO)CC3)cc12"	"IC50"	"'='"	"1.2"	"nM"	"8.92"	""	""	"UO_0000065"	"22.45"	"0.42"	"6.10"	"10.93"	"0"	"CHEMBL4701442"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3663755"	""	"None"	"397.53"	"1"	"5.05"	"BDBM167529"	"CN1CCCC(c2cc3c(-c4cccc(NCc5ccccc5)n4)ccnc3[nH]2)C1"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	"311311"	"UO_0000065"	"17.32"	"0.31"	"1.84"	"12.11"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663788"	""	"None"	"425.96"	"0"	"4.58"	"BDBM167563"	"Clc1ccc(NCC2CCOCC2)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"81.0"	"nM"	"7.09"	""	"311345"	"UO_0000065"	"16.65"	"0.32"	"2.51"	"9.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668507"	""	"None"	"436.49"	"0"	"2.72"	"BDBM167750"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)[C@H]4C[C@@H](O)CN4)CC3)cc12"	"IC50"	"'='"	"56.0"	"nM"	"7.25"	""	"311531"	"UO_0000065"	"16.61"	"0.31"	"4.53"	"8.01"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668513"	""	"None"	"396.47"	"0"	"3.30"	"BDBM167756"	"CNC(=O)CN1CCC(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	"311537"	"UO_0000065"	"18.69"	"0.35"	"4.11"	"10.55"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668539"	""	"None"	"471.55"	"0"	"3.69"	"BDBM167783"	"COCCS(=O)(=O)N1CC2C=C(c3cc4c(-c5cc(F)ccc5OC)ccnc4[nH]3)CC2C1"	"IC50"	"'='"	"78.0"	"nM"	"7.11"	""	"311564"	"UO_0000065"	"15.07"	"0.29"	"3.42"	"8.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668548"	""	"None"	"489.55"	"0"	"3.32"	"BDBM167792"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3=CCN(CC(=O)N4CCC[C@H]4CO)CC3)cc12"	"IC50"	"'='"	"172.0"	"nM"	"6.76"	""	"311573"	"UO_0000065"	"13.82"	"0.26"	"3.44"	"6.41"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668555"	""	"None"	"491.57"	"0"	"3.41"	"BDBM167799"	"COc1ccc(F)cc1-c1c(C#N)cnc2[nH]c(C3CCN(CC(=O)N4CCC[C@H]4CO)CC3)cc12"	"IC50"	"'='"	"78.0"	"nM"	"7.11"	""	"311580"	"UO_0000065"	"14.46"	"0.27"	"3.70"	"6.74"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668558"	""	"None"	"480.52"	"0"	"3.05"	"BDBM167802"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CC4CN(CC(=O)N5CC(O)C5)CC4C3)cc12"	"IC50"	"'='"	"70.0"	"nM"	"7.16"	""	"311583"	"UO_0000065"	"14.89"	"0.28"	"4.10"	"8.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668560"	""	"None"	"462.53"	"0"	"2.92"	"BDBM167804"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC4CN(CC(=O)N5CC(O)C5)CC4C3)cc12"	"IC50"	"'='"	"119.0"	"nM"	"6.92"	""	"311585"	"UO_0000065"	"14.97"	"0.28"	"4.00"	"8.48"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673540"	""	"None"	"437.47"	"1"	"5.12"	"BDBM167858"	"Fc1cccc(CNc2nc(-c3ccnc4[nH]c(C5CCNCC5)cc34)c(F)cc2F)c1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"311639"	"UO_0000065"	"19.88"	"0.37"	"3.58"	"13.25"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3673547"	""	"None"	"438.54"	"0"	"4.56"	"BDBM167865"	"CNC(=O)C1CC=C(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"311646"	"UO_0000065"	"18.15"	"0.33"	"3.40"	"8.33"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668379"	""	"None"	"327.82"	"0"	"3.33"	"BDBM167620"	"Nc1ccc(Cl)c(-c2ccnc3[nH]c(C4CCNCC4)cc23)n1"	"IC50"	"'='"	"180.0"	"nM"	"6.75"	""	"311402"	"UO_0000065"	"20.57"	"0.40"	"3.41"	"8.47"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3668382"	""	"None"	"355.41"	"0"	"3.16"	"BDBM167623"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3CCN(CCO)C3)cc12"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	"311405"	"UO_0000065"	"20.70"	"0.39"	"4.20"	"11.99"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4454044"	""	"None"	"423.57"	"0"	"3.40"	"14; LDC3140"	"CC(C)c1cnn2c(NCc3ccccc3N(C)C)nc(OC3CCN(C)CC3)nc12"	"IC50"	"'='"	"7450.0"	"nM"	"5.13"	""	""	"UO_0000065"	"12.11"	"0.23"	"1.73"	"7.24"	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL5091510"	""	"None"	"337.41"	"0"	"3.55"	"24"	"Cc1nc(OCc2ccsc2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'='"	"1900.0"	"nM"	"5.72"	""	""	"UO_0000065"	"16.96"	"0.33"	"2.17"	"6.38"	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL5088687"	""	"None"	"349.37"	"0"	"3.06"	"36"	"Cc1nc(NCc2ncccc2F)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL4303287"	""	"None"	"566.07"	"2"	"6.33"	"THZ2"	"CN(C)C/C=C/C(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1"	"IC50"	"'='"	"6830.0"	"nM"	"5.17"	""	""	"UO_0000065"	"9.13"	"0.17"	"-1.16"	"4.49"	"0"	"CHEMBL4611863"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4610077"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	""	""
"CHEMBL5181709"	""	"None"	"458.61"	"0"	"4.74"	"20"	"Cc1nc2ccc(-c3ccnc4[nH]c(C5CCN(CC(=O)N(C)C)CC5)cc34)cc2n1C(C)C"	"IC50"	"'='"	"13.0"	"nM"	"7.89"	""	""	"UO_0000065"	"17.20"	"0.32"	"3.15"	"11.26"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4744627"	""	"None"	"587.79"	"2"	"5.06"	"MFH-3-168-1"	"C=CC(=O)N1CCc2cc(S(=O)(=O)N3CCCC(Nc4ncc(SCc5ncc(C(C)(C)C)o5)s4)C3)ccc21"	"IC50"	"'='"	"1570.0"	"nM"	"5.80"	""	""	"UO_0000065"	"9.87"	"0.20"	"0.74"	"5.34"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4756594"	""	"None"	"438.54"	"1"	"5.02"	"37"	"CC(C)N1c2cc(Nc3nccc(-c4cccc5cnccc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"79.8"	"nM"	"7.10"	""	""	"UO_0000065"	"16.19"	"0.29"	"2.08"	"9.56"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4800119"	""	"None"	"452.56"	"1"	"5.32"	"43"	"Cc1cnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)nc1-c1cncc2ccccc12"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	""	"UO_0000065"	"15.47"	"0.28"	"1.68"	"9.43"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3927078"	""	"None"	"480.54"	"1"	"5.92"	"BDBM180799"	"CS(=N)(=O)Cc1cccc(Nc2ncc(F)c(-c3ccc(F)cc3OCc3ccccc3)n2)c1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327602"	"UO_0000065"	"18.10"	"0.35"	"2.78"	"9.89"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327618"	"UO_0000065"	"18.00"	"0.41"	"3.59"	"9.89"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL1965660"	""	"None"	"348.19"	"0"	"3.13"	"SGCV1262, 24809803"	"NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"22.98"	"0.48"	"4.87"	"7.23"	"0"	"CHEMBL2422672"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL2417410"	"1"	"Scientific Literature"	"J Med Chem"	"2013"	"None"	""	""	""
"CHEMBL5092828"	""	"None"	"320.36"	"0"	"3.12"	"32"	"Cc1nc(NCc2ccoc2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5093650"	""	"None"	"366.38"	"0"	"3.80"	"34"	"Cc1nc(NCc2c(F)cccc2F)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL4754326"	""	"None"	"417.51"	"0"	"4.48"	"15"	"COc1cccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)c1"	"IC50"	"'='"	"126.4"	"nM"	"6.90"	""	""	"UO_0000065"	"16.52"	"0.30"	"2.42"	"9.77"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4796617"	""	"None"	"417.51"	"0"	"4.48"	"16"	"COc1ccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)cc1"	"IC50"	"'='"	"31.7"	"nM"	"7.50"	""	""	"UO_0000065"	"17.96"	"0.33"	"3.02"	"10.62"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4755816"	""	"None"	"419.50"	"0"	"4.91"	"24"	"Cc1cc(F)ccc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1"	"IC50"	"'='"	"578.2"	"nM"	"6.24"	""	""	"UO_0000065"	"14.87"	"0.27"	"1.33"	"10.17"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4745398"	""	"None"	"444.58"	"1"	"5.29"	"27"	"CC(C)Nc1cccc(-c2ccnc(Nc3ccc4c(c3)N(C(C)C)[C@H](C)C(=O)N4C)n2)c1"	"IC50"	"'='"	"50.9"	"nM"	"7.29"	""	""	"UO_0000065"	"16.40"	"0.30"	"2.00"	"9.94"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3673434"	""	"None"	"385.44"	"0"	"3.53"	"AZ5576"	"COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	""	"UO_0000065"	"18.21"	"0.34"	"3.49"	"8.74"	"0"	"CHEMBL5224441"	"Inhibition of human CDK9 in human MV4-11 cells assessed as decrease in RNAP2 phosphorylation at Ser2 by western blot analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MV4-11"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5199065"	""	"None"	"287.41"	"0"	"2.92"	"KB-0742"	"CCC(CC)c1cc(N[C@H]2CC[C@H](N)C2)n2nccc2n1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"28.61"	"0.53"	"5.30"	"12.05"	"0"	"CHEMBL5224454"	"Inhibition of CDK9 (unknown origin) incubated for 120 mins in presence of ATP by HotSpot kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	"TIME = 2.0 hr"	"INHIBITOR"	""
"CHEMBL3946675"	""	"None"	"483.34"	"1"	"5.11"	"BDBM180824"	"COc1cc(F)ccc1-c1nc(Nc2cc(Br)cc(CS(C)(=N)=O)c2)ncc1F"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	"327619"	"UO_0000065"	"18.00"	"0.41"	"3.59"	"9.89"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3934141"	""	"None"	"459.48"	"0"	"4.26"	"BDBM180827"	"COc1cc(CS(C)(=O)=NC#N)cc(Nc2ncc(F)c(-c3ccc(F)cc3OC)n2)c1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	"327495"	"UO_0000065"	"18.28"	"0.36"	"4.14"	"7.67"	"0"	"CHEMBL3887262"	"CDK9/CycT1 Kinase Assay: Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchased from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI Peptide Technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL4798156"	""	"None"	"429.95"	"0"	"3.81"	"30"	"CC(=O)N[C@H]1CCC[C@@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"310.0"	"nM"	"6.51"	""	""	"UO_0000065"	"15.14"	"0.30"	"2.70"	"7.32"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4741063"	""	"None"	"395.51"	"0"	"3.16"	"22"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)ccn2)C1"	"IC50"	"'='"	"150.0"	"nM"	"6.82"	""	""	"UO_0000065"	"17.25"	"0.32"	"3.66"	"7.68"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3655771"	""	"None"	"397.53"	"0"	"3.60"	"BDBM106959"	"CC[C@H](Nc1nc(NCc2cc(C)nc(C)c2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"1040.0"	"nM"	"5.98"	""	"226147"	"UO_0000065"	"15.05"	"0.28"	"2.38"	"5.94"	"0"	"CHEMBL3707641"	"Kinase Assay: To evaluate the in-vitro kinase potency of the compounds, they were screened against CDK 2 and CDK9. Kinase assays were performed in 96-well plates using recombinant CDK/cyclins generated at Cyclacel. Ltd Dundee, UK."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3638727"	"37"	"BindingDB Database"	""	"2013"	"None"	""	""	""
"CHEMBL3904602"	"LEROCICLIB"	"3.0"	"474.61"	"0"	"3.50"	"G1T38"	"CC(C)N1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1"	"IC50"	"'='"	"28.0"	"nM"	"7.55"	""	""	"UO_0000065"	"15.91"	"0.29"	"4.05"	"8.28"	"0"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4754399"	""	"None"	"415.93"	"0"	"3.57"	"6"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"16.73"	"0.33"	"3.39"	"7.83"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4552441"	""	"None"	"406.49"	"0"	"2.87"	"16a; VII36"	"CC(C)c1cnn2c(NCc3cccc4[nH]ncc34)nc(OC3CCCNC3)nc12"	"IC50"	"'<'"	"50.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4403344"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4474655"	""	"None"	"362.36"	"0"	"3.20"	"21"	"FC(F)(F)c1cnc(N[C@H]2CCCNC2)nc1-c1n[nH]c2ccccc12"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"21.25"	"0.40"	"4.50"	"9.81"	"0"	"CHEMBL4403354"	"Inhibition of CDK9 (unknown origin) after 4 hrs"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4402527"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2019"	"None"	""	""	""
"CHEMBL4777517"	""	"None"	"433.94"	"0"	"3.07"	"6-M2"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cn[nH]c3CCCCO)c(Cl)cn2)C1"	"IC50"	"'>'"	"2000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL4776271"	""	"None"	"532.74"	"1"	"4.48"	"MFH-2-104-1"	"C=CC(=O)NC1CCN(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)CC1"	"IC50"	"'='"	"182.0"	"nM"	"6.74"	""	""	"UO_0000065"	"12.65"	"0.26"	"2.26"	"6.51"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4755256"	""	"None"	"419.88"	"0"	"4.18"	"44"	"COc1cc(F)ccc1-c1cc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)ncc1Cl"	"IC50"	"'='"	"96.0"	"nM"	"7.02"	""	""	"UO_0000065"	"16.71"	"0.33"	"2.84"	"8.74"	"0"	"CHEMBL4701381"	"Inhibition of CDK9 (unknown origin) assessed as reduction in RNA polymerase2 phosphorylation at serine 2 residue by cell based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4741442"	""	"None"	"402.27"	"0"	"1.42"	"5; ZK-304709"	"C[C@H](CO)Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)ncc1Br"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"20.64"	"0.49"	"6.88"	"6.37"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL14762"	"SELICICLIB"	"2.0"	"354.46"	"0"	"3.20"	"10"	"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1"	"IC50"	"'='"	"230.0"	"nM"	"6.64"	""	""	"UO_0000065"	"18.73"	"0.35"	"3.44"	"7.55"	"1"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4744850"	""	"None"	"618.85"	"2"	"5.04"	"MFH-4-40-1"	"CN(C)C/C=C/C(=O)Nc1ccc(S(=O)(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"474.0"	"nM"	"6.32"	""	""	"UO_0000065"	"10.22"	"0.21"	"1.28"	"5.24"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4753350"	""	"None"	"505.64"	"2"	"5.44"	"MFH-3-110-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCCC(Nc3ncc(/C=C/c4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"15.1"	"nM"	"7.82"	""	""	"UO_0000065"	"15.47"	"0.30"	"2.38"	"7.79"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4797288"	""	"None"	"480.62"	"0"	"4.07"	"MFH-4-10-1"	"C=CC(=O)Nc1ccc(C(=O)N2CCC[C@@H](Nc3ncc(SCc4cncnc4)s3)C2)cc1"	"IC50"	"'='"	"7280.0"	"nM"	"5.14"	""	""	"UO_0000065"	"10.69"	"0.21"	"1.07"	"5.13"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4797409"	""	"None"	"525.70"	"2"	"5.56"	"B15; THZ-CE-B-15"	"C=CC(=O)Nc1cccc(C(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)c1"	"IC50"	"'='"	"198.0"	"nM"	"6.70"	""	""	"UO_0000065"	"12.75"	"0.25"	"1.14"	"6.68"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5207871"	""	"None"	"447.58"	"0"	"3.77"	"39"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCC5)CC4)cc23)ccc1=O"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5209369"	""	"None"	"381.45"	"0"	"4.54"	"10"	"COc1cc(F)ccc1-c1ccnc2[nH]c([C@H]3CC[C@H](NC(C)=O)CC3)cc12"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	""	"UO_0000065"	"18.35"	"0.34"	"2.46"	"10.45"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5204939"	""	"None"	"477.61"	"0"	"3.09"	"29"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(CC5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"4000.0"	"nM"	"5.40"	""	""	"UO_0000065"	"11.30"	"0.21"	"2.31"	"6.47"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5090159"	""	"None"	"336.36"	"0"	"2.79"	"25"	"Cc1nc(OCc2cc(C)on2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5091644"	""	"None"	"338.46"	"0"	"3.80"	"38"	"CCCCc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCCC"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL3673434"	""	"None"	"385.44"	"0"	"3.53"	"AZ5576"	"COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1"	"IC50"	"'<'"	"5.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3960348"	""	"None"	"429.45"	"0"	"4.25"	"BDBM180812"	"COc1cc(F)ccc1-c1nc(Nc2cccc(CS(C)(=O)=NC#N)c2)ncc1F"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	"327608"	"UO_0000065"	"18.53"	"0.36"	"3.71"	"7.94"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3984385"	""	"None"	"547.46"	"2"	"5.91"	"BDBM180841"	"COc1cc(F)ccc1-c1nc(Nc2cc(CS(C)(=O)=NC#N)cc(C(F)(F)C(F)(F)F)c2)ncc1F"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	"327635"	"UO_0000065"	"14.79"	"0.30"	"2.19"	"8.08"	"0"	"CHEMBL3887264"	"CDK9/CycT1 : Recombinant full-length His-tagged human CDK9 and CycT1, expressed in insect cells and purified by Ni-NTA affinity chromatography, were purchase from Invitrogen (Cat. No PV4131). As substrate for the kinase reaction biotinylated peptide biotin-Ttds-YISPLKSPYKISEG (C-terminus in amid form) was used which can be purchased e.g. form the company JERINI peptide technologies (Berlin, Germany) For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of CDK9/CycT1 in aqueous assay buffer [50 mM Tris/HCl pH 8.0, 10 mM MgCl2, 1.0 mM dithiothreitol, 0.1 mM sodium ortho-vanadate, 0.01% (v/v) Nonidet-P40 (Sigma)] were added and the mixture was incubated for 15 min at 22° C. to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction."	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886246"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663797"	""	"None"	"449.96"	"1"	"5.84"	"BDBM167572"	"CN1CCC(c2cc3c(-c4nc(NCc5cccc(F)c5)ccc4Cl)ccnc3[nH]2)CC1"	"IC50"	"'='"	"15.0"	"nM"	"7.82"	""	"311354"	"UO_0000065"	"17.39"	"0.33"	"1.98"	"13.76"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663748"	""	"None"	"375.48"	"0"	"3.06"	"BDBM167522"	"COc1ccc(C2=NCCN2)cc1-c1ccnc2[nH]c(C3CCCNC3)cc12"	"IC50"	"'>'"	"12500.0"	"nM"	""	""	"311304"	"UO_0000065"	""	""	""	""	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL3663767"	""	"None"	"326.38"	"0"	"3.24"	"BDBM167542"	"COc1ccc(F)nc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"77.0"	"nM"	"7.11"	""	"311324"	"UO_0000065"	"21.80"	"0.40"	"3.87"	"11.32"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL5170195"	""	"None"	"417.48"	"0"	"4.88"	"7"	"COc1cc(F)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)cc12"	"IC50"	"'='"	"16.0"	"nM"	"7.80"	""	""	"UO_0000065"	"18.67"	"0.34"	"2.92"	"15.47"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5197170"	""	"None"	"461.61"	"0"	"4.16"	"38"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCCC5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	""	"UO_0000065"	"17.54"	"0.33"	"3.94"	"10.91"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5169987"	""	"None"	"315.42"	"0"	"4.00"	"FIT-039"	"Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1"	"IC50"	"'='"	"5800.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.60"	"0.33"	"1.24"	"18.60"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4560679"	""	"None"	"387.44"	"0"	"3.61"	"BAY-1143572"	"COc1cc(F)ccc1-c1ncnc(Nc2cccc(C[S@@](C)(=N)=O)c2)n1"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"21.22"	"0.42"	"4.61"	"8.15"	"0"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4747227"	""	"None"	"445.95"	"0"	"3.31"	"24-M1"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4O)c(Cl)cn2)C1"	"IC50"	"'='"	"170.0"	"nM"	"6.77"	""	""	"UO_0000065"	"15.18"	"0.30"	"3.46"	"6.20"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4753256"	""	"None"	"415.93"	"0"	"3.42"	"28"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	""	"UO_0000065"	"17.90"	"0.35"	"4.02"	"8.37"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4753076"	""	"None"	"409.53"	"0"	"3.47"	"26"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(C)cn2)C1"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	""	"UO_0000065"	"18.06"	"0.34"	"3.93"	"8.32"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4799201"	""	"None"	"389.89"	"0"	"3.08"	"10"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc(C)n3C)c(Cl)cn2)C1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL3668361"	""	"None"	"323.37"	"0"	"3.75"	"1"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCNCC3)cc12"	"IC50"	"'='"	"14.0"	"nM"	"7.85"	""	""	"UO_0000065"	"24.29"	"0.45"	"4.10"	"15.73"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668374"	""	"None"	"381.41"	"0"	"2.99"	"3"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(C(=O)CO)CC3)cc12"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	""	"UO_0000065"	"19.52"	"0.36"	"4.45"	"9.49"	"1"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL225519"	""	"None"	"213.24"	"0"	"1.36"	"96; PHA-767491"	"O=C1NCCc2[nH]c(-c3ccncc3)cc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"35.02"	"0.64"	"6.11"	"12.93"	"1"	"CHEMBL5227297"	"Inhibition of human CDK9 incubation of 30 mins in presence of ATP"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5226297"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 0.5 hr"	"INHIBITOR"	""
"CHEMBL3668554"	""	"None"	"463.55"	"1"	"5.50"	"14"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"200.0"	"nM"	"6.70"	""	""	"UO_0000065"	"14.45"	"0.27"	"1.20"	"8.54"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL3668361"	""	"None"	"323.37"	"0"	"3.75"	"1"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCNCC3)cc12"	"IC50"	"'='"	"18.0"	"nM"	"7.75"	""	""	"UO_0000065"	"23.95"	"0.44"	"3.99"	"15.51"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL5266005"	""	"None"	"396.50"	"0"	"2.28"	"SCH 727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"0"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4784117"	""	"None"	"415.93"	"0"	"3.42"	"33"	"CC(=O)N[C@@H]1CC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"40.0"	"nM"	"7.40"	""	""	"UO_0000065"	"17.79"	"0.35"	"3.98"	"8.32"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4785242"	""	"None"	"409.53"	"0"	"3.55"	"20"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)CC4)ccn2)C1"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	""	"UO_0000065"	"17.87"	"0.33"	"3.77"	"8.23"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"2; SCH727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"1.0"	"nM"	"9.00"	""	""	"UO_0000065"	"22.70"	"0.42"	"6.72"	"9.72"	"0"	"CHEMBL4841252"	"Inhibition of CDK9 (unknown origin) expressed in Sf9 insect cells using biotinylated peptide derived Histone H1 as substrate incubated for 1 hr in presence of [gamma33P]ATP by liquid scintillation counter method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4840335"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.0 hr"	"INHIBITOR"	""
"CHEMBL4747648"	""	"None"	"441.54"	"0"	"4.35"	"36"	"CC(C)N1c2cc(Nc3nccc(-c4cccc5nn(C)cc45)n3)ccc2N(C)C(=O)[C@H]1C"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"15.76"	"0.29"	"2.61"	"8.79"	"0"	"CHEMBL4728482"	"Inhibition of human CDK9 by mobility shift assay relative to control"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4725348"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4749175"	""	"None"	"429.95"	"0"	"3.81"	"29"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnc4n3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'='"	"36.0"	"nM"	"7.44"	""	""	"UO_0000065"	"17.31"	"0.34"	"3.63"	"8.37"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4758821"	""	"None"	"389.89"	"0"	"3.08"	"7"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn(C)c3C)c(Cl)cn2)C1"	"IC50"	"'='"	"440.0"	"nM"	"6.36"	""	""	"UO_0000065"	"16.30"	"0.32"	"3.28"	"7.15"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"MK7965; SCH727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4346792"	"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of cyclin by [33P]-ATP-based liquid scintillation counting method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4346652"	"1"	"Scientific Literature"	"J Med Chem"	"2019"	"CHEMBL3308860"	""	""	""
"CHEMBL5288241"	""	"None"	"518.58"	"2"	"5.15"	"B2"	"C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cncc(NC[C@@H](O)c5ccccc5)c4)cc23)cc1"	"IC50"	"'='"	"526.0"	"nM"	"6.28"	""	""	"UO_0000065"	"12.11"	"0.22"	"1.13"	"4.76"	"0"	"CHEMBL5238233"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5236590"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4872494"	""	"None"	"395.43"	"0"	"3.99"	"9"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(NCC(=O)O)CC3)cc12"	"IC50"	"'='"	"1500.0"	"nM"	"5.82"	""	""	"UO_0000065"	"14.73"	"0.27"	"1.83"	"6.68"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL3668508"	""	"None"	"437.52"	"1"	"5.01"	"10"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N[C@@H](C(=O)O)C(C)C)CC3)cc12"	"IC50"	"'='"	"370.0"	"nM"	"6.43"	""	""	"UO_0000065"	"14.70"	"0.27"	"1.42"	"7.37"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL4861217"	""	"None"	"449.53"	"1"	"5.11"	"11"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN([C@H]4CC[C@@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"210.0"	"nM"	"6.68"	""	""	"UO_0000065"	"14.86"	"0.28"	"1.57"	"8.51"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"2; SCH727965"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL5253662"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5252533"	"1"	"Scientific Literature"	"J Med Chem"	"2016"	"None"	""	"INHIBITOR"	""
"CHEMBL4530229"	""	"None"	"748.75"	"2"	"4.42"	"45"	"O=C1CCC(N2C(=O)c3cccc(NC(=O)CCCCCCCn4cc(COc5c(O)cc(O)c6c(=O)cc(-c7ccccc7)oc56)nn4)c3C2=O)C(=O)N1"	"IC50"	"'='"	"523.0"	"nM"	"6.28"	""	""	"UO_0000065"	"8.39"	"0.16"	"1.86"	"2.81"	"0"	"CHEMBL5217382"	"Inhibition of CDK9 (unknown origin) incubated for 1 hr by fluorescent polarisation based assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5214967"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 1.0 hr"	"INHIBITOR"	""
"CHEMBL5092245"	""	"None"	"254.29"	"0"	"2.65"	"20"	"COc1nc(C)nc2[nH]cc(-c3ccnc(C)c3)c12"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5092157"	""	"None"	"330.40"	"0"	"3.52"	"29"	"Cc1nc(NCc2ccccc2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL4594423"	"TP-1287"	"1.0"	"481.83"	"0"	"3.07"	"2; TP-1287"	"CN1CC[C@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	""	"UO_0000065"	"14.69"	"0.30"	"4.01"	"5.03"	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL4755256"	""	"None"	"419.88"	"0"	"4.18"	"44"	"COc1cc(F)ccc1-c1cc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)ncc1Cl"	"IC50"	"'<'"	"5.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL4701389"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4699469"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3263773"	""	"None"	"370.43"	"0"	"2.68"	"44; LDC000067"	"COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1"	"IC50"	"'='"	"44.0"	"nM"	"7.36"	""	""	"UO_0000065"	"19.86"	"0.39"	"4.68"	"6.86"	"0"	"CHEMBL5146277"	"Inhibition of recombinant human CDK9 using ULight MBP peptide as substrate incubated for 1 hr in presence of ATP by TR-FRET based LANCE assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 1.0 hr"	"INHIBITOR"	""
"CHEMBL5190816"	""	"None"	"584.70"	"2"	"5.66"	"70; SRX3177"	"CN(C)C(=O)c1cc2cnc(Nc3ccc(-c4csc5c(=O)cc(N6CCOCC6)oc45)cc3)nc2n1C1CCCC1"	"IC50"	"'='"	"2.0"	"nM"	"8.70"	""	""	"UO_0000065"	"14.88"	"0.28"	"3.04"	"8.23"	"0"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3545083"	"RGB-286638"	"1.0"	"545.64"	"1"	"2.42"	"5; RGB-286638"	"COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1"	"IC50"	"'='"	"1.0"	"nM"	"9.00"	""	""	"UO_0000065"	"16.49"	"0.31"	"6.58"	"7.82"	"0"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5171657"	""	"None"	"395.51"	"0"	"3.19"	"7"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(C3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.23"	"0.40"	"5.21"	"9.39"	"0"	"CHEMBL5146290"	"Inhibition of recombinant CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using biotinylated-histone H1 as substrate incubated for 1 hr in presence of 33P-ATP by liquid scintillation counter method"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 1.0 hr"	"INHIBITOR"	""
"CHEMBL3673525"	""	"None"	"441.54"	"0"	"4.15"	"BDBM167843"	"CNC(=O)N1CCC(c2cc3c(-c4cncc(NCc5ccccc5)n4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"35.0"	"nM"	"7.46"	""	"311624"	"UO_0000065"	"16.89"	"0.31"	"3.31"	"7.54"	"0"	"CHEMBL3706310"	"LANCE ULight TR-FRET Kinase Assay: CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3639207"	"37"	"BindingDB Database"	""	"2015"	"None"	""	""	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"8"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5109328"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5107985"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3938690"	""	"None"	"391.45"	"0"	"3.75"	"BDBM223791"	"CNC(=O)N1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"30.0"	"nM"	"7.52"	""	"390893"	"UO_0000065"	"19.22"	"0.35"	"3.77"	"11.71"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3943802"	""	"None"	"450.56"	"0"	"4.84"	"BDBM223800"	"CN1Cc2c(C3CCN(CC(=O)OC(C)(C)C)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"2800.0"	"nM"	"5.55"	""	"390902"	"UO_0000065"	"12.32"	"0.23"	"0.71"	"9.03"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3985017"	""	"None"	"448.54"	"0"	"4.95"	"BDBM223812"	"CC(C)[C@H](NC1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1)C(=O)O"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	"390914"	"UO_0000065"	"15.43"	"0.29"	"1.97"	"8.52"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4846069"	""	"None"	"285.35"	"0"	"2.87"	"Cpd 1"	"COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1"	"IC50"	"'='"	"1080.0"	"nM"	"5.97"	""	""	"UO_0000065"	"20.91"	"0.39"	"3.10"	"8.90"	"1"	"CHEMBL5224491"	"Inhibition of CDK9 in human HCT-116 cells assessed as decrease in substrate phosphorylation using RPB1 as substrate measured after 6 hrs by western blot analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5170524"	""	"None"	"404.51"	"0"	"3.94"	"9"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5197170"	""	"None"	"461.61"	"0"	"4.16"	"38"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCCC5)CC4)cc23)ccc1=O"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5198038"	""	"None"	"421.55"	"0"	"3.24"	"24"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5173492"	""	"None"	"367.42"	"0"	"4.10"	"13"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"84.0"	"nM"	"7.08"	""	""	"UO_0000065"	"19.26"	"0.36"	"2.98"	"12.15"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5195947"	""	"None"	"410.49"	"0"	"3.65"	"18"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"20.03"	"0.37"	"4.57"	"13.38"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5181709"	""	"None"	"458.61"	"0"	"4.74"	"20"	"Cc1nc2ccc(-c3ccnc4[nH]c(C5CCN(CC(=O)N(C)C)CC5)cc34)cc2n1C(C)C"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5198594"	""	"None"	"491.64"	"0"	"3.48"	"30"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(CCC5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"4500.0"	"nM"	"5.35"	""	""	"UO_0000065"	"10.88"	"0.20"	"1.87"	"6.41"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5169733"	""	"None"	"433.56"	"0"	"3.38"	"31"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C5CCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"70.0"	"nM"	"7.16"	""	""	"UO_0000065"	"16.50"	"0.31"	"3.77"	"9.64"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5177440"	""	"None"	"407.52"	"0"	"2.90"	"34"	"CNC(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C(C)C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"19.63"	"0.36"	"5.10"	"9.64"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5191725"	""	"None"	"336.44"	"0"	"3.44"	"40"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCNCC4)cc23)ccc1=O"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5173492"	""	"None"	"367.42"	"0"	"4.10"	"13"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"340.0"	"nM"	"6.47"	""	""	"UO_0000065"	"17.61"	"0.33"	"2.37"	"11.11"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3663770"	""	"None"	"339.41"	"0"	"4.19"	"15"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"71.0"	"nM"	"7.15"	""	""	"UO_0000065"	"21.06"	"0.39"	"2.96"	"17.37"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5175957"	""	"None"	"423.52"	"0"	"2.20"	"22"	"COc1cc(=O)n(C)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL5198594"	""	"None"	"491.64"	"0"	"3.48"	"30"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(CCC5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL5200778"	""	"None"	"400.47"	"0"	"4.42"	"36"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(F)F)CC4)cc23)ccc1=O"	"IC50"	"'='"	"110.0"	"nM"	"6.96"	""	""	"UO_0000065"	"17.38"	"0.33"	"2.54"	"12.91"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3905910"	"VORUCICLIB"	"2.0"	"469.84"	"0"	"4.32"	"P1446A-05"	"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccc(C(F)(F)F)cc4Cl)oc23)[C@@H]1CO"	"IC50"	"'='"	"1.7"	"nM"	"8.77"	""	""	"UO_0000065"	"18.66"	"0.37"	"4.45"	"9.32"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5273925"	""	"None"	"380.54"	"0"	"3.66"	"SNS-032"	"CC(C)(C)c1coc(CSc2cnc(NC(=O)C3CCNCC3)s2)n1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"22.07"	"0.46"	"4.74"	"10.49"	"0"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3263773"	""	"None"	"370.43"	"0"	"2.68"	"LDC000067"	"COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"22.41"	"0.44"	"5.62"	"7.74"	"0"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5192139"	""	"None"	"326.38"	"0"	"3.24"	"5"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)nc12"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	""	"UO_0000065"	"22.20"	"0.41"	"4.00"	"11.53"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5173041"	""	"None"	"497.60"	"0"	"4.37"	"4"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc12"	"IC50"	"'='"	"9.0"	"nM"	"8.05"	""	""	"UO_0000065"	"16.17"	"0.30"	"3.68"	"9.63"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5180640"	""	"None"	"369.44"	"0"	"3.55"	"16"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(CCO)CC3)cc12"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL3663760"	""	"None"	"325.39"	"0"	"3.84"	"8"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5201044"	""	"None"	"467.57"	"0"	"4.36"	"2"	"O=C(c1ccc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)cc1)N1CCCC1"	"IC50"	"'='"	"4900.0"	"nM"	"5.31"	""	""	"UO_0000065"	"11.36"	"0.21"	"0.95"	"7.14"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5198372"	""	"None"	"453.61"	"0"	"3.02"	"27"	"CSCCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	""	"UO_0000065"	"17.55"	"0.34"	"4.94"	"10.72"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5170195"	""	"None"	"417.48"	"0"	"4.88"	"7"	"COc1cc(F)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)cc12"	"IC50"	"'='"	"140.0"	"nM"	"6.85"	""	""	"UO_0000065"	"16.42"	"0.30"	"1.97"	"13.60"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5207146"	""	"None"	"446.55"	"0"	"4.20"	"14"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCN(C(C)=O)CC3)cc12"	"IC50"	"'='"	"410.0"	"nM"	"6.39"	""	""	"UO_0000065"	"14.30"	"0.26"	"2.19"	"8.13"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"11; L86-8275, HMR1275"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"19.91"	"0.39"	"4.70"	"8.50"	"0"	"CHEMBL5131646"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131375"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5180640"	""	"None"	"369.44"	"0"	"3.55"	"16"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(CCO)CC3)cc12"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	""	"UO_0000065"	"19.89"	"0.37"	"3.80"	"11.97"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5176464"	""	"None"	"407.52"	"0"	"2.68"	"23"	"CCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"1000.0"	"nM"	"6.00"	""	""	"UO_0000065"	"14.72"	"0.27"	"3.32"	"8.08"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5203694"	""	"None"	"435.57"	"0"	"3.32"	"25"	"CC(C)Cn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"560.0"	"nM"	"6.25"	""	""	"UO_0000065"	"14.35"	"0.27"	"2.93"	"8.42"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5197170"	""	"None"	"461.61"	"0"	"4.16"	"38"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCCC5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	""	"UO_0000065"	"15.69"	"0.29"	"3.08"	"9.76"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL1496098"	""	"None"	"277.28"	"0"	"2.65"	"Indirubin-3'-monoxime"	"O=C1Nc2ccccc2/C1=C1\Nc2ccccc2\C1=N/O"	"IC50"	""	""	""	""	""	"Not Determined"	""	""	""	""	""	"0"	"CHEMBL5033649"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5032523"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2021"	"None"	""	""	""
"CHEMBL5188909"	""	"None"	"470.53"	"0"	"3.92"	"7; CDK-IN-3"	"CC(C)n1cnc2c(NCc3nc4ccc(F)c(F)c4[nH]3)nc(N3CCCC[C@H]3CCO)nc21"	"IC50"	"'='"	"9090.0"	"nM"	"5.04"	""	""	"UO_0000065"	"10.71"	"0.20"	"1.12"	"4.68"	"0"	"CHEMBL5109322"	"Inhibition of CDK9 (unknown origin) in presence of high ATP"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5107985"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5084166"	""	"None"	"454.33"	"0"	"3.59"	"58"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C[C@@H](C)Oc1cccc(Br)n1"	"IC50"	"'='"	"467.0"	"nM"	"6.33"	""	""	"UO_0000065"	"13.93"	"0.30"	"2.74"	"5.38"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4874984"	""	"None"	"463.55"	"1"	"5.36"	"21"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(C4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	""	"UO_0000065"	"14.66"	"0.27"	"1.44"	"8.66"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4857987"	""	"None"	"457.51"	"1"	"5.30"	"22"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCN(c4ccc(CC(=O)O)cc4)CC3)cc12"	"IC50"	"'='"	"75.0"	"nM"	"7.12"	""	""	"UO_0000065"	"15.57"	"0.29"	"1.82"	"9.08"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4849746"	""	"None"	"464.54"	"0"	"4.02"	"24"	"COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CCC(N4CCN(CC(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	""	"UO_0000065"	"14.82"	"0.28"	"2.87"	"8.43"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4850143"	""	"None"	"474.51"	"0"	"3.46"	"8"	"CCOC(=O)NS(=O)(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"210.0"	"nM"	"6.68"	""	""	"UO_0000065"	"14.07"	"0.28"	"3.22"	"5.88"	"0"	"CHEMBL4836673"	"Inhibition of CDK9 in human A-431 cells assessed as reduction in RNA polymerase2 phosphorylation at C-terminal ser2 residue incubated for 4 hrs by In-cell Western analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"A-431"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 4.0 hr"	"INHIBITOR"	""
"CHEMBL5169987"	""	"None"	"315.42"	"0"	"4.00"	"50; FIT-039"	"Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1"	"IC50"	"'='"	"5800.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.60"	"0.33"	"1.24"	"18.60"	"1"	"CHEMBL5131985"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131376"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5275774"	""	"None"	"361.32"	"0"	"2.15"	"49b"	"O=C1N=NC(=O)/C(=C\Nc2ccc(-c3nc4ncccc4[nH]3)cc2)C(=O)N1"	"IC50"	"'='"	"500.0"	"nM"	"6.30"	""	""	"UO_0000065"	"17.44"	"0.32"	"4.15"	"4.45"	"0"	"CHEMBL5230772"	"Inhibition of CDK9 (unknown origin) using TMB as substrate by spectrophotometric analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL5170195"	""	"None"	"417.48"	"0"	"4.88"	"7"	"COc1cc(F)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)cc12"	"IC50"	"'<'"	"3.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4750648"	""	"None"	"416.91"	"0"	"3.05"	"18"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3NCCC4)c(Cl)cn2)C1"	"IC50"	"'='"	"860.0"	"nM"	"6.07"	""	""	"UO_0000065"	"14.55"	"0.29"	"3.02"	"6.01"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4759053"	""	"None"	"411.89"	"0"	"3.68"	"8"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4ccccc34)c(Cl)cn2)C1"	"IC50"	"'='"	"140.0"	"nM"	"6.85"	""	""	"UO_0000065"	"16.64"	"0.32"	"3.17"	"7.75"	"0"	"CHEMBL4678925"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA Polymerase 2 CTD phosphorylation at Ser2 residues measured after 6 hrs by immunofluorescence assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4673352"	"1"	"Scientific Literature"	"J Med Chem"	"2020"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL296468"	"BMS-387032"	"1.0"	"380.54"	"0"	"3.66"	"EUB0000694a"	"CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"22.07"	"0.46"	"4.74"	"10.49"	"1"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"Flavopiridol"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL3673434"	""	"None"	"385.44"	"0"	"3.53"	"AZ5576"	"COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"21.54"	"0.40"	"4.77"	"10.33"	"0"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5203694"	""	"None"	"435.57"	"0"	"3.32"	"25"	"CC(C)Cn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"260.0"	"nM"	"6.58"	""	""	"UO_0000065"	"15.12"	"0.28"	"3.27"	"8.87"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5177440"	""	"None"	"407.52"	"0"	"2.90"	"34"	"CNC(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C(C)C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"94.0"	"nM"	"7.03"	""	""	"UO_0000065"	"17.24"	"0.32"	"4.13"	"8.46"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5191725"	""	"None"	"336.44"	"0"	"3.44"	"40"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCNCC4)cc23)ccc1=O"	"IC50"	"'='"	"120.0"	"nM"	"6.92"	""	""	"UO_0000065"	"20.57"	"0.38"	"3.48"	"11.04"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5082044"	""	"None"	"336.42"	"0"	"3.58"	"30"	"Cc1nc(NCc2cccs2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5078833"	""	"None"	"345.36"	"0"	"3.31"	"37"	"Cc1nc(-c2ccc3c(c2)OCO3)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5083159"	""	"None"	"336.42"	"0"	"3.58"	"31"	"Cc1nc(NCc2ccsc2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5207813"	""	"None"	"393.49"	"0"	"2.20"	"21"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"20.33"	"0.38"	"5.80"	"10.78"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4450322"	""	"None"	"515.62"	"1"	"3.85"	"39; YKL-5-124"	"C=CC(=O)Nc1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)cc1"	"IC50"	"'='"	"3020.0"	"nM"	"5.52"	""	""	"UO_0000065"	"10.71"	"0.20"	"1.67"	"4.51"	"0"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5082456"	""	"None"	"296.38"	"0"	"2.77"	"36"	"CCCCn1c(C)nc2ccc(-c3cc(N)nc(N)c3)nc21"	"IC50"	"'='"	"1244.0"	"nM"	"5.91"	""	""	"UO_0000065"	"19.92"	"0.37"	"3.14"	"6.17"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5080497"	""	"None"	"350.35"	"0"	"3.31"	"49"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCCC(F)(F)F"	"IC50"	"'='"	"1407.0"	"nM"	"5.85"	""	""	"UO_0000065"	"16.70"	"0.32"	"2.54"	"6.12"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5092833"	""	"None"	"375.44"	"0"	"2.83"	"54"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C[C@@H](C)Oc1ccccn1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL5192139"	""	"None"	"326.38"	"0"	"3.24"	"5"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCNCC3)nc12"	"IC50"	"'='"	"4700.0"	"nM"	"5.33"	""	""	"UO_0000065"	"16.32"	"0.30"	"2.09"	"8.48"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5207871"	""	"None"	"447.58"	"0"	"3.77"	"39"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCC5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"18.37"	"0.34"	"4.45"	"11.08"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5199352"	""	"None"	"405.50"	"0"	"4.37"	"12"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCOCC3)cc12"	"IC50"	"'='"	"57.0"	"nM"	"7.24"	""	""	"UO_0000065"	"17.86"	"0.33"	"2.87"	"10.74"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5175957"	""	"None"	"423.52"	"0"	"2.20"	"22"	"COc1cc(=O)n(C)cc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"30000.0"	"nM"	"4.52"	""	""	"UO_0000065"	"10.68"	"0.20"	"2.32"	"5.42"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5195947"	""	"None"	"410.49"	"0"	"3.65"	"18"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(CC(=O)N(C)C)CC3)cc12"	"IC50"	"'='"	"32.0"	"nM"	"7.50"	""	""	"UO_0000065"	"18.26"	"0.34"	"3.84"	"12.19"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5287103"	""	"None"	"361.32"	"0"	"2.15"	"VI"	"O=C1N=NC(=O)/C(=C/Nc2ccc(-c3nc4ncccc4[nH]3)cc2)C(=O)N1"	"IC50"	"'='"	"500.0"	"nM"	"6.30"	""	""	"UO_0000065"	"17.44"	"0.32"	"4.15"	"4.45"	"0"	"CHEMBL5224487"	"Inhibition of CDK9 (unknown origin) using TMB as substrate by ELISA"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4297488"	"CT-7001"	"2.0"	"394.52"	"0"	"2.85"	"20; CT7001"	"CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12"	"IC50"	"'='"	"1200.0"	"nM"	"5.92"	""	""	"UO_0000065"	"15.01"	"0.28"	"3.07"	"6.84"	"1"	"CHEMBL5146294"	"Inhibition of CDK9 (unknown origin) using YSPTSPSYSPTSPSYSPTSPS peptide as substrate in presence of ATP by luciferase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5187219"	""	"None"	"326.37"	"0"	"4.27"	"11"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCOCC3)cc12"	"IC50"	"'='"	"1100.0"	"nM"	"5.96"	""	""	"UO_0000065"	"18.26"	"0.34"	"1.69"	"12.64"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5192909"	""	"None"	"463.58"	"0"	"3.01"	"28"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL5204939"	""	"None"	"477.61"	"0"	"3.09"	"29"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(CC5CCOCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	""	""
"CHEMBL16171"	"WOGONIN"	"None"	"284.27"	"0"	"2.88"	"Wogonin"	"COc1c(O)cc(O)c2c(=O)cc(-c3ccccc3)oc12"	"IC50"	"'='"	"190.0"	"nM"	"6.72"	""	""	"UO_0000065"	"23.64"	"0.44"	"3.84"	"8.41"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL2103840"	"DINACICLIB"	"3.0"	"396.50"	"0"	"2.28"	"Dinaciclib"	"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"21.18"	"0.40"	"6.12"	"9.07"	"1"	"CHEMBL4124403"	"Inhibition of CDK9 (unknown origin) expressed in baculovirus infected Sf9 insect cells using histone H1 as substrate after 1 hr by liquid scintillation counting analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"Sf9"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4118232"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2018"	"None"	""	""	""
"CHEMBL1922219"	""	"None"	"369.47"	"0"	"2.99"	"CCT068127"	"CC[C@H](Nc1nc(NCc2cccnc2)c2ncn(C(C)C)c2n1)[C@@H](C)O"	"IC50"	"'='"	"90.0"	"nM"	"7.05"	""	""	"UO_0000065"	"19.07"	"0.36"	"4.06"	"6.99"	"0"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5092362"	""	"None"	"225.25"	"0"	"2.66"	"10"	"Nc1cc(-c2ccc3occc3c2)cc(N)n1"	"IC50"	"'='"	"41.0"	"nM"	"7.39"	""	""	"UO_0000065"	"32.80"	"0.59"	"4.73"	"9.46"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4756935"	""	"None"	"561.76"	"2"	"5.11"	"MFH-3-151-1"	"C=CC(=O)Nc1ccc(S(=O)(=O)N2CCCC(Nc3ncc(SCc4ncc(C(C)(C)C)o4)s3)C2)cc1"	"IC50"	"'='"	"197.0"	"nM"	"6.71"	""	""	"UO_0000065"	"11.94"	"0.25"	"1.60"	"5.71"	"0"	"CHEMBL4739785"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4739712"	"38"	"Patent Bioactivity Data"	""	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"Alvocidib"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"1"	"CHEMBL4770022"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4765319"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL269538"	"HARMINE"	"1.0"	"212.25"	"0"	"3.03"	"Harmine"	"COc1ccc2c(c1)[nH]c1c(C)nccc12"	"IC50"	"'='"	"720.0"	"nM"	"6.14"	""	""	"UO_0000065"	"28.94"	"0.52"	"3.11"	"16.20"	"0"	"CHEMBL5235537"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5233266"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL5081341"	""	"None"	"255.28"	"0"	"1.92"	"19"	"COc1nc(C)nc2[nH]cc(-c3ccnc(N)c3)c12"	"IC50"	"'='"	"4400.0"	"nM"	"5.36"	""	""	"UO_0000065"	"20.98"	"0.39"	"3.44"	"5.97"	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	"INHIBITOR"	""
"CHEMBL5081888"	""	"None"	"331.38"	"0"	"3.49"	"28"	"Cc1nc(OCc2ccccc2)c2c(-c3ccnc(N)c3)c[nH]c2n1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5034572"	"Inhibition of CDK9 (unknown origin) by TR FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5034005"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	""	""	""
"CHEMBL5181511"	""	"None"	"378.48"	"0"	"3.70"	"37"	"CC(=O)N1CCC(c2cc3c(-c4ccc(=O)n(C(C)C)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"39.0"	"nM"	"7.41"	""	""	"UO_0000065"	"19.58"	"0.36"	"3.71"	"10.44"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5192022"	""	"None"	"432.59"	"1"	"5.41"	"35"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(Cc5cccs5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"23.0"	"nM"	"7.64"	""	""	"UO_0000065"	"17.66"	"0.34"	"2.23"	"14.17"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5094409"	""	"None"	"296.38"	"0"	"2.72"	"39"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C(C)(C)C"	"IC50"	"'='"	"1837.0"	"nM"	"5.74"	""	""	"UO_0000065"	"19.35"	"0.36"	"3.02"	"6.00"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5089294"	""	"None"	"312.38"	"0"	"2.00"	"42"	"COCCCn1c(C)nc2ccc(-c3cc(N)nc(N)c3)nc21"	"IC50"	"'='"	"3027.0"	"nM"	"5.52"	""	""	"UO_0000065"	"17.67"	"0.33"	"3.52"	"5.26"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5077927"	""	"None"	"304.30"	"0"	"2.23"	"47"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CC(F)F"	"IC50"	"'='"	"5692.0"	"nM"	"5.25"	""	""	"UO_0000065"	"17.24"	"0.33"	"3.01"	"5.48"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5072926"	""	"None"	"350.47"	"0"	"3.94"	"43"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCC1CCCCC1"	"IC50"	"'='"	"470.0"	"nM"	"6.33"	""	""	"UO_0000065"	"18.06"	"0.33"	"2.39"	"6.62"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5073581"	""	"None"	"348.38"	"0"	"3.15"	"44"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1Cc1ccc(F)cc1"	"IC50"	"'='"	"4575.0"	"nM"	"5.34"	""	""	"UO_0000065"	"15.33"	"0.28"	"2.19"	"5.58"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4442620"	"RONICICLIB"	"2.0"	"430.45"	"0"	"3.96"	"4"	"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"19.28"	"0.39"	"4.34"	"7.67"	"1"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5173041"	""	"None"	"497.60"	"0"	"4.37"	"4"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc12"	"IC50"	"'='"	"990.0"	"nM"	"6.00"	""	""	"UO_0000065"	"12.07"	"0.22"	"1.63"	"7.18"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL225519"	""	"None"	"213.24"	"0"	"1.36"	"51; PHA-767491"	"O=C1NCCc2[nH]c(-c3ccncc3)cc21"	"IC50"	"'='"	"34.0"	"nM"	"7.47"	""	""	"UO_0000065"	"35.02"	"0.64"	"6.11"	"12.93"	"1"	"CHEMBL5131646"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131375"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5169987"	""	"None"	"315.42"	"0"	"4.00"	"50; FIT-039"	"Fc1ccc(N2CCCCC2)c(NC(=S)c2ccncc2)c1"	"IC50"	"'='"	"5800.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.60"	"0.33"	"1.24"	"18.60"	"0"	"CHEMBL5131952"	"Inhibition of Cdk9 (unknown origin) incubated fro 2 hrs by measuring remaining ATP by kinase Glo"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5131376"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	"TIME = 2.0 hr"	"INHIBITOR"	""
"CHEMBL3991935"	""	"None"	"438.31"	"0"	"3.30"	"P276-00"	"CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl"	"IC50"	"'='"	"20.0"	"nM"	"7.70"	""	""	"UO_0000065"	"19.16"	"0.38"	"4.40"	"8.18"	"0"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3940387"	""	"None"	"448.62"	"0"	"4.65"	"LY2857785"	"CC(C)c1c2cc(-c3ccnc(N[C@H]4CC[C@H](NC5CCOCC5)CC4)n3)ccc2nn1C"	"IC50"	"'='"	"11.0"	"nM"	"7.96"	""	""	"UO_0000065"	"17.74"	"0.33"	"3.31"	"10.35"	"0"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5088553"	""	"None"	"254.30"	"0"	"1.50"	"35"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C"	"IC50"	"'='"	"1257.0"	"nM"	"5.90"	""	""	"UO_0000065"	"23.20"	"0.42"	"4.40"	"6.17"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4460561"	""	"None"	"280.34"	"0"	"2.30"	"40"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C1CC1"	"IC50"	"'='"	"2149.0"	"nM"	"5.67"	""	""	"UO_0000065"	"20.22"	"0.37"	"3.37"	"5.93"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL4462530"	"AZD-4573"	"2.0"	"429.95"	"0"	"3.81"	"AZD4573"	"CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1"	"IC50"	"'<'"	"4.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"1"	"CHEMBL5230720"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5230096"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2020"	"None"	""	"INHIBITOR"	""
"CHEMBL3656841"	""	"None"	"513.09"	"1"	"4.88"	"NVP-2"	"COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1"	"IC50"	"'<'"	"0.514"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5224442"	"Inhibition of CDK9 (unknown origin) by Kinomescan method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL428690"	"ALVOCIDIB"	"3.0"	"401.85"	"0"	"3.30"	"Flavopiridol"	"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1"	"IC50"	"'='"	"3.0"	"nM"	"8.52"	""	""	"UO_0000065"	"21.21"	"0.42"	"5.22"	"9.05"	"1"	"CHEMBL5224411"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4575900"	""	"None"	"374.45"	"0"	"3.43"	"51"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1C[C@@H](C)Oc1ccccc1"	"IC50"	"'>'"	"3000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	""	""
"CHEMBL3979619"	""	"None"	"405.47"	"1"	"5.07"	"BDBM223839"	"CCOC(=O)C1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"400.0"	"nM"	"6.40"	""	"390941"	"UO_0000065"	"15.78"	"0.29"	"1.33"	"10.99"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3908656"	""	"None"	"467.52"	"0"	"3.00"	"BDBM223849"	"CN(CCO)C(=O)CN1CC=C(c2[nH]c3ncc(F)c4c3c2CN(C)c2ccc(F)cc2-4)CC1"	"IC50"	"'='"	"100.0"	"nM"	"7.00"	""	"390951"	"UO_0000065"	"14.97"	"0.28"	"4.00"	"9.25"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3899072"	""	"None"	"465.50"	"0"	"2.75"	"BDBM223850"	"CN1Cc2c(C3=CCN(CC(=O)N4CC(O)C4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"79.0"	"nM"	"7.10"	""	"390952"	"UO_0000065"	"15.26"	"0.29"	"4.35"	"9.38"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3900733"	""	"None"	"392.43"	"0"	"3.49"	"BDBM223890"	"CN1Cc2c(C3=CCCN(CC(=O)O)C3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"240.0"	"nM"	"6.62"	""	"390992"	"UO_0000065"	"16.87"	"0.31"	"3.13"	"9.14"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3944510"	""	"None"	"507.61"	"1"	"2.86"	"BDBM223897"	"CN(CC(O)CO)C(=O)CN1CC=C(c2[nH]c3nccc4c3c2CN(C)c2ccc(F)cc2-4)C(C)(C)C1"	"IC50"	"'='"	"1300.0"	"nM"	"5.89"	""	"390999"	"UO_0000065"	"11.60"	"0.22"	"3.03"	"6.14"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3958069"	""	"None"	"474.58"	"1"	"5.44"	"BDBM223902"	"CN1Cc2c(C3=CCN([C@H]4CC[C@@H](CC(=O)O)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"48.0"	"nM"	"7.32"	""	"391004"	"UO_0000065"	"15.42"	"0.29"	"1.88"	"10.10"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3915400"	""	"None"	"492.57"	"1"	"5.58"	"BDBM223945"	"CN1Cc2c(C3=CCN([C@H]4CC[C@H](CC(=O)O)CC4)CC3)[nH]c3ncc(F)c(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"67.0"	"nM"	"7.17"	""	"391047"	"UO_0000065"	"14.56"	"0.27"	"1.59"	"9.90"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL3920906"	""	"None"	"453.57"	"1"	"5.80"	"BDBM223951"	"CN1Cc2c(C3=CCN(C4CCC(=CC#N)CC4)CC3)[nH]c3nccc(c23)-c2cc(F)ccc21"	"IC50"	"'='"	"45.0"	"nM"	"7.35"	""	"391053"	"UO_0000065"	"16.20"	"0.30"	"1.55"	"12.46"	"0"	"CHEMBL3888351"	"LANCE ULight TR-FRET Kinase Assay : CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were diluted in 100% DMSO then diluted with 1:10 in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. Equal volume of the compound dilutions was added to a final reaction mixture containing LANCE detection buffer (PerkinElmer CR97-100), 100 nM ULight MBP (PerkinElmer TRF0109M), 1000 μM ATP, and CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 1 hour before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer. The reaction was incubated for 1 hour and the signal was read in Envision in TR-FRET mode (excitation at 320 nm and emission at 615/665 nm)."	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL3886673"	"37"	"BindingDB Database"	""	"2016"	"None"	""	""	""
"CHEMBL4846069"	""	"None"	"285.35"	"0"	"2.87"	"Cpd 1"	"COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1"	"IC50"	"'='"	"1080.0"	"nM"	"5.97"	""	""	"UO_0000065"	"20.91"	"0.39"	"3.10"	"8.90"	"1"	"CHEMBL5224490"	"Inhibition of CDK9 in human HCT-116 cells assessed as decrease in substrate phosphorylation using FAK as substrate measured after 6 hrs by western blot analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4754493"	"BTX-A51"	"1.0"	"360.89"	"0"	"3.16"	"BTX-A51"	"Cn1ncc(-c2nc(N[C@H]3CC[C@H](N)CC3)ncc2Cl)c1CC1CC1"	"IC50"	"'='"	"4.0"	"nM"	"8.40"	""	""	"UO_0000065"	"23.27"	"0.46"	"5.24"	"10.29"	"0"	"CHEMBL5224428"	"Binding affinity to CDK9 (unknown origin) by KINOMEscan method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4777981"	""	"None"	"467.52"	"1"	"5.25"	"A-1592668"	"COc1ccc(F)cc1-c1c(F)cnc2[nH]c(C3=CCN([C@H]4CC[C@H](C(=O)O)CC4)CC3)cc12"	"IC50"	"'='"	"2.6"	"nM"	"8.59"	""	""	"UO_0000065"	"18.36"	"0.34"	"3.34"	"10.94"	"1"	"CHEMBL5224480"	"Inhibition of CDK9 (unknown origin) by LANCE ULight TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5083646"	""	"None"	"494.62"	"1"	"6.94"	"ZINC09036109"	"COc1cc(/C=C2\S/C(=N/c3ccc(C)c(C)c3)NC2=O)ccc1OCc1ccc2ccccc2c1"	"IC50"	"'>'"	"10000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5033649"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5032523"	"1"	"Scientific Literature"	"Bioorg Med Chem Lett"	"2021"	"None"	""	""	""
"CHEMBL5171361"	""	"None"	"437.54"	"0"	"2.31"	"26"	"COCCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"1000.0"	"nM"	"6.00"	""	""	"UO_0000065"	"13.71"	"0.26"	"3.69"	"7.19"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL3663770"	""	"None"	"339.41"	"0"	"4.19"	"15"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCN(C)CC3)cc12"	"IC50"	"'='"	"10.0"	"nM"	"8.00"	""	""	"UO_0000065"	"23.57"	"0.44"	"3.81"	"19.44"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5176464"	""	"None"	"407.52"	"0"	"2.68"	"23"	"CCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"330.0"	"nM"	"6.48"	""	""	"UO_0000065"	"15.90"	"0.30"	"3.80"	"8.73"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5198038"	""	"None"	"421.55"	"0"	"3.24"	"24"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"25.0"	"nM"	"7.60"	""	""	"UO_0000065"	"18.03"	"0.33"	"4.36"	"10.24"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5188442"	""	"None"	"418.47"	"0"	"4.27"	"3"	"COc1cc(F)ccc1-c1ccnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc12"	"IC50"	"'='"	"19.0"	"nM"	"7.72"	""	""	"UO_0000065"	"18.45"	"0.34"	"3.45"	"12.20"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5200778"	""	"None"	"400.47"	"0"	"4.42"	"36"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(F)F)CC4)cc23)ccc1=O"	"IC50"	"'='"	"160.0"	"nM"	"6.80"	""	""	"UO_0000065"	"16.97"	"0.32"	"2.38"	"12.60"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5169733"	""	"None"	"433.56"	"0"	"3.38"	"31"	"CN(C)C(=O)CN1CCC(c2cc3c(-c4ccc(=O)n(C5CCC5)c4)ccnc3[nH]2)CC1"	"IC50"	"'='"	"380.0"	"nM"	"6.42"	""	""	"UO_0000065"	"14.81"	"0.27"	"3.04"	"8.65"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5088511"	""	"None"	"360.42"	"0"	"3.05"	"46"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCOc1ccccc1"	"IC50"	"'='"	"1019.0"	"nM"	"5.99"	""	""	"UO_0000065"	"16.62"	"0.30"	"2.94"	"5.71"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5070553"	""	"None"	"322.29"	"0"	"2.53"	"48"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CC(F)(F)F"	"IC50"	"'='"	"5700.0"	"nM"	"5.24"	""	""	"UO_0000065"	"16.27"	"0.31"	"2.71"	"5.48"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL3668485"	""	"None"	"380.42"	"0"	"3.81"	"4"	"CNC(=O)N1CC=C(c2cc3c(-c4cc(F)ccc4OC)ccnc3[nH]2)CC1"	"IC50"	"'='"	"21.0"	"nM"	"7.68"	""	""	"UO_0000065"	"20.18"	"0.37"	"3.87"	"10.93"	"0"	"CHEMBL4836671"	"Inhibition of CDK9 (unknown origin) using Ulight-labeled substrate measured after 1.5 hrs by TR-FRET LANCE method"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL4834469"	"1"	"Scientific Literature"	"ACS Med Chem Lett"	"2021"	"None"	"TIME = 1.5 hr"	"INHIBITOR"	""
"CHEMBL4846069"	""	"None"	"285.35"	"0"	"2.87"	"Cpd 1"	"COc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1"	"IC50"	"'='"	"1080.0"	"nM"	"5.97"	""	""	"UO_0000065"	"20.91"	"0.39"	"3.10"	"8.90"	"1"	"CHEMBL5224489"	"Inhibition of CDK9 in human HCT-116 cells assessed as decrease in substrate phosphorylation using RB as substrate measured after 6 hrs by western blot analysis"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"HCT-116"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5223102"	"1"	"Scientific Literature"	"RSC Med Chem"	"2022"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5191333"	""	"None"	"368.41"	"0"	"3.54"	"6"	"COc1cc(F)ccc1-c1ccnc2[nH]c(C3CCC(NC(C)=O)C3)nc12"	"IC50"	"'='"	"47.0"	"nM"	"7.33"	""	""	"UO_0000065"	"19.89"	"0.37"	"3.79"	"9.17"	"0"	"CHEMBL5098671"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of ATP at Km concentration by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5207871"	""	"None"	"447.58"	"0"	"3.77"	"39"	"CC(C)n1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N5CCCC5)CC4)cc23)ccc1=O"	"IC50"	"'='"	"74.0"	"nM"	"7.13"	""	""	"UO_0000065"	"15.93"	"0.30"	"3.36"	"9.61"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL4589249"	""	"None"	"404.44"	"0"	"4.35"	"32"	"COc1cc(F)ccc1-c1cc(Nc2cc(C[S@](C)(=N)=O)ccn2)ncc1F"	"IC50"	"'='"	"6.0"	"nM"	"8.22"	""	""	"UO_0000065"	"20.33"	"0.40"	"3.87"	"9.35"	"0"	"CHEMBL5037481"	"Inhibition of CDK9 (unknown origin) in high presence of high ATP incubated for 25 min by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5036331"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 0.4167 hr"	"INHIBITOR"	""
"CHEMBL5193291"	""	"None"	"532.65"	"2"	"5.46"	"14; CDK12-IN-2"	"Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)C3CCC(Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O"	"IC50"	"'='"	"16000.0"	"nM"	"4.80"	""	""	"UO_0000065"	"9.00"	"0.16"	"-0.66"	"4.65"	"0"	"CHEMBL5109328"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5107985"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL4442620"	"RONICICLIB"	"2.0"	"430.45"	"0"	"3.96"	"BAY-1000394"	"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F"	"IC50"	"'='"	"5.0"	"nM"	"8.30"	""	""	"UO_0000065"	"19.28"	"0.39"	"4.34"	"7.67"	"1"	"CHEMBL5250746"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5247634"	"1"	"Scientific Literature"	"Eur J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5277470"	""	"None"	"602.70"	"1"	"4.81"	"B9"	"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(C(=O)/C(C#N)=C/c5ccccc5)CC4)cn3)nc2n(C2CCCC2)c1=O"	"IC50"	"'>'"	"1000.0"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"0"	"CHEMBL5256395"	"Covalent inhibition of CDK9 (unknown origin) using histone H1 as substrate incubated for 10 mins in presence of [gamma-32P]ATP by radioactivity based kinase assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5252647"	"1"	"Scientific Literature"	"Bioorg Med Chem"	"2023"	"None"	"TIME = 0.1667 hr"	""	""
"CHEMBL5171361"	""	"None"	"437.54"	"0"	"2.31"	"26"	"COCCn1cc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"130.0"	"nM"	"6.89"	""	""	"UO_0000065"	"15.74"	"0.29"	"4.58"	"8.25"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5209369"	""	"None"	"381.45"	"0"	"4.54"	"10"	"COc1cc(F)ccc1-c1ccnc2[nH]c([C@H]3CC[C@H](NC(C)=O)CC3)cc12"	"IC50"	"'='"	"560.0"	"nM"	"6.25"	""	""	"UO_0000065"	"16.39"	"0.30"	"1.71"	"9.33"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
"CHEMBL5093661"	""	"None"	"395.85"	"0"	"3.09"	"57"	"Cc1nc2ccc(-c3cc(N)nc(N)c3)nc2n1CCOc1cccc(Cl)n1"	"IC50"	"'='"	"222.0"	"nM"	"6.65"	""	""	"UO_0000065"	"16.81"	"0.32"	"3.56"	"5.65"	"0"	"CHEMBL5042807"	"Inhibition of CDK9 (unknown origin) using Ulight-MBP as substrate and ATP as co-substrate incubated for 40 mins and measured after 1 hr by TR-FRET assay"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5042474"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL3656841"	""	"None"	"513.09"	"1"	"4.88"	"45; NVP2"	"COC[C@@H](C)N[C@H]1CC[C@H](Nc2cc(-c3cccc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1"	"IC50"	"'<'"	"0.5"	"nM"	""	""	""	"UO_0000065"	""	""	""	""	"1"	"CHEMBL5146278"	"Inhibition of CDK9 (unknown origin)"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5143610"	"1"	"Scientific Literature"	"J Med Chem"	"2022"	"None"	""	"INHIBITOR"	""
"CHEMBL5204473"	""	"None"	"422.53"	"0"	"2.64"	"32"	"CC(C)n1nc(-c2ccnc3[nH]c(C4CCN(CC(=O)N(C)C)CC4)cc23)ccc1=O"	"IC50"	"'='"	"8.0"	"nM"	"8.10"	""	""	"UO_0000065"	"19.16"	"0.36"	"5.46"	"9.29"	"0"	"CHEMBL5098674"	"Inhibition of CDK9 (unknown origin) using FITC-X-GSRTPMY-NH2 as substrate preincubated for 10 mins followed by substrate addition and measured after 90 mins in the presence of 5 mM ATP by plate reader analysis"	"B"	"BAO_0000357"	"single protein format"	"Homo sapiens"	"None"	"None"	"None"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 1.667 hr"	"INHIBITOR"	""
"CHEMBL5170524"	""	"None"	"404.51"	"0"	"3.94"	"9"	"COc1cc(C(=O)N2CCCC2)ccc1-c1ccnc2[nH]c(C3CCNCC3)cc12"	"IC50"	"'='"	"200.0"	"nM"	"6.70"	""	""	"UO_0000065"	"16.56"	"0.30"	"2.76"	"9.54"	"0"	"CHEMBL5098675"	"Inhibition of CDK9 in human MCF7 cells assessed as reduction in RNA polymerase II phosphorylation at ser2 residue incubated for 6 hrs by fluorescence based assay"	"B"	"BAO_0000219"	"cell-based format"	"Homo sapiens"	"None"	"None"	"MCF7"	"None"	""	""	""	"CHEMBL3116"	"Cyclin-dependent kinase 9"	"Homo sapiens"	"SINGLE PROTEIN"	"CHEMBL5096204"	"1"	"Scientific Literature"	"J Med Chem"	"2021"	"None"	"TIME = 6.0 hr"	"INHIBITOR"	""
